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10 | Introduction 
In this thesis, the focus is on the brain. More specifically, the focus is on 
abnormalities in brain function and brain volume in patients with major 
depressive disorder (MDD) and anxiety disorders as measured using Magnetic 
Resonance Imaging (MRI). The main questions of this thesis are: 1) do MDD 
and anxiety disorders share brain abnormalities that can explain the shared 
symptoms and high comorbidity (i.e., concurrent manifestation)?; 2) should 
MDD with comorbid anxiety disorder be considered a different diagnostic 
category than MDD without comorbid anxiety and anxiety disorders without 
comorbid MDD when considering abnormalities in structure and function of 
regions associated with emotion perception and regulation? Furthermore, we 
will explore whether shared risk factors of both MDD and prevalent anxiety 
disorders are associated with brain abnormalities, abnormalities that may give 
insight in the aetiology of the disorders. 
CLINICAL CHARACTERISTICS
MDD is among the most prevalent and disabling psychiatric disorders in adult 
age and is in the top-10 of diseases with the largest global disease burden (Blair 
et al., 2008; Lopez, Mathers, Ezzati, Jamison, & Murray, 2006). Symptoms of 
MDD include a persistent low or sad mood, a diminished capacity to experience 
pleasure, difficulties in eating and sleeping, and concentration problems. A 
diagnosis of MDD or any other mental disorder, except for posttraumatic stress 
disorder, is solely based on the presented symptoms. Aetiological or biological 
factors including a positive family history of depression and anxiety, genetics, 
adverse life events, and childhood trauma are not considered in the process 
of diagnostics. Nevertheless, these factors have been recognized to play an 
important role in the aetiology of MDD (Belmaker & Agam, 2008). Appendix 1 
lists the diagnostic criteria of MDD according to the Diagnostic and Statistical 
Manual of mental disorders (DSM) version IV. 
About 20-30% of the male population and 30-40% of the female population 
in western countries will experience at least one episode of MDD (Kruijshaar et 
al., 2005). At any point in time, four to ten percent of the population will suffer 
within one year from a major depressive episode that will typically last 24 weeks 
(Kruijshaar et al., 2005). Also, risk of recurrence is high, and most strongly 
predicted by illness severity and comorbidity of (social) anxiety disorders 
(Melartin et al., 2004). In the outpatient setting, approximately one-third will 
recover from MDD, whereas two-third of the MDD patients will experience 
at least one more episode of MDD within 5 years (Holma, Holma, Melartin, 
Rytsala, & Isometsa, 2008). MDD is associated with increased mortality rates, 
illness costs, and loss of productivity (Cassano & Fava, 2002). 
Ten to 30% of those who suffer from MDD also meet criteria for an anxiety 
disorder, such as social anxiety disorder, panic disorder, and generalized anxiety 
disorder (Gorman, 1996; Gorman & Coplan, 1996; Ressler & Mayberg, 2007). 
Panic disorder is characterized by an excessive fear for panic attacks, social 
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anxiety disorder by extensive fear for social situations, and generalized anxiety 
disorder by excessive general worrying. Diagnostic criteria for these anxiety 
disorders are listed in detail in Appendix 1. Prevalence of anxiety disorders is 
also high, with a mean life-time prevalence of 28% (Ressler & Mayberg, 2007). 
The economic burden of anxiety disorders is comparable to that of MDD 
in terms of loss of productivity, quality of life decrement, and medical care 
utilization (Hoffman, Dukes, & Wittchen, 2008). 
Approximately 50% of persons who suffer from an anxiety disorder will 
suffer from at least one major depressive episode in their lives (Gorman, 1996), 
although comorbidity figures vary between 20% and 90%. The comorbid 
condition of depression and anxiety disorders has been associated with more 
severe psychopathology (Kessler, Chiu, Demler, & Walters, 2005; Roy-Byrne 
et al., 2000; Rush et al., 2005), increased disability (Gorman, 1996), and worse 
outcome compared with patients with only a diagnosis of MDD or anxiety 
disorders (Bruce et al., 2005; Gorman, 1996; Gorman & Coplan, 1996; Melartin 
et al., 2004; Roy-Byrne et al., 2000; Rush et al., 2005). Because of these 
differences, it has been suggested that MDD with comorbid anxiety disorders 
and MDD without comorbid anxiety disorders should be considered as different 
diagnostic groups (Penninx et al., 2010). At the same time, MDD and anxiety 
disorders might share a common neurobiological pathology. This is suggested 
because of their high comorbidity, but also because patients with MDD and 
anxiety disorders tend to respond to the same treatment strategies such as 
treatment with Selective Serotonin Reuptake Inhibitors (SSRIs )1 and cognitive 
behavioral therapy2  (Ressler & Mayberg, 2007). Furthermore, MDD and 
anxiety disorders show overlap in symptoms, such as restlessness, irritability, 
feelings of rejection, dysphoria, sleep and appetite disturbances, increased self-
consciousness, and oversensitivity to criticism (Gorman, 1996). Both MDD and 
anxiety disorders are associated with increased vulnerability to psychosocial 
stress, as reflected by an abnormal cortisol response of the hypothalamus-
pituitary-adrenal (HPA)-axis3  (Veen et al., 2009; Vreeburg et al., 2009; Vreeburg 
et al., 2010), although findings have been inconsistent (Chida & Steptoe, 2009). 
Also, MDD and anxiety disorders are associated with common risk factors, 
including neuroticism, a positive family history of depression and anxiety, 
childhood trauma, and aversive life events (Spinhoven et al., 2010; Warner, 
Mufson, & Weissman, 1995; Weinstock & Whisman, 2006). These shared risk 
factors also suggest a shared aetiology in MDD and anxiety disorders. 
DIAGNOSTIC CLASSIFICATION
The discussion whether MDD and anxiety disorders should be considered 
separate diagnostic categories with specific phenomenological and 
neurobiological characterizations, or should be considered different 
manifestations of the same disorder is not new. Since the late 1960’s researchers 
attempted to find shared and unique phenomenological, treatment, course and 
outcome characteristics of MDD, anxiety disorders, and comorbid depression-
1 Since the 1950’s, successful 
treatment of MDD with tri-
cyclic medication led to the 
monoamine hypothesis of 
MDD and anxiety disorders. 
This hypothesis predicts that 
MDD and anxiety disorders 
are characterized by deficient 
monoaminergic transmission. 
Nowadays, selective seroton-
in reuptake inhibitors (SSRIs) 
and to a lesser extent selec-
tive noradrenalin reuptake 
inhibitors (SNRIs) are adminis-
tered. These medications pro-
duce fewer side effects than 
the older tricyclic medication. 
SSRIs and SNRIs primarily act 
by preventing uptake of the 
monoamines by the pre-syn-
aptic receptors, thereby pro-
moting uptake of the agents 
by the post-synaptic recep-
tors. However, up to 60% of 
patients may not achieve a 
sufficient response (Ressler & 
Mayberg, 2007).
2 Cognitive behavioral thera-
py is based on the hypothesis 
that MDD and anxiety disor-
ders are in part the product of 
a maladaptive set of depres-
sive or anxious cognitions. In 
cognitive-behavioral therapy, 
these cognitions are chal-
lenged and exchanged for 
more adaptive cognitions and 
behavior. 
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anxiety (Stavrakaki & Vargo, 1986). A problem in psychiatric classification 
is that psychiatric disorders are not discrete biomedical entities with clear 
phenotypic boundaries.  Consequently, classification of psychiatric disorders is 
not stable and subject to ongoing discussion between scientist and clinicians. 
For instance, before 1994, the year that version IV of the DSM was published, 
symptomatology of panic disorder and generalized anxiety disorder was 
considered as one entity and referred to as anxiety neurosis. In contrast, 
generalized anxiety disorders is currently considered a separate disorder that 
is principally related to MDD owing to the large overlap in symptomatology.
It has also been suggested that MDD and anxiety disorders should be 
characterized along one continuum from anxiety to depression (Stavrakaki & 
Vargo, 1986). Such an approach could explain the overlapping symptomatology 
and the high ‘turn-over’ rate, that is the ‘replacement’ of a primary diagnosis 
of an anxiety disorder with a primary diagnosis of MDD over the course of the 
disease. Models including more than one continuum have been proposed as 
well (Clark & Watson, 1991; Goldberg, 2000; Wardenaar et al., 2010a; Wardenaar 
et al., 2010b), including dimensions of general distress, physiological or anxious 
arousal, anhedonia/lack of positive affect, mood and cognition/negative affect, 
and sleep. 
Such dimensional approaches have the advantage of avoiding problems 
associated with a categorical classification, especially when studying biological 
factors associated with MDD and anxiety disorders. Describing patients 
along dimensions of depression and anxiety symptomatology avoids artificial 
comorbidity that may arise owing to the large overlap in symptoms. Next, no 
strict dichotomy between healthy and ill is needed, and subsyndromal levels of 
depressed and/or anxious symptoms are not systematically overlooked. Finally, 
the use of a categorical disorder classification system to describe patients leads 
to high levels of heterogeneity within diagnostic classes: e.g. in MDD, patients 
receive the same diagnosis even if they only overlap on one of nine symptoms. 
For the forthcoming version of the DSM, version V, it has been proposed 
to include a dimensional characterization of mood and anxiety symptoms 
next to the categorical classification for the diagnosis of mood and anxiety 
disorders. Such an approach may fill the gap between clinicians and scientist 
in an attempt to further identify and acknowledge the shared and unique 
phenomenological and neurobiological characteristics of various psychiatric 
disorders. Importantly, taking into account aetiological factors (e.g., childhood 
trauma, negative life events, family history), psychological factors (e.g., 
personality factors, dysfunctional cognitive schemas), and laboratory findings 
(e.g. neuroimaging findings, genetics, stress hormone measurements) could 
have implications for the psychiatric nomenclature (Rounsaville et al., 2002). 
Considering information on aetiology, symptomatology, and neurobiology 
could help answer the question of how to regard MDD and prevalent anxiety 
disorders: consider the symptomatology as manifestations of the same 
disorder, classify the disorders as distinct diagnostic groups, or characterize
1 
3 The HPA-axis is the body’s 
primary stress-response and 
feed-back system. Cortisol, a 
glucocorticoid, is the primary 
human stress hormone that 
is synthesized in the adrenal 
glands. Cortisol is the end 
product of a cascade initiated 
by hormones released by the 
hypothalamus. The stress hy-
pothesis of MDD and anxiety 
disorders states that a disrupt-
ed homeostasis of the human 
stress system is at the base of 
the disorder. 
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patients along axes within a multi-dimensional space. However, as of yet, the 
common and disorder specific neurobiological characteristics of MDD and 
prevalent anxiety disorders have not been studied extensively. Also, support for 
the suggestion that MDD with and without comorbid anxiety disorders should 
be considered as different entities, with respect to their neurobiological profile, 
is limited. Moreover, the neurobiological impact of risk factors of depression 
and anxiety disorders has been hardly studied. Importantly, neurobiological 
insights could contribute to the discussion of how to regard MDD, anxiety 
disorders, and the comorbid condition of depression-anxiety. Accurate 
characterization of the disorders is important because the way patients are 
diagnosed has implications for both treatment and prognosis.
NEUROIMAGING
One approach in studying the neurobiological underpinnings of MDD and 
anxiety disorders is to focus on brain morphology and brain functioning. 
Technological developments in the past 30 years have made it possible to 
study the brain in a non-invasive way in vivo. Neuroimaging techniques such as 
Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) 
have contributed enormously to the knowledge of brain structure and function 
in healthy individuals and in psychiatric patients. Using PET, a radioactive tracer 
is injected in the bloodstream. Frequently used tracers are 18F-labeled glucose 
(Fluordeoxyglucose [FDG]) and 15O-labeled water4. Subsequently, distribution 
of the radioactively labeled glucose or water is imaged, giving an estimate of 
energy consumption (glucose metabolism) or perfusion across the brain. MRI 
does not require the administration of a radioactive tracer. Using functional 
(f)MRI, scans are acquired that are sensitive to changes in the ratio of oxygen 
bound to haemoglobin molecules in venous blood. This is called the Blood 
Oxygenation Level Dependency (BOLD) effect, and is reflective of neuronal 
activity (Logothetis, 2002). Using both 15O-PET and BOLD-fMRI, perfusion 
or activity in reaction to certain stimuli or responses are usually compared 
with a chosen baseline, and therefore provide relative measurements. In the 
last 10 years, researchers became increasingly interested in the low frequency 
fluctuations of the BOLD signal. These low frequency fluctuations are used to 
study synchronicity of time courses across the brain, providing an estimate of 
the functional connectivity of separate brain regions. Major advantages of fMRI 
are that scans are acquired without exposure to radiation, and that both the 
spatial and temporal resolution is better than for PET. MRI can also be used 
for structural imaging of brain volume (gray matter, white matter, and cerebro-
spinal fluids), diffusion, and white matter tracts. 
Neuroimaging in MDD 
Up to 2005, brain activation has been studied in MDD predominantly with PET 
during the ‘resting state’, that is when patients are not engaged in a task. From 
1998 on, researchers started using fMRI to study brain activity in MDD using
4 Other nuclear imaging appli-
cations of PET for biochemical 
imaging exist but will not be 
discussed in this thesis.
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various emotional and cognitive tasks. Most consistent metabolism/perfusion 
(PET) and BOLD (fMRI) abnormalities have been observed in the cingulate gyrus, 
dorsolateral prefrontal cortex, orbitofrontal cortex, insula, hippocampus, and 
putamen, although little overlap is found between different activation studies 
(Fitzgerald, Laird, Maller, & Daskalakis, 2008). Emotional processes have been 
most frequently studied in MDD, such as emotional face viewing, emotional 
autobiographical script processing and emotional picture viewing. Such 
emotional paradigms have been used to test the hypothesis of abnormal limbic 
activation to disorder relevant information. Abnormal sensitivity of limbic areas 
might explain the heightened responsiveness to stress and negative emotions 
associated with MDD.  
Cognitive theories of MDD predict that MDD is the product of automatic 
maladaptive thoughts and cognitions (i.e., negative views of the self, the world, 
and the future) and associated selective processing of negative information 
(Beck, 1976). When encountering negative events, only a limited pallet of 
stereotyped ideas is available, further biasing the view of self, the world, and 
the future in a negative way. Such biased information processing towards 
negative information is refered to as the mood-congruent bias, whereas biased 
information processing away from positive information has been refered to 
as the mood-incongruent bias (Beck, 1976; Bower, 1981; Bradley, Mogg, & 
Williams, 1995). These mood-congruent and mood-incongruent processing 
biases may affect memory formation and thereby further affect the course 
of the disorder in a negative way (Elliott, Rubinsztein, Sahakian, & Dolan, 
2002). Also, cognitive abnormalities in depression have been related to deficits 
in effortful processing (Elliott, 1998; Hartlage, Alloy, Vazquez, & Dykman, 
1993). Some researchers have proposed that stressful conditions, including 
depression and anxiety reduces cognitive capacity, resulting in diminished 
available attentional resources (Hasher & Zacks, 1979). Others proposed that 
cognitive capacity in MDD is unaffected, but that attentional resources in a 
depressed state are allocated to depression-relevant thoughts and information. 
This ‘narrowed attention’ is proposed to be the result of the availability of more 
relevant ‘nodes’ to link negative information to or by the incapacity to inhibit 
negative information flow (see Hartlage et al., 1993 for an overview). As a result, 
less attentional resources are available for (external) task-relevant processes. 
In support of these theories, researchers observed abnormal activity of (para)
limbic regions during ‘mood-congruent’ and ‘mood-incongruent’ information 
processing (Epstein et al., 2006; Fossati, Ergis, & Allilaire, 2002; Keedwell, 
Andrew, Williams, Brammer, & Phillips, 2005b; Sheline et al., 2001; Siegle, 
Thompson, Carter, Steinhauer, & Thase, 2007). Next, cognitive processes 
such as selective and sustained attention and executive control  that are often 
reported to be abnormal in MDD (Fossati et al., 2002) have received attention in 
neuroimaging studies. Executive tasks are considered effortful, and therefore 
thought to be affected in MDD (Elliott, 1998). Importantly, these executive 
processes are thought to rely on cortical prefrontal cortex (PFC) regions, such
1 
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as the ventrolateral PFC, dorsolateral PFC, and anterior cingulate cortex 
(ACC) that are also implicated in mood regulation. Therefore researchers 
administered these cognitive tasks to test the functional integrity of these 
regions during non-emotional processes. Abnormal executive performance and 
associated abnormal activity of dorsolateral PFC and ACC regions have been 
observed (Fossati et al., 2002) and support the effortful processing hypothesis 
of depression. However, results have been inconsistent. 
MRI has also been used to study brain morphometry in MDD. Structural 
abnormalities (gray matter volume reductions) in MDD have been most 
consistently found in the ACC and orbitofrontal cortex, and moderate 
volumetric reductions have been observed in the hippocampus, putamen and 
caudate nucleus (Koolschijn, van Haren, Lensvelt-Mulders, Hulshoff Pol, & 
Kahn, 2009). These volumetric abnormalities have been explained in light of the 
abnormal stress and emotion regulation associated with MDD.
Overall, brain imaging studies in MDD often lack an adequate sample size. 
Also, results may have been confounded by the inclusion of MDD patients 
with a variety of comorbid psychiatric disorders including anxiety disorders, 
posttraumatic stress disorder, obsessive compulsive disorder, and attention 
deficit hyperactivity disorder. Also, use of antidepressant medication may have 
confounded the results. Antidepressive drugs such as benzodiazepines, tricyclic 
antidepressants (TCAs), and antipsychotics could influence the cerebral blood 
flow (Matthew et al., 1995; Ngan, Lane, Ruth, & Liddle, 2002) and thereby the 
BOLD signal. In conclusion, imaging studies in MDD patients with adequate 
sample sizes that are able to control for confounding factors including 
psychiatric comorbidity and medication use are rare. 
Neuroimaging in anxiety disorders
The literature on brain function and structure in the highly prevalent anxiety 
disorders panic disorder, social anxiety disorder, and generalized anxiety 
disorder is limited. The less prevalent anxiety disorders posttraumatic stress 
disorder and obsessive-compulsive disorder have been most extensively 
studied. As mentioned earlier, a diagnosis of posttraumatic stress disorders is 
made only in the presence of a traumatic experience in the (near) past. Other 
anxiety disorders are diagnosed solely based on presented symptomatology 
without including aetiological factors in the diagnostic process. Obsessive-
compulsive disorder on the other hand has been characterized by a different 
neurobiological profile compared with other anxiety disorders (Radua, van 
den Heuvel, Surguladze, & Mataix-Cols, 2010; Rounsaville et al., 2002; van 
den Heuvel et al., 2005b). Also, for the new version of the DSM, obsessive 
compulsive disorder has been proposed for possible reclassification in another 
or separate diagnostic category. Therefore, these anxiety disorders and their 
associated neurobiological abnormalities may not be representative of the 
cluster of anxiety disorders at large. 
The focus of activation studies in anxiety disorders has traditionally been on 
16 | Introduction 
5 ‘Ventral’ or ‘inferior’ refers to 
the lower portion of the brain. 
‘Dorsal’ or ‘superior’ refers to 
the top portion of the brain. 
threat perception and fear-conditioning, and hardly any studies focused on 
executive and attentional processes. Overall, generalized anxiety disorder has 
received very limited attention in the field of neuroimaging. In social anxiety 
disorder, emotional paradigms most consistently demonstrated increased 
responsiveness of the amygdala and the insula (Etkin & Wager,  2007). In anxiety 
disorders, studies investigating dorsal involvement in emotional processes 
are limited in number. In one paper normal attentional control and related 
prefrontal activation was reported during non-emotional task in patients with 
panic disorder, but compromised functioning was observed under emotional 
distraction (van den Heuvel et al., 2005b). Overall, few studies have studied 
whether effortful processing is compromised in anxiety disorders as well.
The focus of most structural imaging studies in anxiety disorders has been on 
panic disorder, and researchers reported decreased amygdalar, insular, dorsal 
ACC volume (Asami et al., 2008; Massana et al., 2003; Uchida et al., 2008). A 
recent meta-analysis showed that reduced dorsal ACC and putaminal volume 
are the most consistently observed abnormalities in panic disorder (Radua et 
al., 2010), although considered together with posttraumatic stress disorder. 
Similar to the research in MDD, most studies in anxiety disorders lack sufficient 
sample size and adequate controlling for comorbidity and medication use. 
NEUROANATOMICAL MODELS OF MOOD AND ANXIETY 
DISORDERS
Based on the variety of brain regions associated with abnormal structure or 
function, MDD and anxiety disorders  are not considered disorders of a single 
brain region; Instead, MDD and anxiety disorders are considered the result of 
complex deficient interactions between highly integrated networks of limbic-
cortical regions (Seminowicz et al., 2004). Several neuroanatomical models have 
been proposed in an attempt to explain the variety of symptoms observed in 
MDD including depressed mood, anhedonia, somato-vegetative dysregulation, 
and concentration problems. These models propose that symptoms are based 
on abnormal functioning of both (para)limbic and neocortical brain regions. 
(Para)limbic regions are primarily associated with perception of emotional 
information and the generation of a primary emotional response, whereas the 
neo-cortical regions are mainly associated with cognitive and emotional control. 
(Para)limbic, or ‘ventral’ 5, regions include amongst others the amygdala, insula, 
ventral striatum, thalamus, and subgenual ACC. Dorsolateral PFC, dorsal ACC, 
and dorsomedial PFC are considered ‘dorsal’ regulatory neocortical areas, in the 
context of emotion regulation models.  
In a prominent neuroanatomical model of limbic-cortical dysregulation 
developed by Helen Mayberg in 1997 and updated in 2004 (Seminowicz et al.), 
increased activation of ventral paralimbic regions and decreased activation 
of dorsal neocortical regions are proposed as prominent features of MDD, 
responsible for sad mood. The Mayberg model emphasizes the importance of 
a third ‘emotion-cognition integration component’, including the rostral ACC,
1 
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medial PFC, and orbitofrontal cortex. In his model, the rostral component 
serves as a modulatory hub between ventral ‘autonomic integration’ regions 
(e.g., sub- genual ACC, thalamus) and dorsal ‘sensory-cognitive integration’ 
regions (e.g., dorsolateral PFC, hippocampus) and is implicated in normal mood 
regulation. 
A second neuroanatomical model, developed by Mary Phillips and colleagues 
(2003b) proposes that direct deficient interactions between ‘ventral’ ((para)
limbic) and ‘dorsal’ (neocortical) regions could result in the symptomatology 
of a range of psychiatric disorders such as schizophrenia, bipolar disorder, 
and MDD. This Phillips model predicts that excessive activity of ventral and 
decreased activation of dorsal structures gives rise to the experience of 
inappropriate threat and a decreased range of emotional states. Figure 1 
depicts the models of Mayberg and Phillips combined for the purpose of this 
thesis. 
Although frequently associated with salience detection (See box I), and 
therefore an evident region of interest, the amygdala is not included in every 
model of mood regulation in MDD and in the most consistent functional or 
structural abnormalities reported to date in MDD (Seminowicz et al., 2004). In 
the study of anxiety disorders, disrupted interaction between amygdalar nuclei 
and dorsal PFC structures has been proposed to underlie the symptomatology 
(Etkin, Prater, Hoeft, Menon, & Schatzberg, 2010; Etkin, Prater, Schatzberg, 
Menon, & Greicius, 2009), giving a more central role for the amygdala in the 
pathophysiology of anxiety disorders than in the models of MDD. The model
FIGURE 1:
Graphical representation 
of the combined models of 
Mayberg (1997; Seminowicz 
et al., 2004) and Phillips 
(Phillips, Drevets, Rauch, & 
Lane, 2003b) displayed within 
the contours of the brain, as 
viewed from aside.  In this 
model the orbitofrontal cortex 
(OFC), is depicted in gray, as 
it serves a different role in 
the two models. Finally, the 
hippocampus is also depicted 
in gray, as in both models, 
this structure is considered to 
serve a dorsal regulatory role, 
despite its ventral location. 
In Box I, an overview of 
functions of several ventral 
and dorsal regions and 
their relation with the 
psychopathology in MDD and 
anxiety disorders is presented. 
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 of Mayberg (1997) is primarily proposed for MDD, whereas the model of Phillips 
(2003b) is considered a more general framework for psychiatric disorders, 
such as posttraumatic stress disorder and schizophrenia. To what extent 
these models are applicable to thefunctional and structural neuropathology 
of prevalent anxiety disorders and to comorbid depression-anxiety is barely 
studied. 
AIM OF THE PRESENT STUDY
Most studies performed to date focused either on MDD or on anxiety disorders 
and failed to systematically exclude comorbid psychiatric disorders. Also, 
studies performed to date failed to test for shared and unique characteristics 
in brain function and structure of MDD and anxiety disorders. Importantly, no 
study explicitly studied the comorbid condition of MDD and anxiety disorders 
and compared the neurophysiological profile of this comorbid condition with 
‘singular’ (i.e. without comorbidity) MDD and anxiety. Also, owing to the small 
numbers of participants included in most studies, comorbidity of MDD on the 
correlates of anxiety, and vice versa could not be controlled for. This limited 
power (small sample size) constitutes a further problem, as it has been shown 
that reliable and replicable task effects in fMRI studies are only obtained in 
samples of over approximately 15 persons (Thirion et al., 2007). Small sample 
sizes lead to unreliable results and do not allow one to control for important 
confounders, such as use of antidepressive medication, illness severity, and 
psychiatric comorbidity. The inconsistencies in imaging results reported so far 
could be the result of such factors. 
In addition to including predominantly medicated patients, the inclusion of 
severely ill, hospitalized patients in previous studies may have confounded 
results. Hospitalization may be a very stressful experience itself, which often 
involves change of medication or administration of a sedative drug. Including 
patients who suffer from concentration problems related to the negative side 
effects of hospitalization or use  of psychotropic acting drugs may result in 
activation abnormalities. Subsequently, these abnormalities might be falsely 
attributed to the psychopathology. Also, cognitive dysfunction may be an 
important predictor for hospitalization (Jaeger, Berns, Uzelac, & vis-Conway, 
2006). Therefore, inpatients may be characterized by a distinct symptom- or 
functional impairment profile than outpatients. 
Furthermore, few studies have investigated whether functional and structural 
abnormalities that are observed in the ‘active’ depressed or anxious state 
continue into the remitted phase. PET studies have demonstrated abnormal 
orbitofrontal, ACC and dorsolateral PFC perfusion in the remitted state in MDD 
in a mood provocation paradigm, indicating a functional vulnerability that 
could explain the heightened sensitivity to relapse into another MDD episode. 
Recent evidence exist that those who reach full remission after six weeks of 
SSRI treatment, differ in both brain morphology and cognitive functioning 
from patients who do not reach remission (Li et al., 2010). However, whether 
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such ‘trait’ phenomenon are observed during cognitive and emotional tasks in 
MDD patients, or are observed in patients with remitted anxiety disorders, is 
barely studied. 
In anxiety disorders, studies primarily focused on the signaling function of 
ventral regions in response to negative or threat eliciting stimuli. Dorsal PFC 
involvement during cognitive tasks has hardly been studied in panic disorder, 
and studies on PFC involvement in social anxiety disorder and generalized 
anxiety disorder are virtually absent. Studying fMRI correlates of cognitive tasks 
that depend on intact functioning of dorsal PFC regions such as the dorsolateral 
PFC, dorsal ACC and inferior frontal gyrus is important because of the role these 
regions play in (models of) emotional regulation. 
The studies presented in the current thesis aimed to overcome such limitations 
by studying both cognitive and emotional processes in a large sample of 
outpatients with MDD and anxiety disorders (panic disorder, social anxiety 
disorder, generalized anxiety disorder), and healthy controls. Participants were 
recruited from the Netherlands Study of Depression and Anxiety (NESDA; 
described below), a large-scale, observational study in the outpatient setting. 
This allowed for the inclusion of large numbers of participants and to study 
MDD and anxiety in a ‘real-life’ setting. By including a large sample of patients 
with both MDD and anxiety disorders, the shared and unique correlates in MDD 
and anxiety disorders could be studied. At the same time, this set-up allowed 
to explicitly test for the effect of comorbidity of depression and anxiety, use of 
antidepressant medication, and illness severity. 
THE NETHERLANDS STUDY OF DEPRESSION AND ANXIETY
The Netherlands Study of Depression and Anxiety (NESDA) is a multi-center, 
longitudinal, observational cohort study, that aims to (1) gain insight in the 
long-term prognosis of depression and anxiety disorders in terms of course and 
public health consequences, (2) study depression and anxiety in concert, and (3) 
integrate biological and psychosocial paradigms of mood and anxiety disorders. 
NESDA has been designed to be representative of those with depressive and 
anxiety disorders in different health care settings and stages of developmental 
history. Therefore, the sample is stratified for setting (community, primary 
care and specialized mental health) and set up to include a range of psychiatric 
disorders. NESDA has a focus on MDD, dysthymia, social anxiety disorder, panic 
disorder, and generalized anxiety disorder. Persons diagnosed with a primary 
clinical diagnosis of a psychiatric disorder not subject of NESDA that is likely 
to affect course trajectory, such as posttraumatic stress disorder, personality 
disorders, and obsessive-compulsive disorder, were not included in NESDA.
Amongst the psychosocial and biological measures included in NESDA are: 
Demographic interview, current and life-time psychopathology interview, 
personal history interview (trauma, life events), health consequences interview 
(medication use, loss of productivity, disability), perceived need for care 
questionnaires, current depressive and anxiety state questionnaires, 
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personality measures, worrying,- depressive and anxious cognitions measures, 
health behavior interview (sports, smoking, alcohol, drugs use, sleep), saliva 
sampling for cortisol measures, measures of heart-rhythm variability, and 
genetic measures. For a complete description of the instruments included in 
NESDA, see Penninx et al. (2008). Most important for this thesis is the inclusion 
of functional and structural MRI in NESDA. 
NESDA NEUROIMAGING STUDY
A subsample (n=301; 200 female, age range: 18-57) of the total NESDA sample 
(N=2981) (See Figure 2 for a flow chart and a graphical representation of the MRI 
sample), was invited to participate in the NESDA neuroimaging study between 
October 2004 and April 2007. The NESDA neuroimaging study is a longitudinal 
study that was designed to study cognitive and emotional processes, as well as 
brain structure in MDD and anxiety disorders. In this thesis ‘anxiety disorders’ 
refers to panic disorder, social anxiety disorder and generalized anxiety 
disorder, unless otherwise specified. 
Aims of the NESDA neuroimaging study at large, that include aims beyond 
the scope of this thesis, were to: (I) Study shared and unique neurophysiological 
correlates of MDD and anxiety disorders in an outpatient sample, related to 
basic cognitive processes, emotional processes, ‘resting state’, and variations 
in brain structure; (II) study the comorbid condition of MDD and anxiety disor- 
ders and make a comparison with both MDD and anxiety disorders on measures 
named in (I); (III) describe patients with MDD and anxiety disorders with respect
1 
FIGURE 2: 
NESDA flow-chart. * 
indicates that the subsample 
also includes patients with 
comorbid GAD. Current 
diagnosis refers to a half-year 
diagnosis. All MRI participants 
were selected from the NESDA 
‘current diagnosis’ sample 
and the HC sample. In this 
figure, patients with a current 
diagnosis are not included 
in the ‘life-time’ sample. 
Approximately one-third of 
the included patients used 
anti-depressant medication at 
the time of scanning.
21
to their course, to identify neurophysiological correlates that are associated 
with outcome (recovery, recurrence, development of comorbidity; (IV) 
describe neurophysiological correlates of risk factors of MDD and anxiety 
disorders, including genetic variations; (V) test whether a dimensional model of 
psychopathology for MDD and anxiety disorders (to be developed in NESDA) 
would describe the functional and structural pathophysiology more accurate 
than a categorical classification system (DSM-IV classes). MRI measurements 
were planned at T0 (baseline measurement), T1 (follow up after two years), 
T2 (four or six years after the baseline measurement). Several tasks were 
administered to all participants during functional MRI: A non-emotional visuo-
spatial planning task (Tower of London; ToL), an emotional word encoding and 
recognition task, and an emotional face viewing task. In addition, structural 
imaging for measurement of regional brain volume and white matter integrity 
measurements and functional imaging for ‘resting state’ fMRI was applied to 
study the brain’s intrinsic organization when participants were not engaged 
in a task. Data acquired during execution of the Tower of London visuospatial 
planning task and the word encoding task will be discussed in this thesis, in 
addition to the structural MRI data.
OUTLINE OF THE THESIS
The main objective of this thesis is to describe the common and unique 
functional and structural MRI correlates of MDD and anxiety disorders, while 
explicitly testing for the effects of their comorbidity. The thesis is structured 
into two sections: in SECTION I, the functional and structural MRI correlates of 
a current diagnosis of MDD and/or anxiety disorders are investigated, while  the 
effects of antidepressant medication use and illness severity are being studied 
as well. In SECTION II, the focus is on factors that are considered risk factors for 
developing mood and anxiety disorders. 
In Chapter 2, common and unique neuroanatomical correlates of MDD and 
anxiety disorders are studied with an optimized voxel based morphometry 
(VBM) approach, a method that allows detecting regional volumetric 
differences across the whole brain.  Aim of this study is to investigate whether 
emotional disturbances in MDD and anxiety could at least in part be explained 
by volumetric variations in regions related to emotional processing. 
In Chapter 3, common and unique neurophysiological correlates of encoding 
and recognizing emotional words in MDD and anxiety disorders are investigated. 
Aim of this study is to test whether disorder specific biases towards negative 
and away from positive information result in altered memory formation and 
performance that could explain the prolonged course of the disease. 
In Chapter 4, fMRI correlates of a visuospatial planning task are discussed. 
Visuospatial planning is an executive process that depends heavily on dorsal 
prefrontal integrity. Aim of this study is to test whether dorsal prefrontal 
involvement during executive processes is equally compromised in both
SECTION I
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depression and anxiety, or whether it should be considered an MDD specific 
phenomenon. 
In Chapter 5, we focus on the intrinsic organization of subcortical and 
cortical brain structures during an emotional word categorization task in MDD. 
As MDD is considered the result of complex deficient interactions between 
highly integrated networks of limbic-cortical regions, we aim to study intrinsic 
functional connectivity between both dorsal and lateral cortical regions on the 
one hand and subcortical and limbic regions on the other hand, while patients 
are engaged in an emotional task.  
Chapter 6 focuses on the effects of childhood emotional trauma or abuse on 
regional brain volume across patients with depression and anxiety disorders. 
Early life trauma is one of the major risk factors for developing emotional 
disturbances. Aim of this study is to indicate a possible neuroanatomical 
vulnerability for developing depression and anxiety disorders resulting from 
early life abuse. 
In Chapter 7, we present a study that focuses on the influence of the 
personality factors neuroticism and extraversion on brain structure. 
Neuroticism and  extraversion are personality factors that have been associated 
with both increased and lower risk of developing mood and anxiety disorders. 
To avoid thepossible confounding effect of current psychopathology, we focus 
on personality correlates in healthy controls. 
In Chapter 8, results are summarized and discussed. Also, recommendations 
will be provided for implementing (f)MRI in an observational study. 
SECTION II
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INVOLVEMENT OF  VENTRAL AND DORSAL 
REGIONS IN MDD AND ANXIETY DISORDERS:
A SUMMARY
The amygdala, a limbic structure, is primarily associated with salience detection 
and processing of emotional cues, also in the context of memory processes 
(Hamilton & Gotlib, 2008). In MDD and panic disorder, the amygdala has found 
to show abnormal gray matter volume (Asami et al., 2009; Hamilton, Siemer, 
& Gotlib, 2008; Hayano et al., 2009; Massana et al., 2003; Wagner et al., 2008). 
An increased BOLD response during (masked) negative face viewing (Sheline 
et al., 2001) and a prolonged response during emotional word classification 
(Siegle et al., 2007) has been observed in MDD. In social anxiety disorders, the 
amygdala has also been associated with an elevated (Stein, Goldin, Sareen, 
Zorrilla, & Brown, 2002) and delayed response (Campbell et al., 2007) during 
negative (contemptuous and angry) face viewing. In both MDD and anxiety 
disorder, amygdala hyperactivation has been found to normalize after 
successful treatment (Ressler & Mayberg, 2007).
The hippocampus has been regarded as an affective state regulatory structure 
(Phillips, Drevets, Rauch, & Lane, 2003a) and has been repeatedly found to be 
reduced in volume in MDD (Campbell & MacQueen, 2006). The hippocampus 
is an important structure related to HPA-axis functioning, the primary stress-
regulatory system of the human body, and is thought to be implicated in the 
feed-back loop on adrenal cortisol secretion (Jacobson & Sapolsky, 1991). 
Volumetric reductions in this region have been linked to the neurotoxic 
effects of excessive cortisol (McEwen, 2005; Sapolsky, 2000). Functionally, the 
hippocampus has been associated with contextual memory processes (McEwen, 
2000), and reduced neurogenesis of hippocampal cells due to excessive cortisol 
may lead to compromised memory functions, as has been found in MDD 
(Zakzanis, Leach, & Kaplan, 1998). Although abnormal hippocampus activation 
is not a commonly observed phenomenon, the hippocampus has been found 
to abnormally inhibit dorsal prefrontal regions in MDD and at the same 
time facilitate ventral prefrontal regions (Hamilton, 2010). These abnormal 
projections may be at the base of depressive symptomatology. Also in the 
study of anxiety disorders, abnormal interactions of the hippocampus with the 
amygdala and cortical areas has been observed (Etkin et al., 2010; Etkin et al., 
2009).
The insular cortex has extensive connections with the amygdala, hypothalamus, 
and peri-aquaductal gray, and has been associated with regulation of the 
autonomic nervous system (Etkin & Wager, 2007). The insula has been related 
to disgust processing (Phillips et al., 1997; Small, 2010), homeostatic regulation 
(Small, 2010), fear conditioning (Buchel, Dolan, Armony, & Friston, 1999), and 
anticipation of negative reward (Phelps et al., 2001). Abnormal insular





functioning in MDD has been observed during aversive emotional paradigms 
(Surguladze et al., 2010) and is thought to reflect the somato-vegetative 
symptoms, such as abnormal sleep and appetite (Wiebking et al.,2010). 
Also, in social anxiety disorder, increased insular activation is among the 
most consistently observed phenomena during emotional paradigms and is 
associated with increased activation of a network related to producing fear 
responses to symptom provoking material (Etkin & Wager, 2007).
The ventral striatum, including the nucleus accumbens, and the ventro-medial 
PFC have been associated with reward processing, and abnormal activation 
of these regions in MDD has been associated with the MDD core symptom of 
anhedonia as reflected in decreased activation during processing of positive 
stimuli (Epstein et al., 2006), positive mood induction (Keedwell et al., 2005b), 
and with a failure to sustain activation over time during upregulation of positive 
emotional states (Heller et al., 2009). In the study of anxiety disorders, the 
ventral striatum has been a target for deep brain stimulation, an invasive 
therapy that aims to influence activation of specific brain targets in order to 
relieve symptom burden. Studies on the results of the effects of deep brain 
stimulation in anxiety disorders, including obsessive compulsive disorder, 
have proposed that the ventral striatum serves as a modulatory hub in the 
information flow between the amygdala and the basal ganglia, thalamus and 
PFC (Sturm et al., 2003).  
The subgenual ACC, the most ventral region of the cingulate cortex, has been 
associated with processing emotional and motivational information and the 
production of affective states (Bush, Luu, & Posner, 2000; Phillips et al., 2003a). 
In MDD, reduced volume of the subgenual ACC has been observed (Botteron, 
Raichle, Drevets, Heath, & Todd, 2002) and blunted regional blood flow in the 
subgenual ACC has been observed during mood induction, even in remitted 
(recovered) MDD patients (Liotti, Mayberg, McGinnis, Brannan, & Jerabek, 
2002). The subgenual ACC has been linked to the treatment response to 
cognitive behavioral therapy in both MDD and social anxiety disorder (Ressler 
& Mayberg, 2007). 
The orbitofrontal cortex has been associated with behavioral inhibition, 
impulsivity, decision making, and interpreting other people’s mood (Elliott, 
Zahn, Deakin, & Anderson, 2010; Milad & Rauch, 2007). The orbitofrontal cortex 
has been related to the autonomic regulation of emotional behaviour (Phillips 
et al., 2003a) and reward related behaviour (Milad & Rauch, 2007). Related to 
mood regulation, the orbitofrontal cortex has been found to exert inhibitory 
control over amygdalar activation (Milad & Rauch, 2007). In MDD, orbitofrontal 
cortex metabolism has been related to symptom improvement after successful 
treatment (Brody et al., 1999). In the study of anxiety disorders, orbitofrontal 







responses ((Milad & Rauch, 2007). 
Dorsal prefrontal cortex (PFC) regions, including the dorsolateral PFC, dorsal 
ACC, inferior frontal gyrus (IFG), and dorsomedial PFC have been predominantly 
linked to executive and attentional control functions, such as sustained attention 
(dorsal ACC), selective attention (IFG) and executive processes (dorsolateral 
PFC), during working memory tasks, switching tasks, planning tasks, and 
verbal fluency tasks; tasks that all have been found to be mildly impaired in 
MDD (Fossati et al., 2002). Verbal fluency and switch functions also have been 
found to depend on involvement of the orbitofrontal cortex. In the study of 
MDD, both increased and decreased activation of these regions have been 
observed (Fossati et al., 2002). In patients with social anxiety disorder, viewing 
of negative (disgust) facial expressions has been associated with increased 
ACC activation (Amir et al., 2005). In generalized anxiety disorder, failure of 
the ACC to dampen the amygdalar response has been associated with a failure 
to regulate emotional conflict (Etkin et al., 2010). Thus, next to executive and 
attentional control, dorsal PFC regions have been thought to exert top-down 
control over the ventral emotional appraisal regions, possibly via the ACC and 
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CHAPTER 2
REGIONAL BRAIN VOLUME IN 
DEPRESSION AND ANXIETY DISORDERS
Background: Major depressive disorder (MDD), panic disorder, and social 
anxiety disorder are among the most prevalent and frequently co-occuring 
psychiatric disorders in adults and may have, at least in part, a common 
etiology. In the present study we aimed to identify the unique and shared 
neuroanatomical profile of depression and anxiety, controlling for illness 
severity, medication use, sex, age of onset, and recurrence. 
Methods: Sixty-eight patients with MDD, 88 patients with MDD and comorbid 
anxiety disorders, 68 patients with panic disorder and/or social anxiety disorder 
and/or generalized anxiety disorders, and 65 healthy controls were recruited 
from the Netherlands Study of Depression and Anxiety. Volumetric Magnetic 
Resonance Imaging was conducted for Voxel Based Morphometry analyses. 
We tested voxel wise for the effects of diagnosis, age of onset, and recurrence 
on gray matter density. Post hoc we studied the effects of use of medication, 
illness severity, and gender.
Results: We demonstrated lower gray matter volumes of the rostral anterior 
cingulate gyrus (ACC), extending into the dorsal ACC in MDD, comorbid 
depression-anxiety, and anxiety disorders without comorbid MDD, independent 
of illness severity, sex, and medication use. Furthermore, we demonstrated 
reduced right lateral inferior frontal volumes in MDD and reduced left middle/
superior temporal volume in patients with anxiety disorders. Also, patients 
with onset of depression before 18 years of age showed lower volumes of the 
subgenual prefrontal cortex.
Discussion: Our findings indicate that reduced volume of the ventral anterior 
cingulate gyrus is a generic effect in depression and anxiety disorders, which 
is present independent of illness severity, medication use, and sex. This 
generic effect supports the notion of a shared etiology and may reflect a 
common symptom dimension related to altered emotional processing. Specific 
involvement of the inferior frontal cortex in MDD and lateral temporal cortex 
in anxiety disorders without MDD, on the other hand, may reflect disorder-
specific symptom clusters. Early onset of depression is associated with a 
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Major depressive disorder (MDD), panic disorder, generalized anxiety 
disorder, and social anxiety disorder are among the most prevalent and most 
frequently co-occurring psychiatric disorders in adults. Estimations of the 
comorbidity of depression and anxiety range from 10% to more than 50% 
(Gorman, 1996; Gorman & Coplan, 1996; Ressler & Mayberg, 2007; Roy-Byrne 
et al., 2000). Therefore, it has been suggested that depression and anxiety have 
a similar etiology, also because they respond to the same treatment strategies 
(Ressler & Mayberg, 2007). The comorbid condition of depression and anxiety, 
however, may differ from MDD in clinical course and characteristics because 
it has been associated with worse outcome (Bruce et al., 2005; Gorman, 1996; 
Gorman & Coplan, 1996; Roy-Byrne et al., 2000; Rush et al., 2005) and more 
severe psychopathology (Kessler et al., 2005; Roy-Byrne et al., 2000; Rush et al., 
2005). Also, the onset of anxiety often precedes the onset of the first depressive 
episode (Parker et al., 1999). However, in studies focusing on the neurobiology 
of depression and anxiety, comorbidity is rarely explicitly studied. 
Major Depressive Disorder has frequently been associated with stress system 
dysregulation, as reflected by abnormal hypothalamus-pituitary-adrenal–
axis function (Belmaker & Agam, 2008), of which the glucocorticoid cortisol 
is an end product. An abnormal glucocorticoid response has been associated 
with volumetric changes in the hippocampus, amygdala, and prefrontal 
cortex in animal studies (McEwen, 2005). These brain structures are rich in 
glucocorticoid receptors and are therefore a target for the putative neurotoxic 
action of excess glucocorticoids/cortisol. However, altered volumes of the 
hippocampus, amygdala, and prefrontal regions are likely to result from other 
pathogenetic mechanisms as well because abnormal cortisol levels have not 
been consistently found in MDD (Chida & Steptoe, 2009). 
A number of neuroimaging studies of MDD have shown altered volumes in 
structures related to hypothalamus-pituitary-adrenal–axis function, emotion 
perception, and regulation, i.e. the hippocampus (Frodl et al., 2006; Lange 
& Irle, 2004; Mervaala et al., 2000; Sheline, Gado, & Kraemer, 2003; Wagner 
et al., 2008; Weniger, Lange, & Irle, 2006), amygdala (Hamilton et al., 2008; 
Sheline, Gado, & Price, 1998; Wagner et al., 2008), striatum (Hickie et al., 2007), 
medial prefrontal cortex (Bremner et al., 2002; Frodl et al., 2006; Wagner et 
al., 2008), and anterior cingulate gyrus (ACC) (Botteron et al., 2002; Caetano 
et al., 2006; Drevets et al., 1997; Hastings, Parsey, Oquendo, Arango, & Mann, 
2004; Tang et al., 2007; Vasic, Walter, Höse, & Wolf, 2008; Yucel et al., 2008). 
Most studies have reported decreased volumes in these structures (Koolschijn 
et al., 2009), although findings have not been wholly consistent (Bremner et 
al., 2002; Caetano et al., 2001; Frodl et al., 2008a; Frodl et al., 2002; Frodl et al., 
2003; Hastings et al., 2004; Koolschijn et al., 2009; Lange & Irle, 2004; Rusch, 
Abercrombie, Oakes, Schaefer, & Davidson, 2001; Vakili et al., 2000; Vasic et 
al., 2008; Weniger et al., 2006). Importantly, only few studies have explicitly 











been identified in anxiety disorders as well (Damsa, Kosel, & Moussally, 2009; 
Radua et al., 2010). Whereas volumetric studies in social anxiety disorder and 
generalized anxiety disorder have been rare, studies in panic disorder have 
fairly consistently found altered volumes of the amygdala (Asami et al., 2009; 
Hayano et al., 2009; Massana et al., 2003), insular cortex (Asami et al., 2009; 
Uchida et al., 2008), dorsomedial prefrontal cortex (Asami et al., 2009), and 
ACC (Asami et al., 2008; Asami et al., 2009; Uchida et al., 2008). In addition, 
altered brainstem (Asami et al., 2008; Protopopescu et al., 2006), orbitofrontal 
cortex (Asami et al., 2009; Mohlman et al., 2009), and superior temporal 
volumes (Asami et al., 2009; Yoo et al., 2005) have been implicated in the 
neuropathology of panic disorder. However, results of these studies may have 
been similarly confounded by the presence of comorbid depression (Asami et 
al., 2008; Uchida et al., 2008). In summary, volumetric studies appear to indicate 
specific involvement of the hippocampus in depression,the insular cortex and 
superior temporal areas in anxiety disorders, and prefrontal and amygdalar 
areas in both depression and anxiety disorders. Moreover, to our knowledge, 
no study to date studied the unique and common neuroanatomical profile of 
depression and anxiety. 
In this cross-sectional study, we investigated the shared and unique 
neuroanatomical profile of depression and anxiety, controlling for the effects 
of illness severity, use of selective serotonin reuptake inhibitors (SSRIs), 
and sex as potential confounders (Campbell & MacQueen, 2006). We also 
investigated the effects of recurrence of depression and age at onset, reflecting 
changes associated with prolonged illness duration (McKinnon, Yucel, Nazarov, 
& MacQueen, 2009) or increased vulnerability to depression and anxiety 
(MacMaster et al., 2006; MacMillan et al., 2003). Based on previous studies, 
we hypothesized that patients with MDD with or without comorbid anxiety 
disorders (panic disorder, social anxiety disorder, generalized anxiety disorder) 
would show decreased volumes in the hippocampus, amygdala, ACC, and 
medial prefrontal cortex. In addition, we predicted decreased volumes in the 
ACC, amygdala, insula, and superior temporal gyrus in patients with an anxiety 
disorder with or without comorbid MDD.
PARTICIPANTS
Participants were recruited from the Netherlands Study of Depression and 
Anxiety (NESDA), a large-scale, multi-site, longitudinal, observational cohort 
study. The design has been described in detail elsewhere (Penninx et al., 2008). 
In short, NESDA was designed to be representative of those with depressive and 
anxiety disorders in different health care settings and stages of developmental 
history. Therefore, the sample is stratified for setting (community, primary care 
and specialized mental health) and set up to include a range of psychopathology. 
Of the 2981 NESDA respondents (main sample), participants aged between 
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they met the DSM-IV criteria for a half year diagnosis of MDD and/or anxiety 
disorder (panic disorder, social anxiety disorder and/or generalized anxiety 
disorder) or no lifetime DSM-IV diagnosis (i.e., healthy controls). Personality 
disorders were not screened for and so were not used in the inclusion/
exclusion criteria, although persons with known personality disorders (through 
information from clinics or through self-report) were not included in NESDA. 
Exclusion criteria for patients were the presence of axis-I disorders other than 
MDD, panic disorder, social anxiety disorder, generalized anxiety disorder 
and any use of psychotropic medication other than a stable use of SSRIs or 
infrequent benzodiazepine use (i.e., equivalent to 2 doses of 10 mg of oxazepam 
3 times per week or use within 48 hrs prior to scanning). Exclusion criteria for 
participants were the presence or history of major internal or neurological 
disorder (e.g., contusio cerebri with loss of consciousness>15 min, diabetes 
mellitus type I), dependency or recent abuse (past year) of alcohol and/or 
drugs, hypertension, and general MRI contraindications. Diagnoses were 
established using the structured Composite International Diagnostic Interview 
(CIDI), according to DSM-IV algorithms were established using the structured 
Composite International Diagnostic Interview (CIDI) – lifetime version 2.1 
(Robins et al., 1988), given by a trained interviewer. Controls were currently free 
of, and had never met criteria for, depressive or anxiety disorders or any other 
axis-I disorder and were not taking any psychotropic drugs.
Overall, 301 native Dutch speaking participants (MRI-sample; 235 patients 
and 66 controls) were included and underwent magnetic resonance imaging 
in one of the three participating centers: Leiden University Medical Center, 
Academic Medical Center Amsterdam, and University Medical Center 
Groningen. The Ethical Review Boards of each participating center approved 
this study. All participants provided written informed consent after receiving 
written information. 
ADDITIONAL PSYCHIATRIC MEASUREMENTS
Severity of depression and anxiety at the day of scanning was assessed using 
Dutch versions of the Beck Anxiety Inventory (Beck, Epstein, Brown, & Steer, 
1988),  the Montgomery Åsberg Depression Rating Scale (Montgomery & 
Åsberg, 1979), the Inventory of Depressive Symptomology (Rush et al., 1986) 
and the Fear Questionaire (Marks & Mathews, 1979). Fear Questionnaire 
ratings were obtained from 243 subjects only. 
IMAGE ACQUISITION
Imaging data were acquired using Philips 3-Tesla magnetic resonance imaging 
systems (Best, The Netherlands) located at the departments of Radiology of 
Leiden University Medical Center, Academic Medical Center Amsterdam, 
and University Medical Center Groningen, equipped with a SENSE-8 (Leiden 
University Medical Center and University Medical Center Groningen) or a 
SENSE-6 (Academic Medical Center Amsterdam) channel head coil. For each
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subject, anatomical images were obtained using a sagittal 3-dimensional 
gradient-echo T1-weighted sequence (time to repetition=9 milliseconds, 
echo time =3.5 milliseconds; matrix 256x256; voxel size, 1x1x1mm; 170 slices, 
duration: 4.5 minutes). 
STATISTICAL ANALYSIS
Demographic and clinical data were analyzed using SPSS 16.0 (SPSS Inc., Il, 
USA). Significance was set at p<.05, and post hoc paired tests were Bonferroni 
corrected for multiple comparisons. 
Imaging data were analyzed using an optimized Voxel Based Morphometry 
(VBM) approach, following the Diffeomorphic Anatomical Registration Through 
Exponentiated Lie algebra (DARTEL (Ashburner, 2007)) using Statistical 
Parametric Mapping software (SPM5) implemented in Matlab 7.1.0. (The 
MathWorks Inc., MA, USA). Diffeomorphic Anatomical Registration Through 
Exponentiated Lie algebra (DARTEL) is a fully deformable method that is 
effectively unconstrained by number of degrees of freedom. It has proven good 
registration accuracy and has been recommended in favor of standard SPM 
normalization or the SPM unified segmentation approaches for whole brain 
and regional analysis without segmenting regions of interest (Yassa & Stark, 
2009).
Preprocessing of VBM-DARTEL included (1) manually reorientation of the 
images to the anterior commissure; (2) segmentation of the anatomical 
images into gray matter, white matter and cerebrospinal fluid using the 
standard segmentation option implemented in SPM5; (3) applying the DARTEL 
approach for registration, normalization, and modulation, leaving the images 
in DARTEL space (in this approach, a DARTEL template is created based on 
the deformation fields that are produced during the segmentation procedure; 
next, all individual deformation fields were registered to this template); (4) 
smoothing of the gray matter and white matter images using an 8-mm full 
width at half maximum Gaussian kernel to increase signal to noise ratio and to 
maximize comparability with published VBM studies of depression and anxiety 
(Frodl et al., 2008b; Tang et al., 2007; Vasic et al., 2008; Wagner et al., 2008; Yoo 
et al., 2005). In the resulting images, each voxel represents an absolute amount 
of brain volume, equivalent to the brain volume per unit prior to normalization. 
Based on previous articles on volumetric differences in MDD and anxiety 
disorders, we set the following a priori regions of interest: hippocampus, 
amygdala, medial PFC, orbitofrontal cortex, ACC, superior temporal gyrus, and 
insula. For the regions of interest, we set a threshold of p<.001, uncorrected, 
with an extent cluster threshold of 50 contiguous voxels. To further protect 
against type 1 error, small volume correction (SVC) was applied for the main 
comparison (effect of diagnosis) by centering a sphere of 16-mm around the 
peak voxel. The resulting volumes of interest had to meet p<.05, corrected for 
Family Wise Error (FWE) rate at the voxel level, to be considered significant. For 
non-regions of interest, a voxel level threshold of p<.05 whole brain FWE
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 corrected was set a priori. 
Next, data were analyzed in the context of the general linear model (Friston 
et al., 1995). For our main comparison, we performed a 1x4 factorial analysis 
with group as random factor over all subjects. To test for effects of depression 
severity, anxiety severity, SSRI use, and sex, the mean signals of significant 
clusters were calculated and exported to SPSS. To test for the effects of 
depression severity, we divided the MDD and comorbid depression-anxiety 
patients into three subgroups (remitted, mild, moderate to severe), based 
on their current Montgomery Åsberg Depression Rating Scale score (Muller, 
Szegedi, Wetzel, & Benkert, 2000). In addition, a whole-brain voxel-wise 
analysis was performed in SPM to test for the effect of early (<18 year) vs. late 
(≥18 year) onset of depressive symptoms in MDD and comorbid depression-
anxiety and for onset of anxiety symptoms within comorbid depression-anxiety 
and anxiety disorders without MDD, as compared with controls. Also, a whole-
brain voxel-wise analysis was performed to test for effects of recurrent vs. a 
single major depressive episode in MDD and comorbid depression-anxiety. 
Age, gray matter total volumes, and center (by means of two dummy 
variables) were entered as covariates in each comparison. White matter images 
were only used to verify whether white matter volume changes occurred in 
the same regions as gray matter volume changes. For each SPM comparison, 
groups were matched for age, sex, scan site, and handedness. A description 
of the total sample is given in the results section. Description of matching 
procedure and resulting samples for the additional analyses (exclusion of SSRI 
users, age of onset, recurrence) can be found in the supplemental material.
To achieve maximal sensitivity, optimize voxel residual smoothness 
estimation, and exclude false positives in non-gray matter tissue, voxel wise 
comparisons were masked using a comparison-specific explicit optimal 
threshold gray matter mask created using the Masking toolbox (Ridgway et 
al., 2009). To preserve optimal normalization accuracy, we left the normalized, 
modulated, and smoothed images in DARTEL space. Therefore, coordinates 
are not equivalent to Montreal Neurological Institute (MNI) coordinates. All 
regions are identified using the detailed brain atlas of Talairach and Tournoux 
(1988).
SAMPLE DESCRIPTIVE
Data from ten participants were excluded because of poor image quality. In 
addition, data from two controls were excluded because they had Montgomery 
Åsberg Depression Rating Scale scores >8 (Muller et al., 2000). We formed 
four groups based on Composite International Diagnostic Interview half-
year diagnoses. Our final sample consisted of 289 subjects: 68 patients with 
MDD (MDD group), 88 with MDD and one or more comorbid anxiety disorder 
(CDA group: MDD and panic disorder and/or social anxiety disorder and/or 








disorder, social anxiety disorder, generalized anxiety disorder) but no MDD 
(ANX group), and 65 controls.
Table 1 lists the sample characteristics. Groups were matched for sex, 
handedness, distribution of participants scanned over sites, and age, but not 
on education. The MDD and comorbid depression-anxiety group both had 
fewer years of education than controls (MDD: U=1370.5, p<.008; CDA: U=1594, 
p<.008). Furthermore, the comorbid depression-anxiety group included more 
SSRI users than the MDD and ANX groups. A main effect of group was found 
on Montgomery Åsberg Depression Rating Scale, Inventory of Depressive 
Symptomatology, Beck Anxiety Inventory, and Fear Questionnaire score. All 
diagnostic groups showed higher Montgomery Åsberg Depression Rating 
Scale, Inventory of Depressive Symptomatology, Beck Anxiety Inventory, 
and Fear Questionnaire total scores than controls (all z>-4.82; all p<.008). In 
addition, the comorbid depression-anxiety group reported higher Montgomery 
Åsberg Depression Rating Scale and Inventory of Depressive Symptomatology 
scores than the MDD and ANX group, and higher Beck Anxiety Inventory scores 
than the MDD group (all z>-2.9, p<.008). 
Between the NESDA baseline interview (T1) and the magnetic resonance 
imaging session (T2), depressive scores decreased in all diagnostic groups 
(Inventory of Depressive Symptomatology; t>3.45; p<.001). The MDD group 
showed an additional decrease in Beck Anxiety Inventory scores (t65=3.15, 
p=.002). Post hoc tests showed that currently remitted and mildly depressed 
subgroups but not the moderately to severely depressed subgroups, showed 
lowered depressive scores at the time of scanning than at time of baseline 
interview: At T1, all groups showed moderate/severe depressive scores. The 
MDD and comorbid depression-anxiety groups did not differ in onset at the 
first MDD episode, and the comorbid depression-anxiety and ANX groups did 
not differ in age at onset of the first anxiety disorder. Within the comorbid 
depression-anxiety group, onset of anxiety generally preceded onset of the first 
depressive episode (Z=-5.22, p<.001). 
VBM RESULTS
Groups did not differ in total gray matter and white matter volumes (gray 
matter F3,284=.25; p=.34 and white matter F3,284=.25; p=.86). Lower regional gray 
matter density of the left rostral ACC (Brodmann area [BA] 24b/c and 32; 1) was 
observed in patients compared with controls, extending into the dorsal ACC 
(BA 32’) (Figure 1a). Voxel based comparison of the MDD, comorbid depression-
anxiety, and ANX group with controls showed that the rostral and dorsal ACC 
reduction was most robust in the comorbid depression-anxiety group and was 
borderline significant in the MDD and ANX groups (MDD: MNI coordinates: [x=0 
y=32 z=-11], Z=2.99; p=.001; ANX: MNI coordinates: [x=0 y=41 z=1], Z=3.08; 
p=.001). Gray matter results are listed in Table 2. The region surrounding the 
rostral and dorsal ACC gray matter reductions showed white matter volumetric 
reductions as well (Table 2).
1 For identifying subregions of 
the ACC, we used the defini-
tion described by Bush et al. 
(2000).

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Furthermore, in the MDD group, gray matter volume reductions in the right 
inferior frontal cortex were observed (Figure 1b).  The ANX group showed less 
left middle and superior temporal gyrus volume compared to controls (Figure 
1c). In both regions, white matter reductions were observed as well. The reverse 
contrasts (MDD, CDA, and ANX groups > controls) did not reveal significant 
clusters.
EFFECTS OF ILLNESS SEVERITY, SEX, AND SSRI-USE
Analysis with SPSS showed that the rostral/dorsal ACC gray matter volume 
reduction occurred in all diagnostic groups relative to controls. (all p <.05, 
Bonferroni corrected), whereas the right inferior frontal gyrus and middle/
superior temporal gyrus volume reductions were specific to the MDD and ANX 
groups, respectively (p<.05, Bonferroni corrected). 
No effect of depressive state was observed within group on ACC (MDD: 
F2,66=.98; p=.38; CDA: F2,80=.09; p=.91) or inferior frontal gyrus volume within 
MDD (F2,67=2.14, p=.13). Adding Beck Anxiety Inventory and Fear Questionnaire 
scores to these models did not change the results (rostral/dorsal ACC: MDD: 
F2,64=.51, p=.61; CDA: F2,78=.1, p=.91; inferior frontal gyrus: F2,64=2.06, p=.14). 
Beck Anxiety Inventory and Fear Questionnaire scores were not predictive of 
rostral/dorsal ACC volume in patients (BAI: β=05; p=.22; FQ: β=-.06; p=.1), of 
inferior frontal gyrus volumes in MDD (BAI: β=-.02; p=.85; FQ: β=.14; p=.24), and 
of middle/superior temporal gyrus volumes in patients with anxiety disorders 
(BAI: β=-.06; p=.52; FQ: β=.02; p=.86). No interaction of sex and diagnosis was 
observed in any region (rostral/dorsal ACC: F3,287=1.46; p=.23; inferior frontal 
gyrus: F3,187=.56; p=.64; middle/superior temporal gyrus: F2,287=1.6; p=.19) and 
omission of the SSRI users from the analysis did not affect the results. Table S-1 
lists the sample characteristics of the SSRI-free diagnostic groups. 
AGE AT ONSET
A voxel-wise, whole-brain analysis showed that patients with early onset of 
depression (MDD and comorbid depression-anxiety) had lower gray matter 
volumes of the right subgenual ACC (BA 25) extending into the medial 
orbitofrontal gyrus compared with controls (Table 2c, Figure 1d), and no effect 
of sex was observed. No volumetric differences were observed in the subgenual 
ACC in persons with late-onset depression vs. controls, and no white matter 
reductions occurred in this region. Also, no effect of early vs. late onset of 
the first anxiety disorder was observed in the ANX and comorbid depression-
anxiety group.  Table S-2 lists the sample characteristics of the early vs. late 
onset subgroups. 
A voxel-wise, whole-brain analysis showed no effect of single vs. recurrent 
depressive episodes in the MDD and comorbid depression-anxiety group. Table 
S-3 lists the sample characteristics of the single vs. recurrent episode MDD 
groups. 
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FIGURE 1: 
VBM EFFECTS 
A) main effect of patients 
< healthy controls showing 
gray matter reductions in the 
rostral and dorsal anterior 
cingulate gyrus; B) lower right 
inferior frontal gyrus volume 
in MDD as compared to HC; 
C) lower right middle/superior 
temporal gyrus volume in ANX 
as compared to HC; D) MDD 
patients (MDD and CDA) with 
onset of the first depressive 
episode before the age of 18 
are characterized by lower 
subgenual OFC volumes than 
HC. All effects are displayed at 
p<.005, uncorrected.
A full-color image can be 
found on the supplementary 
sheet.
2
TABLE 2: VBM RESULTS
MDD= Major Depressive Disorder; CDA= Comorbid MDD and anxiety; ANX= anxiety without MDD; HC= healthy 
controls; SSRI= Selective Serotonin Reuptake Inhibitor; DARTEL-coordinate= coordinates of the voxel showing 
peak significance in mean DARTEL space, R/L= Right/Left hemisphere; BA= Brodmann area; k= cluster size; SVC= 
Small Volume Correction.
comparison R/L region k x y z Z-value
pt < HC L rostral anterior cingulate gyrus 152 0 42 4 3.54
L dorsal anterior cingulate gyrus -2 39 16 3.52
MDD<HC R inferior frontal gyrus 178 36 11 27 3.69
R inferior frontal gyrus 115 47 11 4 3.56
CDA<HC R rostal anterior cingulate gyrus 83 2 42 6 3.50
ANX<HC L middle/superior temporal gyrus 181 -53 -3 -12 4.07
comparison R/L region k x y z Z-value
pt < HC R rostral anterior cingulate gyrus 407 9 42 10 4.32 *
L rostral anterior cingulate gyrus 11 -9 41 10 3.17
comparison R/L region k x y z Z-value
EO<HC R subgenual ACC/ orbitofrontal gyrus 127 2 32 -11 3.77
SVC corrected at p <.05. SPM smoothness 11.2, 11.8, 11.3 mm; 690.5 resels.  
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Statistics, coordinates and cluster sizes of the comparisons between pt (patients; MDD, CDA and ANX), and HC.
SVC corrected at p <.05. SPM smoothness 11.2, 11.8, 11.3 mm; 698.7 resels.  
B: White matter group comparisons, including SSRI-users
A: Gray matter group comparisons, including SSRI-users




Statistics, coordinates and cluster sizes of the comparisons between pt (patients; MDD, CDA and ANX), and HC. 
Uncorrected at p <.001; * SVC FWE corrected at p <.05; SPM smoothness 10.6, 10.9, 10.6 mm; 633.3 resels.  
DARTEL-coordinate
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In this study we investigated the neuroanatomical characteristics of depression 
and anxiety in a large sample of outpatients with MDD, panic disorder, social 
anxiety disorder, and/or generalized anxiety disorder. We used a whole brain, 
DARTEL-VBM approach, tested explicitly for the effects of comorbidity of 
depression and anxiety, and controlled for the effects of illness severity, SSRI 
use, and sex. In addition, we tested voxel-wise for the effects of age at onset 
and recurrence of depression.
We demonstrated lower gray matter volumes of the rostral ACC, extending 
into the dorsal ACC in patients with mood and/or anxiety disorders. This rostral 
ACC decrease occurred in patients with MDD, comorbid depression-anxiety, 
and anxiety disorders without comorbid MDD, independent of depressive 
state or anxiety severity, and no effect of SSRI use or sex was observed. Also, 
white matter reductions occurred in the region bordering the gray matter 
ACC reduction. Furthermore, we demonstrated reduced right inferior frontal 
gyrus volumes in MDD and reduced left middle/superior temporal gyrus 
volume in anxiety disorders compared with healthy controls. In addition, 
depressed subjects (MDD and comorbid depression-anxiety) with onset of 
the first depressive episode before 18 years of age showed lower volumes in 
the subgenual ACC, extending into the medial orbitofrontal gyrus. Finally, 
patients with MDD and comorbid depression-anxiety with recurrent episode 
depression showed no volumetric differences compared with a single episode 
of depression. 
To our knowledge, this is the first study to examine the neuroanatomical (i.e. 
neuroradiological) correlates of both depression and anxiety while explicitly 
testing for the effects of their co-occurrence. Our findings indicate that reduced 
volume of the ACC, and more specifically the regions of the ACC that are part 
of the rostral-ventral affective subdivision (Bush et al., 2000) is a generic effect 
in depression and anxiety disorders, present independently of depressive state 
or anxiety severity. This generic ACC reduction supports the notion of a shared 
etiology in depression and anxiety and may reflect a common pathophysiological 
mechanism related to altered emotion processing. The rostral ACC region has 
been found to be primarily involved in salience assessments of emotional and 
motivational information, while the dorsal ACC has been implicated in effortful 
processing (Bush et al., 2000), motivational processes, and regulating negative 
mood (Mak, Wong, Han, & Lee, 2009). The ventral part of the ACC, (including 
the rostral ACC) has been associated with executive inhibition (Matthews et 
al., 2009), induced sadness (Liotti et al., 2002; Wang et al., 2008), and negative 
emotion processing (Shin et al., 2000) in both patients with MDD and controls. 
The volume reduction observed in this study most likely reflects loss of glial cell 
density and neuronal size (Cotter, Mackay, Landau, Kerwin, & Everall, 2001), 
and may be the result of hypothalamus-pituitary-adrenal axis dysregulation 
(Belmaker & Agam, 2008). The rostral-ventral affective subdivision of the ACC 
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insula (Devinsky, Morrell, & Vogt, 1995) and therefore is an important hub in 
emotion perception and regulation. Also, abnormal ACC morphometry has 
been associated with worse outcome and/or worse treatment response in MDD 
(Chen et al., 2007; Frodl et al., 2008c; Yucel et al., 2008). 
The results are in concordance with previous imaging studies that have 
demonstrated affective ACC abnormalities in depression and anxiety disorders, 
however without consistently controlling for comorbidity (Asami et al., 2009; 
Botteron et al., 2002; Drevets et al., 1997; Tang et al., 2007; Yucel et al., 2009). 
Although our comorbid depression-anxiety group displayed more severe 
depressive and anxiety related pathology, the two depressive groups were 
characterized by a similar rostral ACC gray matter volume reduction. Also, 
within groups, no associations between illness severity and ACC volume 
were observed. The latter finding appears to be at odds with studies that 
did report a negative correlation between illness severity and ACC volumes 
(Frodl et al., 2008c; Yucel et al., 2009). For example, Frodl et al. (2008c) in 
their sample of inpatients who were receiving medication, demonstrated a 
moderate correlation of depression severity with total right ACC volume but 
not left total ACC, or subregions within the ACC. However, our findings are 
in agreement with studies that also failed to demonstrate a relation between 
illness severity and ACC volume (Caetano et al., 2006; Vasic et al., 2008; Yucel 
et al., 2008),  as was confirmed in a recent meta-analysis (Koolschijn et al., 
2009). In this study, we further demonstrated rostral ACC volume reductions 
even in (recently) remitted patients with depression, consistent with findings of 
abnormal rostral ACC activation following mood induction in remitted patients 
(Liotti et al., 2002). Finally, our negative findings regarding SSRI use on ACC 
volume are in agreement with work of Asami et al (2008). Recent animal studies 
also indicated that the neurogenesis promoting effects of SSRIs may only be 
achieved in youth, not in adulthood or old age (Couillard-Despres et al., 2009; 
Navailles, Hof, & Schmauss, 2008).
In addition to our rostral ACC findings, we also demonstrated reduced right 
inferior frontal gyrus gray matter volumes in MDD. This finding is in agreement 
with earlier VBM results of both decreased inferior frontal gyrus concentration 
(Vasic et al., 2008) and density (Frodl et al., 2008a)2 in inpatients with MDD in 
which comorbid anxiety disorders were excluded as well. Data from the present 
study indicate that this finding is specific for patients with MDD without comorbid 
anxiety disorders, independent of depression severity and SSRI use. The right 
inferior frontal gyrus has been implicated in inhibitory processes relevant to 
executive performance (Matthews et al., 2009; Wang et al., 2008), selective 
response suppression (Forstmann, van den Wildenberg, & Ridderinkhof, 2008) 
and cognitive processes related to negative affect (Lieberman et al., 2004), 
functions that are likely to be impaired in MDD. Therefore, reduced right 
inferior frontal gyrus volume may represent a neuroanatomical basis for these 
abnormalities. The left middle/superior temporal reduction in anxiety disorders 
is also in agreement with previous research (Uchida et al., 2003; Vythilingam et
2
2 Concentration refers to the 
proportion of gray matter
in each voxel, in which the 
changes in voxel size have
not been accounted for, i.e., 
the voxel value has not been
modulated with the Jacobian 
determinant derived from the
spatial normalization. This 
does not allow for comparison
of the absolute voxel value 
(Good et al., 2001).
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al., 2000) and has repeatedly been linked to the pathophysiology of panic 
disorder, presumably reflecting impaired evaluation of interoceptive information 
(Uchida et al., 2008) and altered threat processing (Phillips et al., 1998), as has 
been shown in functional neuroimaging studies. Depressed subjects (MDD 
and comorbid depression-anxiety) with onset of the first depressive episode 
before 18 years of age showed lower gray matter volumes of the subgenual 
ACC relative to controls, extending into the medial orbitofrontal, an effect that 
was not observed in patients with onset of the first depressive episode after 
18 years of age. This finding is in line with results of Botteron and colleagues 
(2002), who reported subgenual ACC volume decreases in adolescent-onset 
MDD, although no direct comparison with late-onset MDD was made. The 
subgenual ACC volume reduction may represent an early neurobiological lesion 
resulting in increased vulnerablility to depressed mood, as abnormal subgenual 
ACC activity during sad mood induction through autobiographical episodes, 
even after full remission of depression, has been proposed as a trait marker for 
depression (Liotti et al., 2002). Also, the subgenual ACC has been implicated in 
fear extinction and emotion regulation and appears to serve as a regulatory hub 
between the dorsolateral PFC and amygdala, modulating responsiveness in the 
latter (Delgado, Nearing, Ledoux, & Phelps, 2008). Disruption of this area may 
therefore lead to altered emotion processing. Finally, subgenual ACC volume 
reduction may reflect a genetically determined predisposition to MDD because 
early onset depression is associated with increased familial risk of MDD (Jaffee 
et al., 2002). This hypothesis has received empirical support from findings of 
Nolan and coworkers (2002). Moreover, Drevets et al. (1997) reported subgenual 
ACC reductions in a predominantly familial MDD group in adulthood. Although 
it may be argued that subgenual ACC reduction merely reflects longer disease 
duration, this suggestion conflicts with the observed subgenual ACC reduction 
in the adolescent female cohort of Botteron and colleagues (2002).
In this study, we failed to demonstrate hippocampal and amygdalar volume 
reductions in MDD, panic disorder, social anxiety disorder and generalized 
anxiety disorder. Post hoc analyses revealed hippocampal volume reduction 
only at z=2.17 (p=.02, uncorrected), far below our a priori threshold, and no 
amygdala volume changes were observed. One may argue that VBM techniques 
are less sensitive to detect volumetric alternations in small structures or that 
non-linear registration methods are less sensitive to pick up shape-related 
alterations compared with region of interest segmentation approaches. It 
should be noted that post mortem studies did not found support of apoptosis, 
massive cell loss, or loss of plasticity in the human hippocampus (Campbell & 
MacQueen, 2004; Swaab, Bao, & Lucassen, 2005), although reports have been 
conflicting (Stockmeier et al., 2004). Moreover, post mortem studies have 
mainly included the brains of patients who committed suicide, a subgroup that 
may not be representative of patients with MDD. Also, most of our depressed 
patients, although representative of our local outpatient population, were not 
severely depressed, and therefore did not show hippocampal atrophy.
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However, hippocampal reductions were also absent in our severely depressed 
subgroups (data not shown). In their meta-analysis, MacKinnon et al. (2009) 
showed that hippocampal atrophy is more likely to occur in pediatric or elderly 
samples with recurrent MDD. Therefore, decreased hippocampal volume is 
considered the result of the disease process, as supported by the longitudinal 
findings of Frodl et al (2008b). Regarding the amygdala, Hamilton et al. (2008) 
concluded in their meta-analysis that volume of this region s dependent on 
medication use in MDD. However, this conclusion is not supported by our 
data; we did not observe amygdalar atrophy in our analysis nor depressed and 
anxious patients who did not take an SSRI.  
In this study, we were unable to identify gray matter reductions outside our 
a priori regions of interest that survive whole-brain corrections for multiple 
comparisons. We did, however, observe reductions in the bilateral posterior 
cingulate cortex (BA 30/23; Z=4.04; p<.001 uncorrected) in addition to the 
rostral/dorsal ACC reductions described previously in our patient groups. 
Because most imaging studies to date have focused on frontal and subcortical 
regions, this region was not included in our a priori regions of interest. However, 
inclusion of the posterior cingulate cortex as region of interest in future imaging 
studies will likely be useful in further unraveling the complex neurodynamics of 
depression and anxiety. Notably, this region has been included in the default 
mode network as one of the highest energy consuming regions and has been 
associated with larger deactivations during emotional facial processing (Gentili 
et al., 2009) and threat processing in anxious patients (Zhao et al., 2007). The 
posterior cingulate cortex has shown negative connectivity with the amygdala 
(i.e. increased posterior cingulate cortex activation is correlated with decreased 
amygdalar activation) and positive connectivity with the dorsal ACC (BA 32)
(Stein et al., 2007), indicating that the posterior cingulate cortex is also involved 
in regulatory interactions with the amygdala, directly and via the ACC. 
This study has a number of strengths. First, we were able to include 
large samples of patients and controls who were extensively screened and 
phenotyped according to the NESDA protocol; therefore, we could define 
subgroups of patients based on clinical comorbidity. Second, only stable 
SSRI use was allowed in our study, and less than half of our patients were 
taking antidepressant medication at the time of scanning. Consequently, we 
were able to control for the effects of SSRI on regional brain volume. Third, 
we used a whole brain approach (VBM-DARTEL) that is rater-unbiased in its 
segmentation. Therefore, we did not restrict our analysis to only a limited 
number of brain structures but were able to detect volumetric changes across 
the brain and to verify if gray matter changes were accompanied by white 
matter changes in the same region. Voxel-based methods have been found to 
show satisfactory correlations with manual segmentation approaches (Asami 
et al., 2008; Uchida et al., 2008; Zhao et al., 2007). 
Several potential limitations should also be noted. First, because the 
epidemiological NESDA cohort was recruited through general practitioners
2
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and outpatient clinics, we may not have been fully able to capture the most 
severe end of the depressive spectrum. Second, patients with MDD and 
comorbid depression-anxiety differed slightly from controls in years of 
education. However, adding years of education as a covariate did not change the 
results of the main comparison; if anything, the rostral ACC reduction was more 
robust. Third, assessment of onset and recurrence of depression was based 
on self-report, which theoretically may have resulted in both underdiagnosis 
and overdiagnosis of past depression and anxiety. However, this would have 
biased our results to the null and therefore have led to underestimation of 
the true associations. Fourth, although persons with identified posttraumatic 
stress disorder where not included in the NESDA sample, subjects were not 
systematically screened for it. Therefore, we tested (post hoc) for the effect of 
trauma on ACC volume because data regarding the experience of emotional 
and physical trauma were available but no effect of self-reported trauma was 
observed on ACC volume and no interaction with diagnosis was observed 
(See the supplemental material for detailed information). Fifth, although 
similar Philips 3 tesla systems were used at each site in this multi-center study, 
variability in image acquisition may have occurred owing to minor differences 
in hardware (receiver coil) and timing of software upgrades. However, no 
diagnosis x scan site bias occurred. Moreover, reliability of multiscanner VBM 
has been proven good (Stonnington et al., 2008).
In conclusion, our results suggest a generic involvement of the ventral-
rostral ACC in (comorbid) MDD, panic disorder, social anxiety disorder, and 
generalized anxiety disorder, extending into the dorsal ACC that is independent 
of symptom severity. Although our results do not directly address pathogenetic 
mechanisms involved in depression and anxiety, they support the notion of a 
shared pathogenetic mechanism in these disorders that may reflect impaired 
emotion processing and regulation, presumably through intricate connections 
of the ventral ACC with other limbic structures (i.e., amygdala, orbitofrontal 
cortex, and anterior insula) that have been implicated in mood regulation 
models as well. Psychometric and functional imaging studies focusing on 
the common and distinct symptom profiles of depression and anxiety, may 
further aid in unravelling the common and distinct phenomenological and 
neurobiological correlates of these disorders. In addition to this generic ACC 
effect, we showed disorder specific involvement of the right inferior frontal 
gyrus in MDD, and superior temporal gyrus in panic disorder and/or social 
anxiety disorder and/or generalized anxiety disorder. Longitudinal studies and 
prospective studies should clarify whether these volumetric abnormalities 
are the result of the disease process or represent a vulnerability factor for the 
development of depression and anxiety in adulthood. 
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EFFECTS OF SSRIS: DESCRIPTION OF GROUP
After omission of the SSRI using participants, groups were matched on 
age, gender, scan site, and handedness. Our renewed sample consisted 
of 207 subjects, i.e. 50 MDD, 48 CDA, 47 ANX, and 62 HC. Table S1 lists all 
characteristics for the medication free sample. Groups were comparable on all 
clinical characteristics to the groups that include the SSRI-using participants. 
Also, no effect of group exists with respect to total gray matter (F3,203=.34, 
p=.80) and total white matter (F3,203=.18, p=.91). 
AGE OF ONSET
Groups were matched on age, edu, gender and handedness. Within diagnostic 
groups, early onset (EO) did not differ in MADRS and BAI scores. Clinical 
characteristics are listed in Table S2. Gray matter images were entered in a one-
way ANOVA with group as independent variable and age, gender, gray matter 
totals, and center as covariates. 
RECURRENCE
MDD and CDA were pooled and splitted into a single episode MDD group 
and a recurrent episode MDD group. Groups (single, recurrent, and healthy 
controls) were matched on age, gender and handedness. Groups differed in 
years of education, MADRS scores and BAI scores (edu: F2,204=.14.19, p<.001; 
MADRS: F2,204=74.8, p<.001; BAI: F2;204=45.11, p<.001). Post hoc tests showed 
that healthy controls had more years of education and lower scores on MADRS 
and BAI than single and recurrent MDD. Clinical characteristics are listed in 
Table S3. Gray matter images were entered in a one-way ANOVA with group 
as independent variable and age, gender,  gray matter totals, and center as 
covariates.
EFFECT OF TRAUMA ON ACC VOLUMES
Data regarding the experience of emotional and physical trauma were available 
(assessed with the Nemesis trauma interview; De Graaf et al, 2002). In our 
sample of 289 subjects, 55.9 % of MDD, 69.3% of CDA, 57.4% of ANX, and 38.5 
% of healthy controls reported to have ever experienced emotional or physical 
trauma in their lives (ranging from ‘once’ to ‘very often’). To test for the effect 
of trauma on ACC volumes, we set up ANCOVAs with gray matter ACC volume 
as dependent factor, and diagnosis and trauma (yes/no) as independent factor. 
Age, gray matter totals, and scan center were entered as covariates. No effect 
of self-reported trauma was observed on ACC volume (F1,277=.37, p=.54], and 
no interaction with diagnosis was observed (F3,277=.37, p=,26). The experience 
of a physical or emotional trauma more than once, occurred in 34 % of MDD, 
46% of CDA, 40% of ANX, and 17% of the healthy controls before the age of 16. 
Again, (severe) childhood trauma was not associated with ACC volume when 
compared to subjects that never experienced trauma(F1,215=1.22, p=.27), and no 
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TABLE S-2: CLINICAL CHARACTERISTICS OF MATCHED EARLY AND LATE 
DEPRESSION ONSET GROUPS VS. HC
MDD= Major Depressive Disorder; CDA= Comorbid MDD and anxiety; HC= healthy controls;  EO= early onset 
MDD (onset of first episode before age of 18); LO= late onset MDD (onset of first episode after age of 18); 
SSRI= Selective Serotonin Reuptake Inhibitor; MADRS: Montgomery Åsberg Depression Rating Scale; BAI: 
Beck Anxiety Inventory; GM= gray matter total volume; WM= white mattter total volume. 
2HCEO LO EO LO
N 23 38 32 40 48
gender male/female; N 8/15 12/26 8/24 14/26 17/31
scan site amc/lumc/umcg; N 4/8/11 12/16/10 10/11/11 16/14/10 19/22/7
handedness left/right; N 1/22 5/33 2/30 3/37 5/43
SSRI use current yes/no; N 7/16 7/31 14/18 21/19 0/48
age in years: mean ± sd 34 ± 10.5 37 ± 8.1 32.4 ± 9.9 37 ± 9.6 37.7 ± 8.9
education in years: mean ± sd 13 ± 2.9 12.3 ± 2.6 12.3 ± 2.6 12.6 ± 3.1 13.7 ± 2.2
MADRS total score: mean ± sd 14.4 ± 9.4 13.2 ± 9.4 19.7 ± 8.8 19.1 ± 9.7 .8 ± 1.6
BAI total score: mean ± sd 9.2 ± 7.2 8.9 ± 9.1 20.3 ± 8.7 16.3 ± 9.1 1.9 ± 2.6
onset MDD age in years: mean ± sd 15.17 ± 2.55 30.13 ± 7.32 13.22 ± 3.52 28.18 ± 7.37 -
GM in ml: mean ± sd 742.2±65.8 724.7 ± 68.8 746.5 ± 69.3 732.9 ± 78.9 738.4 ± 75.4
WM in ml: mean ± sd 467.1 ± 62.2 491.1 ± 62.6 485.6 ± 59.6 509.5 ± 71.1 486.4 ± 58.8
MDD CDA
TABLE S-3: CLINICAL CHARACTERISTIC OF MATCHED SINGLE EPISODE VS. 
RECURRENT EPISODE MDD
MDD= Major Depressive Disorder; CDA= Comorbid MDD and anxiety; HC= healthy controls; SSRI= Selective 
Serotonin Reuptake Inhibitor; MADRS: Montgomery Åsberg Depression Rating Scale; BAI: Beck Anxiety 
Inventory; GM= gray matter total volume; WM= white mattter total volume.
HC
single recurrent
N 68 85 58
gender male/female; N 27/41 24/61 21/37
scan site amc/lumc/umcg; N 19/35/14 26/26/33 17/26/22
handedness left/right; N 5/63 7/78 5/53
diagn MDD/CDA; N 29/39 36/49 -
SSRI current use yes/no; N 26/42 30/55 -
age in years; mean ±  sd 37.37 ± 10.13 37.51 ± 9.60 38.9 ± 8.96
education in years; mean ±  sd 13.08 ± 3.12 12.45 ± 3.11 14.59 ± 2.6
MADRS total score: mean ± sd 10.31 ± 11.11 16.14 ± 10.1 .98 ± 1.83
BAI total score: mean ± sd 9.37 ± 10.4 13.2 ± 9.2 1.96 ± 2.46
GM ml; mean ± sd 732.34 ± 77.97 727.94 ± 63.91 730.83 ± 75.06
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Background: Major depressive disorder (MDD), panic disorder, social anxiety 
disorder, and generalized anxiety disorder are among the most prevalent 
and frequently co-occurring psychiatric disorders in adults and may be 
characterized by a common deficiency in processing of emotional information. 
We aimed to identify the unique and shared functional magnetic resonance 
imaging correlates of emotional word memory processes in depression and 
anxiety, controlling for comorbidity and illness severity. 
Methods: Fifty-one patients with MDD (MDD), 59 with comorbid MDD and 
anxiety, 56 patients with a diagnosis of an anxiety disorder (panic disorder, 
social anxiety disorder and/or generalized anxiety disorder) without MDD and 
49 controls performed an emotional word encoding and recognition paradigm 
during functional magnetic resonance imaging. We tested for the effects of 
current psychopathological status on the Blood-oxygen-level-dependent 
response and performance during task execution. Post-hoc we tested for the 
effects of illness severity, regional brain volume, and anti-depressant use.  
Results: Patients with MDD, comorbid depression-anxiety, and anxiety 
disorders without MDD showed a common hypo-response in the right 
hippocampus during positive (>neutral) word encoding compared with controls. 
Also, MDD showed depressive state-independent hyperactivation of the insula, 
and depressive state-dependent hyperactivation of the amygdala, striatum, 
and prefrontal cortex during negative encoding. Recognition was associated 
with increased activation of prefrontal regions, related to illness severity in 
comorbid depression-anxiety and anxiety without MDD. Overall, effects were 
unaffected by SSRI use and regional brain volume.
Conclusion: Our findings indicate that hippocampal blunting during positive 
word encoding is a generic effect in depression and anxiety disorders, 
independent of illness severity, medication use, and regional volume, that 
may constitute a common vulnerability for MDD and anxiety disorders. MDD 
is additionally characterized by increased sensitivity for negative words as 
reflected in increased insular, amygdalar, striatal, and prefrontal response 
during encoding. The present results emphasize the current distinction between 
MDD and anxiety disorders (with and without comorbid MDD) with respect to 
processing of mood-congruent information, although a generic hippocampal 
hypo-response to positive words may mark a general insensitiveness to positive 
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3
Major depressive disorder (MDD), panic disorder, social anxiety disorder, 
and generalized anxiety disorder are among the most prevalent and most 
frequently co-occurring psychiatric disorders in adults (Gorman, 1996; Ressler 
& Mayberg, 2007). Because of this high comorbidity and because MDD and 
anxiety disorders respond to the same treatment strategies, it has been 
suggested that they may share a similar etiology (Ressler & Mayberg, 2007). 
Recently, we reported on shared anatomical abnormalities in the anterior 
cingulate cortex in MDD and anxiety disorders (van Tol et al., 2010) supporting 
this suggestion. In contrast, it has been proposed that MDD with and MDD 
without comorbid anxiety should be considered distinct diagnostic groups 
in view of their course trajectories (Penninx et al., 2011). However, in studies 
investigating the neurobiology of depression and anxiety, comorbidity is rarely 
explicitly studied. 
Major Depressive Disorder, panic disorder, social anxiety disorder, and 
generalized anxiety disorder have been associated with similar biases in 
processing syndrome specific information such as negative, threat, or stress 
eliciting words or pictures (Grant & Beck, 2006; Leppanen, 2006; Musa, Lepine, 
Clark, Mansell, & Ehlers, 2003; van den Heuvel et al., 2005b; Watkins, Martin, & 
Stern, 2000). Also, MDD has been associated with abnormalities in processing 
mood-incongruent (i.e. positive) information (Burt, Zembar, & Niederehe, 
1995), reflective of anhedonia (i.e. loss of the capacity to experience pleasure), 
the MDD core-symptom next to lowered or sad mood. These biases could lead 
to biased memory formation (Coles & Heimberg, 2002; Coles, Turk, & Heimberg, 
2007; Wagner et al., 1998), that might reinforce negative mood and could 
contribute to the course of the disorder (Elliott et al., 2002). Whether anxiety 
disorders are also associated with memory biases for positive information is 
unclear. Moreover, whether comorbid depression-anxiety resembles MDD 
or anxiety disorders in performance and regional brain activation during 
emotional memory processes, or should be considered a sum of its parts, is to 
our knowledge, unknown. 
Neuroanatomical models of MDD propose that symptoms such as lowered 
mood may result from dysregulation of subcortical and (para)limbic regions on 
the one hand, and dorsal and lateral cortical regions on the other hand (Mayberg, 
1997; Phillips et al., 2003b). (Para)limbic regions, such as the amygdala, insula, 
and ventromedial prefrontal regions, have been associated with emotional 
appraisal of information. Dorsal and lateral cortical regions, including 
dorsomedial-, dorsolateral-, and ventrolateral prefrontal (PFC) regions, are 
predominantly linked to regulatory control over subcortical and (para)limbic 
regions, possibly via the medial PFC and anterior cingulate cortex (ACC) 
(Johnstone et al., 2007). Neuroimaging studies in MDD have predominantly 
focused on processing of negative information, and demonstrated differential 
involvement of the amygdala, hippocampus, ACC, lateral PFC (Bremner, 











Vaccarino, & Charney, 2004; Hamilton & Gotlib, 2008; Roberson-Nay et al., 
2006), supporting the hypothesis of altered involvement of subcortical and 
prefrontal regions for memory processing of mood-congruent information. Yet, 
few studies have explicitly tested for the effect of mood-incongruent content 
on memory formation in MDD, although a blunted response in areas linked to 
reward processing such as the ventromedial PFC (Elliott et al., 2002; Keedwell, 
Andrew, Williams, Brammer, & Phillips, 2005a), ventrolateral PFC (Keedwell 
et al., 2005a), and ventral striatum (Epstein et al., 2006; Heller et al., 2009) 
has been associated with positive information processing. Only van Wingen 
et al. (2009) studied memory for positive and neutral faces in MDD. They 
demonstrated altered involvement of the amygdala and fusiform gyrus during 
memory formation, and differential involvement of the amygdala, fusiform 
gyrus, inferior frontal gyrus, orbitofrontal cortex, and posterior cingulate gyrus 
during retrieval. In panic disorder, social anxiety disorder, and generalized 
anxiety disorders, studies focusing on the processing of (social) threat related 
material reported increased prefrontal (Maddock, Buonocore, Kile, & Garrett, 
2003; Monk et al., 2006; Nitschke et al., 2009; van den Heuvel et al., 2005b), 
hippocampal (van den Heuvel et al., 2005b),and amygdalar (Nitschke et al., 
2009; Stein et al., 2002; van den Heuvel et al., 2005b) activation, but effects on 
emotional memory formation have, to our knowledge, not been studied yet. 
In the present study, we investigated unique and shared functional 
magnetic resonance imaging (fMRI) correlates of mood-congruent and mood-
incongruent information processing in MDD and frequently co-occurring anxiety 
disorders during an emotional word memory paradigm. Based on the overlap 
in their phenomenology, neurobiology, and information processing bias, and to 
capitalize on our sample size, we incorporated the anxiety disorders within one 
group. We focused on involvement of (para)limbic ‘appraisal’ and dorsal and 
lateral cortical ‘regulatory’ brain regions during hypothesized biased memory 
formation and recollection, while testing for the effects of the comorbidity 
of depression and anxiety disorders. We hypothesized better recognition 
performance for negative words (relative to neutral), and worse recognition 
performance for positive words (relative to neutral) in MDD compared with 
controls. Furthermore, in MDD, we hypothesized increased activation of the 
amygdala, hippocampus, insula, and decreased activation of prefrontal regions 
during encoding and recognition of negative information, whereas decreased 
activation of amygdala, hippocampus, striatal and medial PFC regions was 
expected during positive word encoding and recognition, relative to controls. 
We investigated whether this pattern generalizes to anxiety disorders with and 
without comorbid MDD and to what extent emotional word memory is affected 
by severity of depression and anxiety. 
52 | Emotional word encoding and recognition in depression and anxiety 
PARTICIPANTS
Three-hundred-one native Dutch speaking participants (233 outpatients with a 
half year diagnosis of MDD and/or PD and/or SAD and/or GAD, and 68 controls) 
recruited from the observational Netherlands Study of Depression and Anxiety 
(NESDA) were included and underwent magnetic resonance imaging in the 
Leiden University Medical Center (LUMC), Academic Medical Center (AMC) 
Amsterdam, or University Medical Center Groningen (UMCG). The Ethical 
Review Boards of each participating center approved this study. All participants 
provided written informed consent. Detailed information on participant 
recruitment and inclusion criteria can be found in the supplemental material.
TASK PARADIGM
We employed an event-related, subject-paced, word encoding- and recognition 
paradigm (Daselaar, Veltman, Rombouts, Raaijmakers, & Jonker, 2003). During 
the encoding part, participants were asked to classify 40 positive, 40 negative, 
and 40 neutral words according to their valence. Words were presented pseudo-
randomized together with 40 baseline trials in 20 blocks of eight words. After a 
retention interval of ten minutes, participants were asked to complete a word 
recognition task. This task consisted of the 120 old encoding target words and 
120 new distracter words, and 40 baselines. During baseline trials participants 
had to indicate the direction of arrows (<<left,<<middle>>,right>>). Words were 
presented pseudo-randomized in 20 blocks of 14 words. Subjects had to indicate 
whether they have ‘seen’ (i.e.,remembered) the words previously, ‘probably 
have seen it’ (‘know’), or ‘haven’t seen it’ (rejection). Participants’ responses 
and response times were registered through two magnet-compatible button 
boxes.  A detailed description of the task is given in the supplemental material. 
Before and after the word encoding-recognition task, we monitored anxiety 
levels using a Visual Analogue Scale (VAS) (Huskisson, 1974) ranging from zero 
to 100. 
ADDITIONAL PSYCHIATRIC MEASUREMENTS
Severity of depression and anxiety at the day of scanning was assessed using 
Dutch versions of the Beck Anxiety Inventory (BAI) (Beck et al., 1988), the 
Montgomery Åsberg Depression Rating Scale (MADRS) (Montgomery & 
Åsberg, 1979), the Inventory of Depressive Symptomology (IDS) (Rush et al., 
1986), and the Fear Questionnaire (FQ) (Marks & Mathews, 1979).
IMAGE ACQUISITION
Imaging data were acquired using Philips 3-tesla MRI-systems (Best, The 
Netherlands) located at the LUMC, AMC, and UMCG, equipped with SENSE-8 
(LUMC and UMCG) and SENSE-6 (AMC) channel head coils. For each subject, 
echo-planar images were obtained using a T2*-weighted gradient echo 
sequence (repetition time [TR]=2300ms; echo time [TE]=30ms [UMCG: 28 ms], 









acquisition, 2.29x2.29mm in-plane resolution [UMCG: 3x3mm], 3mm slice 
thickness). Anatomical imaging included a sagittal 3-dimensional gradient-
echo T1-weighted sequence (TR=9ms, TE=3.5ms; matrix 256x256; voxel size: 
1x1x1mm; 170 slices). 
STATISTICAL ANALYSIS
Psychometric and performance data were analyzed with SPSS (SPSS Inc, 
Chicago, Illinois, USA). Functional imaging data were preprocessed and 
analyzed using Statistical Parametric Mapping software (SPM5; http://www.fil.
ion.ucl.ac.uk/spm/) implemented in Matlab 7.1.0. (The MathWorks Inc., Natick, 
MA, USA).  To test for effects of the diagnosis, groups were formed based on 
current psychopathology and comorbidity. To test for the effects of depressive 
state, we formed subgroups based on current IDS score: 1) remitted (IDS 0-13), 
2) mildly depressed (IDS 14-25), and 3) moderately to severely depressed 
(IDS>25) (Muller et al., 2000). Age and education were added to each model to 
account for variance related to these factors.
Performance 
Abbreviations and descriptions of performance indices are listed in Table 1. 
Proportions Correctly Recognized words (pCREC), proportions False Alarms 
(pFA), and old/new discriminant accuracy (d’;=pCREC - pFA) were calculated, 
overall and per valence (i.e. positive, negative, neutral). 
Effects of diagnosis on recognition performance were analyzed for pCREC_
all, pFA_all, and d’_all using ANCOVAs. Repeated-Measures analyses of 
covariance (ANCOVAs) were performed to test for interaction of valence and 
diagnosis, and valence and depressive state, on task performance. Deviation 
response times [(pos/neg) – neutral] of SCR and CREC were calculated and 
entered in multivariate analyses of covariance (MANCOVAs) to test for effects 
of diagnosis/depressive state on response times. Age and years of education 
were entered as covariates in each analysis. Significance for behavioral analyses 
was set at p<.05, and post hoc paired tests (T-test or Mann-Whitney [U]) were 
Bonferroni-corrected for multiple comparisons (pcrit).
Imaging data
Preprocessing included reorientation of the functional images to the anterior 
commissure, slice time correction, image realignment, registration of the T1-
scan to the mean image, warping to Montreal Neurological Institute (MNI)-
space as defined by the SPM5 T1-template, reslicing to 3x3x3mm voxels and 
spatial smoothing using an 8-mm FWHM Gaussian kernel. Subject movement 
greater than 3mm in more than one direction resulted in exclusion of the data. 
Next, data were analyzed in the context of the General Linear Model (Friston 
et al., 1995). Haemodynamic responses to each stimulus were modeled with 
a delta function convolved with a synthetic haemodynamic response function 
and modulated using response times. The model included regressors for
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1 SCR_pos, SCR_neg, SCR_







MISS_neg, MISS_neu, BL. 
(CREJ=correct rejections;  
MISS=misses)
encoding1 and recognition2 parameters. In addition, filler words, error- and 
no-response trials were included as a regressor of no interest. Low-frequency 
noise was removed by applying a high-pass filter (cut-off: 128s) to the fMRI 
time-series at each voxel. Owing to the small proportion of recognition trials 
that were responded to with a ‘know’ response, these responses were treated 
as ‘remembered’ and consequently added to either CREC or FA.
Following the summary statistics approach, contrast images for ‘SCR_pos > 
SCR_neu’, ‘SCR_neg > SCR_neu’, ‘CREC_pos >CREC_neu’, and ‘CREC_neg>
CREC_neu’, were calculated per subject on a voxel-by-voxel basis and entered 
into second-level analyses for between-group comparisons (MANCOVA) with 
age and education as covariates. Additionally, ‘center’ was added as a regressor 
by means of two dummy variables. We repeated the analysis after omission of 
the SSRI-users. We contrasted positive and negative SCR/CREC trials to neutral 
SCR/CREC trials to avoid inclusion of signal related to familiarity processes 
which might be expected when contrasting against the repetitive lower 
level baseline. We tested for the effects of anxiety severity on encoding and 
recognition related activity by performing a linear regression analysis with BAI 
scores as regressor of interest, and age, IDS scores, and center as covariates, 
masked with a binary mask derived from the relevant main effect at p<.05. 
We defined the following areas of interest: hippocampus, amygdala, 
dorsal medial PFC (Brodmann area (BA) 8 and 9), ventromedial PFC (BA 10), 
dorsolateral PFC (BA 8, 9 and 46), OFC (BA 11), IFG (BA 44, 45, and 47), ACC (BA 
32 and 24), striatum, and insula (BA 13). 
The main effects of task are reported at a threshold of p<.05, corrected for 
Family Wise Error (FWE) at the voxel level, unless specified otherwise. To restrict
3
Encoding phase
SCR Subsequent Correct a word, presented during the encoding phase, that is correctly recognized 
Recognition during the subsequent recognition phase
Recognition phase
CREC Correct RECognition correct recognition of a previously encoded word 
CREJ Correct REJection correct recognition of a newly presented word as a new word 
FA False Alarm incorrect indication of a newly presented word as a previously encoded word
MISS Miss incorrect indication of a previously encoded word as a new word 
PROB Probably seen/known indication that a word is 'probably seen' 
All
p/prop proportion
rt response time in seconds
BL baseline
d' old/new discrimination accuracy (pCREC)-(pFA)
Affixes






the search for significant effects to voxels which were identified in the main 
effect, group comparisons were masked with the orthogonal relevant main 
effect (across groups) at p<.05 (uncorrected). Group by task interaction effects 
(F-tests) were inspected at p<.005, uncorrected and post-hoc t-tests had to 
meet p<.05, FWE voxel wise corrected for the spatial extent of the volume 
of interest, to be considered significant. For this small volume correction, we 
used the Automated Anatomical Labeling atlas (Maldjian, Laurienti, Kraft, 
& Burdette, 2003), implemented in the WFU-Pick Atlas toolbox (Wake Forest 
University School of Medicine). For non-ROIs, a voxel level threshold of p<.05 
FWE whole brain corrected was set a priori. 
The statistical toolbox Biological Parametric Mapping (Wake Forest University 
School of Medicine, 2010) was used to test whether between-group effects 
were affected by variations in regional gray matter volume (Casanova et al., 
2007). We used individual modulated gray matter images derived from the T1 
scans (for a description and results of the optimized voxel based morphometry 
procedure, see van Tol et al. (2010)). Gray matter images were normalized to 
standard MNI space and resliced to 3x3x3 mm voxels. 
SAMPLE CHARACTERISTICS
Group characteristics are listed in Table 2. Our final sample for the present 
report consisted of 215 participants, 51 with a diagnosis of MDD and no anxiety 
disorders (MDD), 59 patients with MDD and anxiety disorder(s) (comorbid 
depression-anxiety [CDA]), 56 patients with one or more anxiety disorder 
(panic disorder, social anxiety disorder, generalized anxiety disorder), but 
no MDD (ANX), and 49 controls. A description of excluded data sets is given 
in  the supplemental material. Importantly, no selective drop out of data over 
diagnosis was observed (X²(3)=1.39; p=.71). 
Groups were matched for age, education (years), sex, handedness, and scan 
center. Patient groups did not differ in number of patients using an SSRI. All 
patient groups showed higher scores on the Montgomery Åsberg Depression 
Rating Scale (MADRS) scores, Inventory of Depressive Symptomology (IDS), 
Beck Anxiety Inventory (BAI), and Fear Questionnaire (FQ) than controls (all: 
U>34;p<.001). Additionally, the comorbid depression-anxiety group showed 
higher depression (MADRS and IDS) and anxiety scores (BAI) than the MDD and 
ANX groups, both at the time of scanning (T2) and at the time of the NESDA 
baseline interview (T1) (all: U>425; P<.001). Also, the comorbid depression-
anxiety group showed higher FQ scores than the MDD group (U=486; p<.001), 
but not than the ANX group (U=1026.5; p=.94). Within diagnostic groups, SSRI-
users did not differ from antidepressant non-users in scan center, sex, age, 
education, scan interval, onset and severity of depression and anxiety, and 
recurrence of depressive episodes in MDD and comorbid depression-anxiety 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































comorbid depression-anxiety), the remitted, mildly and moderately to severely 
depressed groups did not differ in age, education, and sex. See Table S-2 for 
characteristics of the MDD and comorbid depression-anxiety subgroups. 
Between T1 and T2, the remitted and mildly depressed subgroups showed 
a decrease in symptom scores; currently moderately to severely depressed 
groups showed stable symptom scores.
BEHAVIORAL RESULTS
Classification behavior, memory performance, and response times are 
summarized in Table S-3.
Classification behavior: An interaction of diagnosis and valence was observed 
on classification behavior (F6,388=3.67,p=.001,ŋ²=.05): during the encoding task, 
MDD classified fewer words as positive and more words as neutral, compared 
with controls. This effect was observed trend-wise in the ANX group, but not 
in comorbid depression-anxiety group. No effect of group on classification of 
negative words was observed. 
Recognition accuracy: No effect of diagnosis was found on memory 
performance (all F<.74;p>.53) and no effect of group x valence was observed for 
correctly recognized words, false alarms and d’ (all F<.84;P>.54). 
Response times: Analysis of response times revealed an interaction of diagnosis 
and valence on response times (F6,418=2.41;p=.03,ŋ²=.03): controls showed 
shorter response times when encoding positive words than MDD patients. This 
effect was observed independent of illness severity in the MDD group, and in 
the moderately and severely depressed comorbid depression-anxiety group3. 
Also, MDD patients showed longer response times when recognizing positive 
than neutral words, an effect that was absent in controls. No effect of valence 
on response times was observed in anxiety disorders without MDD, and results 
were unaffected by anxiety severity. Results are summarized in Figure-1. 
Results remained unchanged after omission of the SSRI-users. 
FMRI RESULTS
FWE corrected main effects of the contrast ‘SCR_pos>SCR_neu’ and ‘SCR_
neg>SCR_neu’ reflecting encoding related activity are listed in Table S-4. At a 
more liberal voxel-threshold of p<.001, uncorrected, the left ventral putamen/
striatum, right hippocampus, amygdala, insula, and bilateral fusiform gyri also 
showed activation during encoding. No whole brain FWE corrected effects of 
‘CREC_pos>CREC_neu’ and ‘CREC_neg>CREC_neu’, reflecting recognition 
related activity, were observed. At p<.001, uncorrected, emotional recognition 
was associated with activation of the left inferior frontal gyrus and dorso-
medial PFC. Interactions of task and diagnosis and effects of illness severity are 
listed in Table 3. 
3 Only three CDA patients 
were remitted at time of scan-
ning (see Table 2). Therefore, 
we left the remitted CDA 
group out of the severity 
analyses.
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FIGURE 1: RESPONSE TIMES 
PLOTS
Error bars showing mean ± se for 
response times in seconds (s) for 
SCR per valence for MDD, CDA, 
ANC, and HC (top figure); CREC 
per valence for MDD, CDA, ANC, 
and HC (middle figure); SCR per 
valence for CDA_mild, CDA_
mod/sev, and HC (bottom figure).
3
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TABLE 3: MAIN EFFECTS OF DIAGNOSIS AND EFFECTS OF ILLNESS SEVERITY ON EMOTIONAL 
MEMORY
for the contrasts ‘SCR_pos > SCR_neu’, ‘SCR_neg > SCR_neu’, ‘CREC_pos > CREC_neu’, and CREC_neg > CREC_
neu. Results are reported at pFWE < .05, corrected for volume of Anatomic Automatic Label (AAL); BA = Brodmann 
Area; side=hemisphere; L=left; R=right. [] gray matter volume  corrected Z-values  and corresponding p-values 
are printed between brackets. ** significant at p<.001,  uncorrected
regions side BA x y z T Z P SVC_FWE
MDD<HC
hippocampus R n/a 33 -18 -12 4.19 [4.17] 4.14 [4.08] .003 [.005]
ANX<HC
hippocampus R  n/a 33 -24 -9 3.80 [3.77] 3.76 [3.70] .027 [0.034]
MDD_mod/sev>HC
anterior cingulate cortex L 24 -3 3 39 3.75 3.65 .03
regions side BA x y z T Z P SVC_FWE
MDD>HC
insula L 13 -33 12 -15 3.52 [3.33] 3.49 [3.23] .048 [.11]
MDD_mod/sev>HC
anterior hippocampus/amygdala (lateral) R n/a 33 -9 -18 3.36 3.29 .045
caudate head L n/a -6 12 0 3.54 3.46 .028
superior prefrontal gyrus R 8 24 18 48 3.47 3.39 .15 **
putamen R n/a 33 9 0 3.33 3.26 .052 **
regions side BA x y z T Z P SVC_FWE
ANX>MDD
inferior frontal gyrus L 45 -54 18 21 4.29 [3.76] 4.24 [3.69] .004 [.045]
CDA_mod/sev>HC
middle frontal gyrus L 10 -30 48 3 3.94 3.84 .023
middle frontal gyrus L 8 -45 12 45 3.71 3.62 .046
regions side BA x y z T Z P SVC_FWE
negative correlation of BAI within CDA
middle/inferior frontal gyrus R 46 36 42 15 5.38 4.75 .001
Emotional word encoding
positive words > neutral words; encoding
MNI-coordinates
MNI-coordinates
negative words > neutral words; recognition
MNI-coordinates
negative words > neutral words; encoding
MNI-coordinates
Emotional word recognition
positive words > neutral words; recognition
FIGURE 2: 
EFFECTS OF DIAGNOSIS 
AND ILLNESS SEVERITY 
ON ENCODING
A) Effects of groups 
(F statistics) on ‘SCR_
pos>SCR_neu’ overlayed 
(top) and 90% confidence 
intervals (C.I.) centered 
at the right hippocampus 
showing contrast estimates 
of diagnosis (middle) and 
depression severity subgroups 
within MDD and CDA, and HC 
(bottom); 
B) Effect of MDD>HC on ‘SCR_
neg>SCR_neu’ (Z-statistics) 
(top) and 90% confidence 
intervals (C.I.) centered at the 
left ventral insula showing 
effects of group (middle) and 
effects of depression severity 
within MDD and CDA, and HC 
(bottom); 
C) Effects of MDD_mod/sev> 
HC on ‘SCR_pos>SCR_neu’ 
(Z-statistics) (top) and 90% 
confidence intervals (C.I.) 
centered at the left ACC 
showing contrast estimates of 
depression severity subgroups 
within MDD and CDA, and HC 
(bottom); 
D) Effects of MDD_mod/sev> 
HC on SCR_neg>SCR_neu’ 
(Z-statistics) (top) and 90% 
confidence intervals (C.I.) 
centered at the right anterior 
h i p p o c a m p u s / a m y g d a l a 
showing contrast estimates of 
depression severity subgroups 
within MDD and CDA, and HC 
(bottom). Plots centered at 
the left caudate nucleus, right 
putamen, and right superior 
PFC showed similar effects 
(plots not shown). 
Z- and F-statistics are 
displayed on mean T1 
SPM5 template at p<.005, 
uncorrected. Effects on 
positive encoding are 
displayed in the left boxes, 
effects on negative encoding 
in the right boxes. 
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ENCODING
Effect of diagnosis
A group by valence interaction was observed in the right hippocampus 
(F3,418=7.21, Z=3.72). Post-hoc t-tests demonstrated that patients showed 
hypoactivation of the right hippocampus compared with controls during 
positive encoding only, and was most strongly observed in the MDD and 
ANX groups (See Figure-2A). Comorbid depression-anxiety showed this 
hypoactivation below threshold (Z=2.7, pFWE=.21, puncorrected=.004). The 
hippocampal hypoactivation was not explained by regional volume, illness 
severity (Figure-2A_bottom), and SSRI use. Also, within the moderately to 
severely depressed MDD and CDA groups, hippocampal hypoactivation did not 
vary as a function of depression severity (r<|.14|, p>41). Next, we tested for the 
main effect of diagnosis on positive and negative word encoding separately. 
In addition to the hippocampal effect during positive encoding, an effect of 
group was observed on negative encoding in the left insula (F3,418=4.34, Z=2.58). 
Post-hoc t-test showed increased insular activation in MDD relative to controls 
(Figure-2B), that was observed independent of SSRI-use and illness severity 
(Figure-2B_bottom), also within severity groups. This effect was not observed 
during positive word encoding.
Effects of illness severity 
Positive word encoding: Within MDD, an effect of depression severity was 
observed in the left ACC (BA 32; F3,142=5.54, Z=3.02). A post-hoc t-test showed 
that compared to controls, moderately to severely depressed MDD patients 
showed increased ACC activation, whereas remitted and mild MDD patients 
and the comorbid depression-anxiety subgroups did not show this activation 
difference (Figure-2C). No effect of depression severity was observed in the 
comorbid depression-anxiety and ANX groups, and no correlation of anxiety 
severity was observed within groups. Moreover, within moderately to severely 
depressed MDD and comorbid depression-anxiety groups, ACC activation did 
not vary as a function of depression severity (r<-.19, p>.51).
Negative word encoding: An effect of depression severity on negative word 
encoding was observed in the right anterior hippocampus/amygdala, left 
caudate nucleus, right putamen, and right superior PFC (all F3,142>4.47, Z>2.58; 
p<.005; Figure-2D): Post-hoc t-tests showed that moderately to severely 
depressed MDD patients showed hyperactivation of these regions compared 
with controls, although the superior PFC and right putaminal hyperactivation 
were observed subthreshold at pFWE=.15 and pFWE=.052, respectively. Within 
the moderately to severely depressed group, activation in these regions was 
unrelated to IDS and BAI scores (all r<|.36|, p>.20). No effect of depression and/




EFFECTS OF DIAGNOSIS 
AND ILLNESS SEVERITY 
ON RECOGNITION
A) Effects of ANX>MDD 
on ‘CREC_pos>CREC_neu’ 
(Z-statistics) (top) and 90% 
confidence intervals (C.I.) 
centered in the left inferior 
frontal gyrus showing mean 
response per group (bottom); 
B) Effects of CDA_mod/
sev>HC on ‘CREC_pos>CREC_
neu’ (Z-statistics) (top) and 
90% confidence intervals 
(C.I.) centered in the left 
DLPFC (bottom) showing 
contrast estimates of 
depression severity subgroups 
within MDD and CDA, and 
controls. The frontopolar 
hyperactivation was observed 
on ‘CREC_neg>CREC_neu’ as 
well.
Z- and F-statistics are displayed 




No significant interaction of diagnosis x valence occurred at the set threshold. 
For exploratory purposes, we tested for the effects of diagnosis on positive 
and negative word recognition separately. An effect of group was observed on 
positive word recognition in the left inferior frontal gyrus (F3,418=6.91, Z=3.62; 
p<.001; Figure-3A). Post-hoc t-tests demonstrated that the ANX group showed 
hyperactivation of this region compared with MDD, and trend-wise compared 
with controls (Z=3.06; pFWE=.17, puncorrected=.001). No effect of diagnosis was 
observed on negative word recognition. 
Effects of illness severity 
Within the comorbid depression-anxiety group, a main effect of illness severity 
on positive word recognition was observed on left superior PFC and left frontal 
pole activation (F2,142>7.78, Z>3.23; Figure-3C):  the moderately to severely 
depressed group showed increased activation of these regions compared with 
controls. However, this fronto-polar effect was also observed during negative 
word recognition, although subthreshold at pFWE=.07. Also, within the comorbid 
depression-anxiety group, a negative correlation of Beck Anxiety Inventory 
(BAI) scores and activation of the right dorsolateral PFC was observed when 
Inventory of Depressive Symptomatology (IDS) scores were added to the 
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model (Figure-3B). No effect of illness severity was observed within the MDD 
and ANX group on positive  or negative word recognition. 
In this study, we investigated the unique and shared functional MRI correlates 
of mood-congruent and mood-incongruent word encoding and recognition 
in patients with MDD and frequent co-occurring anxiety disorders, explicitly 
testing for the effects of their comorbidity, and at the same time controlling for 
symptom severity, regional brain volume, and SSRI use. 
Overall, we found no evidence for the hypothesized mood-congruent and 
mood-incongruent memory biases, as indicated by equal recognition accuracy 
for emotional words across diagnostic groups and controls. We demonstrated 
a depression related effect on response times during the encoding of positive 
words, unrelated to depressive state in MDD without comorbid anxiety, but 
related to current depressive state in patients with comorbid depressed-
anxiety. Anxiety disorders without MDD were not associated with biases in 
memory or processing speed. Imaging results in MDD largely confirmed our 
hypothesis of differential involvement of (para)limbic and dorsal and lateral 
cortical areas during mood-congruent vs. mood-incongruent word encoding. 
Our results of increased processing times for positive information in MDD and 
currently depressed comorbid depression-anxiety are in concordance with the
mood- incongruent bias theory as proposed by Bower (1981) and suggest that 
positive content impedes encoding and recognition in MDD. 
In anxiety, no memory bias towards positive or negative material was found, 
consistent with previous studies (Coles & Heimberg, 2002). The absence of a 
mood-congruent bias in anxiety may be attributed to the low self-relevance of 
the words presented in our experiment, as previous research in panic disorder 
and generalized anxiety disorder demonstrated an attentional bias only when 
threat words with high self-relevance were presented (Coles et al., 2007). The 
absence of biases on recognition performance in mood and anxiety disorders 
has been described before (Banos, Medina, & Pascual, 2001; Bremner et al., 
2004; van Wingen et al., 2009), although not consistently (Bradley et al., 1995; 
Epstein et al., 2006; Hamilton & Gotlib, 2008). Differences in findings could 
result from memory processes examined (e.g., strategic linking vs. priming; 
recognition vs. free recall) and task specifications, for instance length of the 
retention interval between encoding and recognition.
Our imaging result of a hypo-response during positive encoding in the 
hippocampus in both patients with MDD and anxiety disorders, and trend-wise 
in patients with comorbid depression-anxiety, compared with controls was 
unexplained by regional volume, SSRI use, and illness severity and therefore 
indicates a depression-anxiety generic phenomenon during encoding of 
positive words. Given the important role of the hippocampus in episodic 







memory (Squire, Stark, & Clark, 2004), recollection of previously learned 
material (Daselaar, Fleck, & Cabeza, 2006), and context-based memory 
(Davachi, Mitchell, & Wagner, 2003; Ranganath et al., 2004), our results suggest 
decreased contextual coupling during semantic classification and simultaneous 
encoding of positive words in both depression and anxiety disorders. Possibly, 
mood-incongruent information is insufficiently recognized as positive 
information and subsequently connected less efficiently to (less) available 
memory ‘nodes’, as reflected in fewer words classified as positive, hippocampal 
hypo-activation, and longer response times. Hippocampal blunting in untreated 
patients with MDD during a neutral episodic memory task has been described 
before (Bremner et al., 2004). We now demonstrated hippocampal blunting 
during positive encoding in MDD and patients with anxiety disorders other than 
posttraumatic stress disorder. Also, we demonstrated that this hippocampal 
blunting is not specific to the moderately/severely depressive state, but is 
observed in the mild and (newly) remitted state as well. This finding supports 
previous behavioral studies that demonstrated a state independent memory 
bias in MDD for positive stimuli only, whereas biases towards negative stimuli 
appeared state dependent phenomena (Bradley & Mathews, 1988; Teasdale & 
Dent, 1987). 
In addition, over-recruitment of the dorsal ACC during encoding of positive 
information was specifically observed in moderately and severely depressed 
MDD patients, and not in mild or remitted depressed patients. This over-
recruitment of the dorsal cognitive subdivision of the ACC (Bush et al., 2000) 
may be interpreted as recruitment of extra attentional resources to classify 
mood- incongruent words in currently depressed patients, as this effect was 
not observed during encoding of negative words. As positive words might 
not be associated with a personally relevant state (Lemogne et al., 2009) in 
currently depressed patients, additional ACC resources might be called on to 
resolve this classification conflict (Kerns et al., 2004).
Related to encoding of negative words, exploratory analyses indicated a a 
trait-like effect of MDD was observed in the left ventral insula, that may reflect 
a general increased sensitiveness for negative information (Surguladze et al., 
2010). It has been suggested that abnormal insula functioning in MDD reflects 
the presence of somato-vegetative symptoms and indicates an abnormal sense 
of the self (Wiebking et al., 2010). In addition, a depressive state dependent 
hyperactivation of the right anterior hippocampus/lateral amygdala, caudate 
head, and trend-wise right putamen, and superior frontal cortex was observed 
during encoding of negative words only, results that are in line with the report of 
Hamilton and Gotlib (2008). This finding suggests that an abnormal amygdalar 
response is related to depressive state, and the co-activation of the superior 
PFC and striatum implies increased recruitment of the dorsolateral PFC circuit 
(Mega & Cummings, 1994) that may mark a state dependent sensitivity for 
encoding negative information. Surprisingly, increased amygdalar/striatal/PFC 
activation was not observed in moderately to severely depressed comorbid 
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depression-anxiety patients. The finding of normal subcortical and PFC activity 
during encoding of mood-congruent stimuli in comorbid depression-anxiety is 
in concordance with behavioral studies (Grant & Beck, 2006; Musa et al., 2003; 
Tarsia, Power, & Sanavio, 2003), and it has been suggested that the presence 
of depressive symptoms in anxious patients abolishes the attentional bias. A 
possible explanation is that depression and anxiety are associated with hypo- 
and hyper-vigilant responses (Posner, Russell, & Peterson, 2005), respectively, 
when processing negative information, resulting in a net null effect. 
In MDD, recognition of positive and negative words was unaffected in terms 
of BOLD responsiveness. Exploratory analyses in CDA patients indicated 
increased activation of left frontal pole and DLPFC during both negative and 
positive word recognition associated with depression severity. Moreover, 
in anxiety disorders without MDD left inferior frontal hyperactivation was 
observed during the recognition of positive words compared with MDD 
patients, and trend-wise compared with controls. This inferior frontal gyrus 
over-recruitment may indicate an increased need for attentional resources for 
correct response selection (Thompson-Schill, D’Esposito, Aguirre, & Farah, 
1997), possibly due to less efficient encoding, as reflected in the hippocampal 
blunting during positive word encoding. 
No effect of trait anxiety or depression was observed on recognition of 
negative words. However, as a function of depressive state, CDA patients 
showed increased activation of left frontal pole and DLPFC during both 
negative and positive word recognition. This valence non-specific effect 
suggests an increased demand for attentional and executive control during 
word recognition to maintain adequate task performance (van den Heuvel et 
al., 2003; Wagner, Koch, Reichenbach, Sauer, & Schlösser, 2006), related to 
illness severity. The moderately to severely CDA patients were characterized by 
higher depression and anxiety severity score than the moderately to severely 
MDD patients. This difference in illness severity may explain why we did not 
observe increased frontal recruitment during recognition in MDD patients 
without comorbid anxiety disorders.  
In general our results were largely unaffected by variations in regional gray 
matter volume and inclusion of SSRI users, and no difference in activation in 
the reported regions was observed between SSRI-users and medication free 
patients (data not shown). Effects of SSRI treatment on amygdalar reactivity 
have been previously reported by Sheline et al. (2001) This latter result may be 
alternatively interpreted as an effect of successful treatment (i.e., remission), 
and therefore in line with our findings: only currently depressed MDD, and not 
remitted patients, showed increased anterior hippocampal and amygdalar 
responses to negative information. 
In this study we included large and representative outpatient groups, excluded 
insufficient performers, could test for state and trait like effects, and were 
able to correct for possible confounds such as SSRI use and regional volume. 
However, several potential limitations should also be noted. First, the NESDA 
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strategy of recruiting through general practitioners and outpatient clinics across 
a wide range of disease severity and duration is likely to result in a representative 
sample but may also have increased variability (i.e., noise), without fully 
capturing the most severe end of the depressive spectrum. Second, on average, 
only approx. 15 per cent of the presented words were ‘forgotten’ (i.e., MISS). 
Therefore, the contrast ‘recognized>forgotten’ was underpowered and could 
not be calculated. Hence, caution should be taken when interpreting the results 
as purely reflecting memory related activity. However, we only analyzed signal 
related to events with a high probability of reflecting successful encoding and 
recognition related activity (i.e. SCR/CREC), and concentrated on valence 
effects during successful encoding and recognition which are likely to be subtle. 
Also, our strategy to control for type I error using an individual ROI approach 
rather than correcting for the overall search volume, although customary 
in imaging research, should be considered a potential limitation. Third, the 
negative words used in our study were not selected based on their relevance for 
mood and specific anxiety disorders, but had a negative connotation in general. 
We therefore could not examine encoding and recognition effects of disorder 
specific and non-specific negative words. Fourth, although similar 3-tesla 
systems were used at each site in this multi-center study, variability in image 
acquisition may have occurred due to minor differences in hardware (receiver 
coil), imaging parameters, and timing of software upgrades, but no systematic 
scanning site x diagnosis bias occurred. Finally, we aggregated the anxiety 
disorders in order to capitalize on our sample size and to compare the neural 
profile of these anxiety disorders with those observed in comorbid depression-
anxiety and MDD. Therefore, no conclusions regarding the specific neural 
patterns of individual anxiety disorders within the ANX group could be drawn.
In conclusion, our results indicate that abnormal encoding of positive 
information is a shared feature of depression and anxiety, whereas abnormal 
encoding of negative information is a unique feature of MDD without comorbid 
anxiety. Hippocampal blunting during positive word encoding appeared 
as a common and state-independent neurophysiological phenomenon in 
depression and anxiety that may mark a general insensitiveness to positive 
information. At the same time, MDD is characterized by increased reactivity 
for negative words, reflected in an increased insular, amygdalar, striatal, and 
PFC response. With respect to their functional MRI profile during negative 
word processing, MDD with and without comorbid anxiety disorders should be 
considered separate groups. Possibly, comorbid depression-anxiety is primarily 
characterized by anxiety related functional neuropathology since the onset of 
anxiety disorders often precedes the manifestation of the first episode of MDD 
(Parker et al., 1999). Future studies should investigate whether individuals at 
high risk for depression and anxiety are characterized by abnormal processing 
of positive stimuli, as this may constitute a risk factor for mood and anxiety to 
be considered in prevention programs. Furthermore, we underline that current 
comorbid anxiety disorders should be controlled for when studying processing
67
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PARTICIPANT RECRUITMENT AND INCLUSION CRITERIA
Participants were recruited from NESDA (Netherlands Study of Depression 
and Anxiety), a large-scale multi-site longitudinal observational cohort study 
(Penninx et al., 2008). The rationale, methods, and recruitment have been 
described in detail elsewhere (Penninx et al., 2008). Out of the 2981 NESDA 
respondents (main sample, T1), participants aged between 18 and 57 years 
were asked to participate in the NESDA neuroimaging study (T2) if they met 
DSM-IV criteria for a half-year diagnosis of MDD and/or anxiety disorder (PD, 
SAD and/or GAD), or no lifetime DSM-IV diagnosis (i.e. healthy controls). At this 
interval, no specific intervention occurred. Exclusion criteria for patients were 
1) the presence of axis-I disorders other than MDD, PD, SAD or GAD, 2) any 
use of psychotropic medication other than a stable use of selective serotonin 
reuptake inhibitors (SSRIs) or infrequent benzodiazepine use (i.e., equivalent 
to 2 doses of 10 mg of oxazepam 3 times per week or use within 48 hrs prior to 
scanning). Exclusion criteria for all NESDA-participants were: 3) the presence 
or history of major internal or neurological disorder 4) dependency or recent 
abuse (past year) of alcohol and/or drugs, 5) hypertension, 6) general MR-
contraindications. Diagnoses were established using the structured Composite 
International Diagnostic Interview (CIDI) (Robins et al., 1988), administered by a 
trained interviewer. Healthy controls were currently free of, and had never met 
criteria for, depressive or anxiety disorders or any other axis-I disorder and were 
not taking any psychotropic drugs.
Complete word encoding and recognition data (EPIs and e-prime output) 
were not available of 15 participants. Data of another 61 participants were 
excluded because of 1) bad quality of the EPI data acquired during encoding 
and/or recognition (n=22), 2) movement >3mm (n=6), 3) not enough coverage 
of the hippocampus and amygdala (n=4), 4) loss of voxels in the first level mask, 
owing to large inter-hemispheric frontal space (n=1), 5) very low discriminant 
power (i.e. d’=<.1; n=17) or >40 missing responses (n=7), indicating unreliable 
task involvement, 6) medication use (n=2; 1x mirtazepine, 1x corticosteroids), 
7) MADRS scores of HC (n=2) that were indicative of possible depressive 
psychopathology (Muller et al., 2000). To obtain a good match on both age and 
education, data of another ten subjects (CDA patients: n=7; HC: n=3) had to be 
excluded. Characteristics of the CDA patients were: male/female: 2/5; mean 
(sd) age: 41.1 (4.8); mean (sd) years of education: 6.7 (1.6); mean (sd) IDS score: 
24.7 (11.38), mean (sd) BAI: 13.7 (8.3). Of the three excluded healthy controls, 
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TASK PARADIGM
We employed an event-related, subject-paced, implicit word encoding- and 
recognition paradigm (Daselaar et al., 2003), programmed in E-prime software 
(Psychological Software Tools, Pittsburgh, PA). During the encoding part 40 
positive, 40 negative, and 40 neutral words, and 40 baseline trials were presented 
in 20 blocks of eight words. Words were presented with an average ISI of 1026 
ms (minimum, 1018 ms; maximum, 1035 ms). Within each block, two negative 
words, two positive words, two neutral words and two baseline trials were 
presented randomized. Over valence (i.e. negative, neutral, positive), words 
were matched for length (ranging from three to twelve letters) and frequency of 
occurrence in the Dutch language. The task was paced by the subject, but each 
word was presented with a maximal duration of 5 sec. During each stimulus 
presentation, response options were displayed at the bottom of the screen. 
Subject had to indicate whether they thought the word presented was positive, 
negative, or neutral to them. Baseline (BL) words were ‘<<left’, ‘<<middle>>’, 
and ‘right>>’ and participants were instructed to press the corresponding 
button. To protect against primacy and recency effects three filler (1 positive, 1 
negative, 1 neutral) words were presented at the start and end of the encoding 
task. These filler words were not part of the subsequent recognition task. The 
recognition test phase consisted of the 120 old encoding target words and 120 
new distracter words, and 40 baselines. Again, words were presented pseudo-
randomized in 20 blocks of 14 words, each block containing two old and two 
new negative words, two old and two new positive words, two old and two new 
neutral words, and two baseline trials. 'Old' and 'new' words were matched 
on complexity, word length, and emotional intensity. Subjects had to indicate 
whether they have ‘seen’ (i.e. remembered) the words previously, ‘probably 
have seen it’ (i.e. know), or ‘haven’t seen it’ (rejection). Interval between the 
encoding task and recognition task was 10 minutes. Participants’ responses and 
response times were registered through two magnet-compatible button boxes. 
No feedback regarding the answers was provided.
The words encoding and recognition task was administered as part of a 
larger functional and structural imaging study, results of which will be reported 
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T1 and T2. Rem
=rem
itted depressed state at T2; m
ild=m
ild depressed state at T2; m
od/sev=m
oderately to severely depressed state at T2. * significant w
ithin-
group difference p<.05 (non-param
etric related sam
ples test).
TABLE S-3: TASK PERFORMANCE
Classification behavior: number of words classified as positive, neutral, and negative during the encoding phase. 
Mean proportion correct and response times for encoding and recognition indices. Abbreviations can be found in 
Table 1. A one-way ANCOVA showed no effect of diagnosis on proportion PROB responses (Mold_words= .13, sd=.09; 
F=.42, p=.74; Mnew_words=.14, sd=.09; F=.23, p=.88). Therefore, we added the PROB trials to the CREC or FA and 
recalculated the proportion CREC and FA (and d’). * In the word encoding task, 42 positive, 42 neutral and 42 
negative words (including the filler words) were presented.
3
MDD CDA ANX HC
# words classified as:pos mean ± sd 39.32 ± 9.95 41.45 ± 11.03 39.51 ± 8.8 44.62 ± 9.82
neu "" 46.52 ± 10.74 42.04 ± 11.84 44.61 ± 11.37 40.21 ± 9.89
neg "" 39.79 ± 2.80 40.81 ± 5.06 41.28 ± 5.27 40.40 ± 4.51
MDD CDA ANX HC
CREC _all prop; mean ± sd .85 ± .08 .84 ± .09 .84 ± .09 .82 ± .11
_neg "" .84 ± .10 .84 ± .11 .84 ± .10 .82 ± .13
_pos "" .85 ± .10 .86 ± .09 .85 ± .11 .83 ± .12
_neu "" .84 ± .11 .83 ± .12 .84 ± .10 .79 ± .14
FA _all "" .26 ± .12 .25 ± .14 .25 ± .10 .25 ± .13
_neg "" .32 ± .12 .31 ± .15 .31 ± .12 .33 ± .16
_pos "" .28 ± .15 .27 ± .18 .27 ± .13 .28 ± .18
_neu "" .19 ± .11 .18 ± .16 .16 ± .09 .15 ± .10
d' _all "" .58 ± .14 .59 ± .14 .60 ± .12 .56 ± .12
_neg "" .52 ± .12 .53 ± .13 .53 ± .12 .50 ± .12
_pos "" .57 ± .17 .59 ± .18 .58 ± .15 .56 ± .18
_neu "" .65 ± .16 .65 ± .17 .68 ± .14 .64 ± .15
MDD CDA ANX HC
rt_SCR _neg in sec: mean ± sd 1.27 ± .26 1.28 ± .35 1.26 ± .28 1.23 ± .36
_pos "" 1.49 ± .35 1.48 ± .39 1.42 ± .27 1.36 ± .31
_neu "" 1.53 ± .33 1.58 ± .41 1.53 ± .38 1.49 ± .36
rt_CREC _neg "" 1.24 ± .21 1.24 ± .23 1.24 ± .24 1.25 ± .27
_pos "" 1.34 ± .27 1.31 ± .26 1.29 ± .23 1.32 ± .27
_neu "" 1.28 ± .22 1.31 ± .27 1.32 ± .27 1.34 ± .29
rt_CREJ _neg "" 1.46 ± .30 1.46 ± .34 1.44 ± .28 1.47 ± .32
_pos "" 1.5 ± .31 1.52 ± .33 1.52 ± .29 1.49 ± .32
_neu "" 1.38 ± .26 1.36 ± .30 1.41 ± .25 1.38 ± .26
rtFA _neg ""  1.50 ± .49 1.49 ± .43 1.48 ± .46 1.49 ± .51
_pos "" 1.66 ± .59 1.69 ± .65 1.57 ± .55 1.74 ± .76
_neu "" 1.54 ± .54 1.90 ± .71 1.68 ± .67 2.04 ± .83
rtMISS _neg "" 1.79 ± .62 1.98 ± .80 1.92 ± .69 1.84 ± .60
_pos "" 1.97 ± .68 1.89 ± .68 1.91 ± .73 1.99 ± .68
_neu "" 1.66 ± .65 1.62 ± .55 1.69 ± .57 1.77 ± .63
rtBL_enc "" .83 ± .17 .81 ± .16 .79 ± .14 .83 ± .24





Regions side BA x y z T Z
Frontal
inferior frontal gyrus L 45/47 -51 21 0   6.95   6.95
inferior frontal gyrus L 44 -57 9 18   5.17   5.17
anterior cingulate gyrus L 32 -3 45 -3   6.56   6.56
medial superior frontal gyrus L 10 -3 57 0   6.32   6.32
medial frontal gyrus L 10 0 60 18   5.96   5.96
middle frontal gyrus L 6 -33 -9 57   5.94   5.94
middle frontal gyrus L 6 -45 3 51   5.43   5.43
middle/superior frontal gyrus R 6 27 -3 57   5.13   5.13
inferior frontal gyrus R 44 51 6 30   4.94   4.94
precentral gyrus L 4 -30 -24 48   4.87   4.87
temporal/parietal
superior temporal gyrus/middel temporal gyrus L 22/39 -51 -54 18   7.36   7.36
superior temporal gyrus/gyrus supramarginalis L 39/40 -57 -51 30   5.61   5.61
middle temporal gyrus L 37 -51 -66 3   5.11   5.11
posterior cingulate gyrus L 31 -6 -54 27   5.66   5.66
inferior parietal lobule R 40 45 -30 42   5.44   5.44
inferior parietal lobule L 40 -39 -39 42   5.30   5.30
inferior parietal lobule L 40 -45 -33 42   5.21   5.21
inferior parietal lobule L 40 -42 -33 57   5.27   5.27
middle temporal gyrus L 21 -48 -30 -6   5.03   5.03
inferior parietal lobule L 40 -33 -48 57   4.83   4.83
other (subcortical)
caudate nucleus L -9 -3 12   4.94   4.94
Regions side BA x y z T Z
Frontal
middle frontal gyrus L 6 -30 -6 54   6.42  6.26
medial frontal gyrus L 9 -6 51 24   5.67  5.56
inferior frontal gyrus R 44 48 9 30   5.14  5.06
inferior frontal gyrus L 44 -48 9 27   5.10  5.02
precentral gyrus L 6 -39 3 36   5.08  5.00
inferior frontal gyrus R 44 57 15 24   4.94  4.87
Temporal/Parietal
inferior parietal lobule L 40 -42 -42 39   7.28  7.06
inferior parietal lobule L 40 -33 -48 42   6.86  6.68
supramarginal gyrus L 40 -57 -48 27   6.35  6.20
middle temporal gyrus L 21 -48 9 -27   6.42  6.27
middle temporal gyrus L 21 -54 -3 -18   6.00  5.88
middle temporal gyrus L 21 -57 -24 -6   5.99  5.87
inferior parietal lobule R 40 45 -33 42   5.59  5.49
posterior cingulate gyrus L 31 0 -48 24   5.53  5.43
middle temporal gyrus L 39 -48 -63 6   5.19  5.11
inferior parietal lobule R 40 33 -51 51   5.02  4.95
Occipital
middle occipital gyrus R 18 48 -63 -6   5.20  5.11
occipital gyrus R 19 39 -81 0   5.19  5.10
middle occipital gyrus L 19 -30 -78 21   5.08  5.00
Main effect of SCR_pos>SCR_neu (whole brain FWE corrected)
MNI-coordinates
Main effect of SCR_neg>SCR_neu (whole brain FWE corrected)
MNI-coordinates
TABLE S-4: MAIN EFFECTS OF ENCODING OF POSITIVE AND NEGATIVE 
(VS. NEUTRAL WORDS)
Main effects of contrast ‘SCR_pos>SCR_neu’ and ‘SCR_neg>SCR_neu’ across groups (p<.05, FWE 
whole brain corrected); BA = Brodmann Area; side=hemisphere; L=left; R=right.
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Background: Major depressive disorder (MDD) has been associated with 
executive dysfunction and related abnormal prefrontal activity, whereas the 
status of executive function (EF) in frequently co-occurring anxiety disorders 
and in comorbid depression-anxiety is unclear. We aimed to study functional 
MRI correlates of (visuospatial) planning in MDD and anxiety disorders, and to 
test for the effects of their comorbidity. 
Methods: Functional-MRI was employed during performance of a parametric 
Tower of London task in outpatients with MDD (n=65), MDD with comorbid 
anxiety (n=82), or anxiety disorders without MDD (n=64), and controls (n=63).
Results: Moderately/severely depressed MDD patients showed increased 
left dorsolateral prefrontal activity as a function of task load, together with 
subtle slowing during task execution. In mildly depressed and remitted MDD 
patients, in anxiety patients and in patients with comorbid depression-anxiety, 
task performance was normal and no activation differences were observed. 
Medication use and regional brain volume were not associated with altered 
visuospatial planning. 
Conclusion: Prefrontal hyperactivation during high planning demands is not a 
trait characteristic, but a state characteristic of MDD without comorbid anxiety, 
occurring independent of SSRI-use. Disturbances in planning or the related 
activation are probably not a feature of anxiety disorders with or without 








78 | fMRI correlates of visuospatial planning in depression and anxiety 
Executive functions are essential for successful adaptation to daily life and 
comprise a complex set of cognitive function, dysregulation of which may 
result in changes in coordination, organization, and inhibition of behavior 
(Elliott, 2003). Executive deficits have been repeatedly associated with Major 
Depressive Disorder (MDD) (Rogers et al., 2004). However, MDD frequently co-
occurs with anxiety disorders, such as panic disorder, and social anxiety disorder 
(Ressler & Mayberg, 2007). Executive impairments in these common anxiety 
disorders (panic disorder, social anxiety disorder, and generalized anxiety 
disorder) are less well established and findings may have been confounded by 
the presence of comorbid MDD (Kaplan et al., 2006). Notably, the comorbid 
condition of depression and anxiety disorders has been associated with more 
severe psychopathology (Kessler et al., 2005; Roy-Byrne et al., 2000; Rush 
et al., 2005), increased disability (Fichter, Quadflieg, Fischer, & Kohlboeck, 
2010; Gorman, 1996; Spijker et al., 2004), and worse outcome compared with 
patients with only a diagnosis of MDD or anxiety disorders (Bruce et al., 2005; 
Gorman,1996; Gorman & Coplan, 1996; Melartin et al., 2004; Roy-Byrne et 
al., 2000; Rush et al., 2005). Nevertheless, the neural correlates of executive 
functions in comorbid depression-anxiety disorders have not been investigated 
yet. 
A key aspect of executive functioning is planning (i.e. the process of making 
a plan when facing a problem, and performing the plan, while monitoring its 
execution), associated with recruitment of a dorsal prefrontal-parietal-striatal 
network during functional Magnetic Resonance Imaging (fMRI) in healthy 
controls as measured with the Tower of London visuospatial planning task (van 
den Heuvel et al., 2003; Wagner et al., 2006). In MDD, conflicting findings have 
been reported: Whereas two emission tomography studies (i.e., PET (Elliott et 
al., 1997) and SPECT (Goethals et al., 2005)) observed reduced prefrontal and 
subcortical perfusion coupled with impaired performance, in the only fMRI 
study to date increased dorsolateral PFC activation was found in depressed 
subjects relative to healthy controls (Fitzgerald et al., 2008). However, the size 
of the included depressed groups was rather small, limiting the power of the 
studies and the generalizability to the depressive population at large. Also, 
inconsistencies in results may have arisen owing to differences in scanning 
modalities and clinical characteristics of patient groups, including medication 
use and the presence of comorbidity.
In the present study, we aimed to investigate neural correlates of visuospatial 
planning in a large sample of outpatients with a half-year diagnosis of MDD, 
MDD with a comorbid anxiety disorder or an anxiety disorder without comorbid 
MDD, and in healthy controls. We also investigated whether illness severity 
(McDermott & Ebmeier, 2009) and use of antidepressant medication was 
associated with (abnormal) planning performance and its neural correlates. 
Executive processes including visuospatial planning have been shown to rely on 












dorsolateral PFC, and anterior cingulate cortex (ACC) (van den Heuvel et al., 
2003; Wagner, Koch, Reichenbach, Sauer, & Schlösser, 2006). Importantly, 
these regions have also been implicated in neuroanatomical models of 
mood regulation in psychiatric disorders (Drevets et al., 2008a; Phillips et 
al., 2003b) and some evidence exists that top-down regulatory brain regions 
are compromised in MDD (Heller et al., 2009; Johnstone et al., 2007). 
However, whether such deficient DLPFC and ACC involvement is implicated 
in the neuropathology of both depression and anxiety disorders has, to our 
knowledge, rarely been studied. Therefore, we aimed to examine executive 
function during a planning task in patients with MDD, anxiety disorders 
or comorbid depression-anxiety. We hypothesized that relative to healthy 
controls, outpatients with MDD with and without comorbid anxiety exhibit 
impaired visuospatial planning performance coupled with abnormal DLPFC 
and anterior cingulate cortex (ACC) activity, correlated with illness severity. 
Finally, we aimed to explore whether anxiety disorders were characterized by a 
similar pattern of visuospatial planning abnormalities.
PARTICIPANTS
Participants were recruited from the NESDA study (Netherlands Study of 
Depression and Anxiety), a large-scale, multi-site longitudinal observational 
cohort study (Penninx et al., 2008). NESDA has been designed to be 
representative of those with depressive and anxiety disorders in different 
health care settings and different stages of the developmental history of 
disorders (e.g., normal controls, high familial risk, subthreshold disorders, 
first and recurrent episodes). Therefore, the sample is stratified for setting 
(community, primary care, and specialized mental health) and set up to include 
a range of psychopathology. The rationale, methods, and recruitment have 
been described in detail elsewhere (Penninx et al., 2008).
Out of the 2981 NESDA respondents, participants aged between 18 and 57 
years were asked to participate in the NESDA neuroimaging study if they met 
diagnostic and statistical manual for mental disorders (DSM) version IV criteria 
for MDD and/or anxiety disorder (panic disorder and/or social anxiety disorder 
and/or generalized anxiety disorder) during the last six months, or no lifetime 
DSM-IV diagnosis. 
Exclusion criteria for patients were 1) the presence of axis-I disorders other 
than MDD, panic disorder, social anxiety disorder, generalized anxiety disorder, 
lifetime, 2) any use of psychotropic medication other than a stable use of SSRIs 
or infrequent benzodiazepine use (i.e., equivalent to 2x10 mg oxazepam 3 times 
a week, or use within 48 hrs prior to scanning). Healthy control participants 
had never met criteria for any DSM-IV disorder and were not taking any 
psychotropic drugs. 
Exclusion criteria for all participants were: 3) presence of major internal and/
or neurological disorders (including contusio cerebri), 4) dependency or recent






abuse (past year) of alcohol and/or drugs, 5) hypertension, 6) general MRI 
contraindications. Diagnoses according to DSM-IV algorithms were established 
using the structured Composite International Diagnostic Interview (CIDI) – 
lifetime version 2.1 (Robins et al., 1988), administered by a trained interviewer. 
Overall, 301 native Dutch speaking participants (233 patients and 68 HC) 
were included and underwent magnetic resonance imaging in one of the three 
participating centers (i.e., Leiden University Medical Center [LUMC], Academic 
Medical Center [AMC], University of Amsterdam, and University Medical 
Center Groningen [UMCG]). The study was carried out in accordance with the 
Declaration of Helsinki. Also, the Ethical Review Boards of each participating 
center approved this study. All participants provided written informed consent 
after complete description of the study. 
TASK PARADIGM
We used an event-related parametric version of the Tower of London, 
described in detail elsewhere (van den Heuvel et al., 2003). Briefly, participants 
were presented a starting configuration and a target configuration and were 
requested to work out the minimum number of steps (ranging from one to 
five) to reach the target (Figure 1). In the baseline condition, participants were 
instructed to count the number of blue and yellow beads. We used a pseudo-
randomized, self-paced design with maximal response duration of 60s for each 
trial, presented using E-prime (Psychological Software Tools, Pittsburgh, PA, 
USA). Participants’ responses and response times were registered through two 
magnet-compatible button boxes. No feedback regarding the answers was 
provided. 
FIGURE 1:
EXAMPLE OF THE 
TOWER OF LONDON
A) example of a one-step 
planning trial. 





Severity of depression and anxiety at the day of scanning was assessed using 
Beck Anxiety Inventory (Beck et al., 1988) and the Montgomery Åsberg 
Depression Rating Scale (Montgomery & Åsberg, 1979). During the scanning 
session, we monitored anxiety levels using a Visual Analogue Scale (Huskisson, 
1974) ranging from 0 to 100. Prior to scanning, participants underwent a brief 
training session (10 trials).
The Tower of London paradigm was performed as part of a larger functional 
imaging session, including a verbal memory task, an emotional faces paradigm, 
and ‘resting state’ imaging, results of which will be reported elsewhere. The 
Tower of London paradigm was administered as the first paradigm in each 
session. 
IMAGE ACQUISITION
Imaging data were acquired using Philips 3-Tesla magnetic resonance 
systems (Best, The Netherlands) located at the Leiden University Medical 
Center, Academic Medical Center Amsterdam, and University Medical Center 
Groningen, equipped with a SENSE-8 (Leiden University Medical Center and 
University Medical Center Groningen) and a SENSE-6 (Academic Medical 
Center) channel head coil, respectively. For each subject, echo-planar 
images (EPI) were obtained using a T2*-weighted gradient echo sequence 
(repetition time [TR]=2300 ms, echo time [TE]=30ms [University Medical 
Center Groningen: TE=28 ms], matrix size: 96x96 [University Medical Center 
Groningen: 64x64], 35 axial slices [University Medical Center Groningen: 39 
slices], interleaved acquisition, 2.29x2.29mm in-plane resolution [University 
Medical Center Groningen: 3x3mm], 3mm slice thickness). Echo planar images 
were scanned parallel to the anterior-posterior commissure plane. 
Anatomical imaging included a sagittal 3-dimensional gradient-echo T1-
weighted sequence (TR=9 ms, TE=3.5 ms; matrix 256x256; voxel size: 1x1x1mm; 
170 slices). 
DATA ANALYSIS
Task performance and clinical characteristics
Psychometric and performance data were analyzed with SPSS (SPSS Inc., 
Chicago, Il, USA). If the data did not meet the assumptions required to perform 
parametric analyses, and log-transforming did not resolve these problems, 
the appropriate non-parametric test was performed (Kruskall-Wallis multiple 
independent sample test [H] and subsequent Mann-Whitney test for two 
independent samples [U]). Performance was analyzed by means of a Repeated-
Measures-ANCOVA, using the proportion correct scores and mean response 
times per trial type as dependent factors, group ( 1) MDD without comorbid 
anxiety disorders [MDD], 2) comorbid depression-anxiety [CDA], 3) anxiety 
disorders [ANX], healthy contols [HC]) as between subject factor, and age as a
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covariate. Significance for behavioral analyses was set at 5%, and post hoc 
paired tests were Bonferroni-corrected for multiple comparisons. 
Image processing
Functional imaging data were preprocessed and analyzed using Statistical 
Parametric Mapping software (SPM5; http://www.fil.ion.ucl.ac.uk/spm/) 
implemented in Matlab 7.1.0 (The MathWorks Inc., MA, USA). Preprocessing 
included slice time correction, image realignment, registration of the T1-scan 
to the mean EPI, warping to MNI-space as defined by the SPM5 T1-template, 
reslicing to 3x3x3mm voxels and spatial smoothing using an 8mm FWHM 
Gaussian kernel. Subject movement greater than 3mm in any direction resulted 
in exclusion of the data from further analysis. 
The fMRI experiment was modelled in an event related fashion with 
regressors (i.e. explanatory variables) made by convolving each event-related 
stimulus function (baseline, 1-5 step trials) with a canonical haemodynamic 
response function and modulated using reaction times. In addition, error and 
no-response trials were included as a regressor of no interest. Low-frequency 
noise was removed by applying a high-pass filter (cut-off of 128s) to the fMRI 
time-series at each voxel. 
Main effects of task and between group comparisons
Following the summary statistics approach, contrast images for task load 
(with trial types 1-5 having weights [-1.5 –1 –0.5 1 2]) were calculated per 
subject on a voxel-by-voxel basis and entered into second-level analyses for 
between-group [MDD, CDA, ANX, HC] comparisons (1x4 ANCOVA), with age 
as covariate. Additionally, ‘center’ was added as a regressor by means of two 
dummy variables. We repeated this analysis after exclusion of the SSRI using 
patients and also directly compared the functional maps of SSRI using patients 
to SSRI-non using patients. To test for the impact of depression severity on 
planning activity we formed 3 clinical relevant subgroups (Muller et al., 2000) 
and compared them to HC: 1) remitted (MADRS 0-8), 2) mild (MADRS 9-18), 
3) moderate/severe depressed (MADRS>18). We performed an ANCOVA with 
age and center as covariates within MDD, CDA, and HC, and repeated these 
analyses with BAI scores as additional covariate. Separately, we tested for 
the effects of anxiety severity within group by performing a linear regression 
analysis with BAI scores as regressor of interest, and age, MADRS score, and 
center as covariates, masked with a binary mask derived from the relevant main 
effect at p<.005, uncorrected. 
The main effect of task is reported at a threshold of p<.05 whole brain corrected 
for Family Wise Error (pFWE_wholebrain). For the between-group comparisons, we 
choose the dorsolateral PFC and anterior cingulate cortex (ACC) as regions 
of interest (ROI). To restrict the search for interaction effects to voxels which 
were identified in the main effect, group comparisons were masked with the 
orthogonal relevant main effect at p<.005 (uncorrected).
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Group by task interaction effects were inspected at p<.001, uncorrected 
(puncorrected). To further protect against Type-I error, Small Volume Correction 
(SVC) was applied for the main comparison (effect of diagnosis), by centering 
a sphere with a 16mm radius around the peak voxel (i.e., twice the size of the 
smoothing kernel and equivalent to 17.2 ml). The resulting volumes of interest 
had to meet p<.05, FWE voxel  corrected (pFWE_SVC), to be considered significant. 
Non-ROIs had to meet p<.05, whole brain FWE corrected (pFWE_wholebrain).
In a previous study, we reported decreased ACC volumes in both patients 
with MDD and anxiety disorders (van Tol et al., 2010). Therefore, we used the 
statistical toolbox Biological Parametric Mapping (BPM; Wake Forest University 
School of Medicine) to test whether between-group effects were affected by 
variations in regional grey matter volume (Casanova et al., 2007). 
SAMPLE CHARACTERISTICS
Data from 12 participants were excluded because of poor imaging data 
quality or incomplete data. In addition, task involvement was considered 
insufficiently reliable when overall performance was below 75%, (including 
baseline accuracy) in order to maximize the likelihood of analyzing planning-
related activity and to reduce possible bias due to non-task related processes. 
Distribution of sufficient/insufficient performance was similar over groups 
(MDD: 65/4; comorbid depression-anxiety: 82/3; panic disorder and/or social 
anxiety disorder: 64/4; healthy controls: 65/2, X²3,289= 1,12, p=.77). We excluded 
insufficient performers from further analysis (n=13). Finally, two healthy 
controls were excluded because of Montgomery Åsberg Depression Rating 
Scale scores >8 (Muller et al., 2000). 
Our final sample consisted of 274 participants, i.e. 65 patients with a half-year 
diagnosis of MDD (MDD), 82 patients with MDD plus panic disorder and/or social 
anxiety disorder and/or generalized anxiety disorder (comorbid depression-
anxiety [CDA]), 64 patients with panic disorder and/or social anxiety diosrder, 
and/or generalized anxiety disorder without MDD (ANX), and 63 healthy 
controls (HC). Group characteristics are listed in Table 1. All diagnostic groups 
showed higher Montgomery Åsberg Depression Rating Scale and Beck Anxiety 
Inventory scores than the healthy controls. In addition, comorbid depression-
anxiety patients showed higher Montgomery Åsberg Depression Rating Scale 
and Beck Anxiety Inventory scores than patients with MDD or anxiety disorders, 
and patients with anxiety disorder showed higher Beck Anxiety Inventory 
scores than MDD (Montgomery Åsberg Depression Rating Scale: all z> -4.26, 
p<.001; Beck Anxiety Inventory: all z> -3.01,all p<.003). The sample was highly 
representative of the main NESDA sample (see supplemental material). 
Depression severity scores decreased during the interval between baseline 
assessments (T1) and subsequent MRI sessions (T2) (Table S-1). Splitting of the 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































TABLE 2: DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF THE REMITTED, MILD, 
AND MODERATE/SEVERE MDD AND CDA SUBGROUPS
MADRS= Montgomery Asberg Depressive Rating Scale; BAI: Beck Anxiety Inventory; IDS= Inventory of 
Depressive Symptomatology; rem=MADRS scores indicative of a remitted depressive state (0-8); mild=MADRS 
scores indicative of a mild depressive state (9-18); modsev=MADRS scores indicative of a moderate to severe 
depressive state(>18); T1= baseline assessment; T2=MRI measurement; interval= time between T1 and T2. * = 
significant at p<.05, paired T-test.  
revealed that only the currently remitted and mildly depressed subgroups, 
but not the  moderate/severe subgroups, showed this decrease in symptom 
severity (see Table 2).
Groups matched on gender, handedness, distribution of diagnosis over 
scan-center, and age (all X²< 7.23, p>.3; age: H3= 6.36, p=.10). SSRI use was not 
significantly different across patient groups (X²2= 5.06, p=0.08). Groups differed 
in years of education (H3=28.77, p<.001), due to healthy controls being higher 
educated than MDD and comorbid depression-anxiety (HC>MDD: U=1361.5; 
HC>CDA: U=1292; all p<.008).
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BEHAVIORAL RESULTS
Overall, no effect of diagnosis was observed on planning accuracy (F 7.77;699.66= 
1.29, p=.25) and performance speed (F4.99;449.26= .35, p=.86). During the task, 
patients with anxiety disorders reported higher levels of anxious arousal than 
healthy controls (ANX>HC: VAS: U=1457, z= -2.7, p<.008; all other comparisons: 
All z< -2.24, all p>.025) (Table 3). 
IMAGING RESULTS
Brain activation patterns reflecting increasing task load were highly consistent 
over groups (Figure 2), involving clusters in bilateral DLPFC, frontopolar 
regions, superior frontal regions, lateral parietal cortices, and precuneus (Table 
S-2, reported at pFWE_wholebrain<.05). 
A main effect of diagnostic group was observed in the left DLPFC (Figure 
3-A): MDD subjects showed increased activation in the left DLPFC relative to 
HC ([x=-39 y=36 z=30], BA 9/46, Z=3.59, pFWE_SVC=.04). CDA showed increased 
left DLPFC activation as compared to HC that approached significance ([x=-
39 y=36 z=30], BA 9/46, Z=2.69, puncorrected =.004). No other group comparison 
revealed significant differences. Results were unaffected by regional brain 
volume differences. 
Effects of SSRI’s
We repeated our analysis over 205 SSRI-free participants. Groups were similar 
to the overall groups with respect to demographic and clinical characteristics. 
Exclusion of the SSRI using patients did not change behavioral and imaging 
results. In addition, we directly compared SSRI-using and SSRI-free subjects. 
Clinical characteristics were similar in SSRI-free and SSRI-using groups. No 
effect of SSRI use was found. 
Effects of illness severity
Within the MDD and comorbid depression-anxiety1 group, depressive state 
(remitted, mild, and moderate/severe) was unrelated to gender, scan center, 
and SSRI use. 
Within MDD patients, illness severity was trend-wise associated with response 
times (F2,58=3.07, p=.054, ŋ²=.1). Explorative post hoc t-tests showed that the 
moderately to severely depressed MDD patients showed increased response 
times during execution of all trial types, except for step-5 trials as compared 
to remitted patients (Step 1-4: all T38= >.2.12, p<.04: Step 5: T38=1.69, p=.1). 
Within patients with comorbid depression-anxiety, no effect of illness severity 
on response times was observed (F1,68=.93, p=.34). Also, no effect of depression 
severity was observed on planning accuracy (MDD: F2,60=1.05, p=.36; CDA: 
F1,68=.87, p=.37).
A multivariate analysis of covariance (MANCOVA) with Beck Anxiety Inventory 
scores as fixed factor showed no effect of anxiety scores on performance and 
response times (all F<1.07, p>.32). Adding Montgomery Åsberg Depression
1 Only three CDA patients were 
remitted at time of scanning 
(see Table 2). Therefore, we left 
the remitted CDA group out of 
the severity analyses.
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TABLE 3: TASK PERFORMANCE
VAS=Visual Analogue Scale. Baseline: baseline trials of the ToL task. Step 1 thru 5: ToL trials with the minimum 
amount of steps to achieve the goal configuration ranging from 1 thru 5. Total: total proportion of correct trials. 
Variable Mean SD Mean SD Mean SD Mean SD
VAS total score 32.8 24.44 37.89 25.05 42.94 26.20 29.86 24.08
baseline proportion correct 0.98 0.03 0.98 0.04 0.98 0.04 0.98 0.04
1 step " 0.96 0.06 0.95 0.05 0.96 0.06 0.96 0.06
2 step " 0.92 0.12 0.92 0.09 0.94 0.07 0.93 0.08
3 step " 0.94 0.09 0.93 0.10 0.92 0.09 0.94 0.08
4 step " 0.85 0.15 0.78 0.19 0.81 0.15 0.84 0.14
5 step " 0.80 0.16 0.77 0.23 0.76 0.19 0.78 0.17
total " 0.94 0.06 0.93 0.06 0.93 0.05 0.94 0.04
baseline response time (s) 3.51 1.11 3.89 1.26 3.60 1.22 3.43 1.05
1 step " 4.69 1.40 5.08 1.51 4.86 1.47 4.46 1.09
2 step " 5.82 1.73 6.24 1.69 6.19 1.94 5.66 1.46
3 step " 8.07 2.68 8.17 2.30 8.31 2.27 7.95 2.71
4 step " 11.44 4.36 11.58 3.69 11.40 3.63 11.62 4.02
5 step " 15.77 6.41 16.13 5.49 16.54 5.97 15.86 4.94
MDD CDA ANX HC
FIGURE 2:
MAIN EFFECTS OF 
INCREASING TASK 
LOAD
Activation maps of the main 
effect of increasing task load 
within the four diagnostic 
groups (MDD: n=65; CDA: 
n=82; ANX: n=64; HC: n=63). 






A) Left: Increased DLPFC 
activation as compared to HC. 
Right: Parameter estimates 
and 95% confidence intervals 
showing increased activation 
of the left DLPFC in MDD as 
compared HC, and trendwise 
in CDA; B) Left: Areas showing 
increased DLPFC activation 
in the moderately/severely 
depressed MDD patients 
as compared to HC. Right: 
Parameter estimates and 
95% confidence intervals 
showing increased activation 
of the left DLPFC is specific 
for moderately/severely 
depressed MDD patients. 
Group difference is displayed 
at p<.001, uncorrected. 
Rem=remitted depressed 
patients; mild= mildly 
depressed patients; mod/
s e v = m o d e r a t e l y / s e v e r e l y 
depressed patients
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Rating Scale scores as a covariate or omitting the SSRI users from the analysis 
did not affect these results. 
Imaging correlates of depression severity
The increased left dorsolateral PFC activation relative to healthy controls was 
found to be specific for the moderately and severely depressed MDD patients: 
MNI coordinates: [x=-36 y=33 z=27], BA 46/9, Z=3.62, pSVC=.04 [see Figure3-B]. 
No differences in left dorsolateral PFC activation were observed between the 
mild and remitted MDD subgroups and healthy controls. Within comorbid 
depression-anxiety patients, no effect of depression severity on dorsolateral 
PFC activation was observed. Omission of the SSRI-users from the analysis did 
not affect these results. Adding Beck Anxiety Inventory scores to the models 
did not change the effects of depressive state on activation patterns. 
Imaging correlates of anxiety severity 
No effect of anxiety severity was observed on task related activity in MDD, CDA 
and ANX. 
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In the present study, we used a parametric visuospatial planning task (Tower of 
London) to investigate the neurophysiological correlates of increased planning 
load in a large sample of outpatients with MDD, MDD with comorbid anxiety 
disorders, and anxiety disorders only, compared with healthy controls. Anxiety 
disorders included in this study were panic disorder, social anxiety disorder, 
and generalized anxiety disorder. To our knowledge, this is the first functional 
neuroimaging study that was able to test for effects comorbidity of depression 
and anxiety, depressive state, and medication use on visuospatial planning 
and its neural correlates. Also, to our knowledge, this is the first functional 
neuroimaging study to investigate the neural correlates of executive function 
(i.e., planning) in PD and SAD, two highly prevalent anxiety disorders. 
Taken together, our results indicate that depression with or without anxiety 
disorders is not associated with gross trait visuospatial planning impairments, 
but with subtle state abnormalities. Increased DLPFC activation coupled 
with subtle decreases in response speed during task execution was observed 
in MDD patients with moderate/severe depression only. MDD patients with 
mild or (newly) remitted depression showed similar performance and DLPFC 
activation as HC. This observation is in line with 18FDG-PET findings of Holthoff 
and colleagues (2004), who reported that remission was accompanied by 
dorsolateral and dorsomedial PFC (and cingulate) metabolism as compared 
with the active depressed state, although no direct comparison with healthy 
controls was made. Furthermore, we observed that in MDD with comorbid 
anxiety disorders increased left DLPFC activation occured subthreshold, 
independent of illness severity. In PD and SAD, normal performance and 
no planning related activation differences were observed, nor did we find 
significant correlations of anxiety severity in anxiety disorder patients with or 
without comorbid depression. Results were unrelated to variations in regional 
gray matter volume. Finally, no overall effects of SSRI-use were observed, 
consistent with reports in bipolar patients (Goswami et al., 2009).
Our finding of normal executive functioning related fronto-striatal activation 
in panic disorder and social anxiety disorder are consistent with those of Van 
den Heuvel and coworkers (2005b) during classical Stroop performance in 
panic disorder. In the present study we chose to capitalize on our sample 
size by incorporating all anxiety disorders within one group, which enabled 
us to identify their shared task-related activity patterns as compared with 
the comorbid group, in which MDD was often accompanied by more than 
one anxiety disorder. Taken together, these findings suggest that, in contrast 
to obsessive compulsive disorder (van den Heuvel et al., 2005a), executive 
function in panic disorder, social anxiety disorder, and generalized anxiety 
disorder is not abnormal.
Similar to Fitzgerald and coworkers (2007), we observed increased dorsolateral 
PFC activation during Tower of London performance in MDD, although in the 






between the study of Fitzgerald and ours is unclear, but could result from a 
number of methodological issues, such as small sample size, the non-parametric 
task design, and the inclusion of error-trials in the study of Fitzgerald.
In the present study, task-related activity was assessed using a parametric 
load contrast, which is likely to be more specific for detecting task-related 
activity (Friston, Holmes, Poline, Price, & Frith, 1996). In addition, we could not 
replicate the findings of abnormal Tower of London performance coupled with 
decreased frontal-striatal activation as reported by Elliott and colleagues (1997). 
However, the sample size in this early PET study was small (n=6), and the use 
of psychotropic medication and presence of comorbid Axis-I disorders was not 
controlled for. Also, Elliott and coworkers (1997) included the functional maps 
of poorly performing subjects; consequently, the possibility that decreased 
prefrontal activation was due to non-engagement during task blocks cannot be 
ruled out. Finally, our results are not in line with the observations of Goethals 
and coworkers (2005), who observed slower Tower of London performance 
coupled with decreased prefrontal perfusion in nine medicated MDD patients 
relative to nine control subjects. However, these authors used a fixed-order 
dual-scan 99mTc- SPECT method difficult to compare with conventional PET- 
and fMRI paradigms.
This is the first study that explicitly investigated executive functioning in 
comorbid depression-anxiety disorder. Our clinical data appear to support the 
suggestion that patients with comorbid depression-anxiety differ from MDD 
patients in their clinical  profile and course (Bruce et al., 2005; Kessler et al., 
2005; Rush et al., 2005), as the comorbid depression-anxiety patients showed 
higher depression and anxiety symptom scores than MDD patients. Also, the 
number of remitted comorbid depression-anxiety patients did not increase 
between the NESDA baseline measurement (T1) and the MRI measurement 
(T2), whereas depression and anxiety severity decreased substantially between 
T1 and T2 in MDD patients; almost one-third of the MDD patients reached the 
remitted phase by the time of scanning (i.e. within two months on average). 
With respect to task performance, contrary to our expectations, CDA patients 
showed no executive deficits as measured with the Tower of London, but 
showed a trend of increased left DLPFC recruitment as a function of increased 
planning load. This discrepancy in findings may indicate that CDA is primarily 
characterized by anxiety related neuropathology (i.e. no planning deficits), 
as in most patients the anxiety disorder was the first to manifest. However, 
this suggestion should be further tested in future research. Nevertheless, our 
results indicate that with respect to neural correlates of visuospatial planning, 
the comorbid condition of depression and anxiety is not identical to the pattern 
observed in MDD, especially with regard to the effects of depression severity. 
The present results of similar task performance (i.e., error rates) across groups 
appear to be at odds with a number of neuropsychological studies that showed 
executive deficits in MDD. Given that executive functions are implicated 
particularly in novel problem solving (Alvarez & Emory, 2006), the
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Tower of London arguably has adequate face validity. In contrast, the construct 
validity and specificity of executive tasks like the frequently used Wisconsin 
Card Sorting Test and verbal fluency tasks has been called into question (Alvarez 
& Emory, 2006; Carpenter, Just, & Reichle, 2000). Interestingly, whereas 
previous Tower of London imaging studies (Elliott et al., 1997; Fitzgerald et 
al., 2007; Goethals et al., 2005) have reported abnormal performance in MDD, 
neuropsychological studies have shown mixed results: two studies reported 
impaired performance in middle-aged MDD subjects (Elliott et al., 1996; 
Naismith et al., 2003), but studies in younger subjects failed to demonstrate 
impaired Tower of London performance in MDD (Naismith, Longley, Scott, 
& Hickie, 2007; Porter, Gallagher, Thompson, & Young, 2003; Purcell, Maruff, 
Kyrios, & Pantelis, 1997). Behavioral results from the present study are 
therefore in agreement with these latter neuropsychological studies and may 
indicate that cognitive functioning is relatively unaffected in the outpatient 
population (Castaneda et al., 2008; Castaneda et al., 2010; Gladsjo et al., 1998; 
van Wingen et al., 2009). 
Imaging results of the present study are partially in agreement with previous 
imaging studies in MDD using other executive tasks such as the Stroop task, 
working memory tasks (n-back and delayed match to sample) and verbal 
fluency tasks, although these tasks may be characterized as tasks of selective 
attention and behavioural inhibition as well. Most (Matsuo et al., 2007; Wagner 
et al., 2006; Walter, Vasic, Hose, Spitzer, & Wolf, 2007), but not all (Videbech 
et al., 2004) neuroimaging studies using working memory or Stroop tasks 
reported similar task performance in patients and controls. Increased (dorsal) 
lateral PFC (Matsuo et al., 2007; Wagner et al., 2006; Walter et al., 2007), 
frontopolar (Matsuo et al., 2007) and ACC (Wagner et al., 2006) activation 
has been reported during n-back and Stroop performance in MDD, although 
not consistently (Siegle et al., 2007). In contrast, two studies using a verbal 
fluency paradigm in MDD reported impaired performance coupled with 
increased (Okada, Okamoto, Morinobu, Yamawaki, & Yokota, 2003) or normal 
dorsolateral PFC activation (Videbech et al., 2003). However, verbal fluency 
tasks rely heavily on intact semantic memory, and therefore verbal fluency 
impairment may be reflective of a more generalized impairment than executive 
dysfunction (Henry & Crawford, 2005).
The present study has a number of strengths. We recruited a large and 
representative outpatient sample, which allowed us to compare several clinical 
groups to our healthy controls, and to investigate the effects of psychotropic 
drug use (SSRIs) and symptom severity within each clinical group. All patients 
were extensively screened, according to the NESDA protocol (Penninx et al., 
2008). Moreover, our control subjects were also recruited through NESDA, 
were similarly screened and scan-naïve. Therefore, familiarity with researchers 
and/or experimental procedures could be ruled out as a potential confound. 
Furthermore, we used an event-related design, to decrease expectancy effects 
and to allow post hoc selection of correct trials; in addition, we excluded 
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participants that performed insufficiently, to minimize the risk of non-
compliance as a confounder. 
Several potential limitations should also be noted. First, since the 
epidemiological NESDA cohort was recruited through general practitioners 
and outpatient clinics, we may not have been fully able to capture the 
most severe end of the depressive spectrum. Second, MDD and comorbid 
depression-anxiety patients differed slightly from healthy controls in years of 
education, although neither performance nor task-associated brain activity was 
significantly correlated with education level (data not shown). Third, since we 
employed only one executive task, care needs to be taken when generalizing 
our results outside the executive function domains of planning (Kafer & Hunter, 
1997; Unterrainer & Owen, 2006), problem solving (Unterrainer & Owen, 
2006), and inhibition (Culbertson & Zillmer, 1998). Fourth, although similar 
3-tesla systems were used at each site in this multi-center study, variability 
in image acquisition may have occurred due to minor differences in hardware 
(receiver coil), imaging parameters, and timing of software upgrades; also, 
scanning sessions were scheduled at different hours (between 8 am and 8 pm) 
across participating centers, but no systematic scanning time x diagnosis bias 
occurred. 
Our findings of relatively increased prefrontal activation associated with task 
load in currently depressed patients are in agreement with previous studies in 
MDD and could be interpreted as reflecting less efficient recruitment of neural 
resources when faced with increasing task demands in MDD, a suggestion 
that is in line with neurocircuitry models of depression (i.e. Drevets et al., 
2008; Mayberg, 1997; Clark, Chamberlain, Shakian, 2009). We also found that 
increased dorsolateral PFC recruitment in MDD is present only in the moderate 
to severe depressive state, but not in mildly depressed and remitted states, 
which suggests high resilience of the brain executive network and does not 
indicate permanent frontal damage. Also, since the increased recruitment of 
planning resources occurred in the context of normal planning accuracy, we need 
to be careful in interpreting our findings as supportive of the notion of executive 
dysfunction in MDD outpatients. Finally, our results of increased dorsolateral 
PFC activation in severe MDD, but not in severe comorbid depression-anxiety 
seem to indicate subtle differences in neurophysiological profiles in MDD 
patients with or without comorbid anxiety disorders. Therefore, we may 
conclude that prefrontal hyperactivation during high planning demands is not a 
trait characteristic, but a state characteristic of MDD, occurring independent of 
SSRI use; however, executive dysfunction is not a feature of anxiety disorders 
(i.e., panic disorder, social anxiety disorder, generalized anxiety disorder), 
supporting the current distinction between anxiety disorders and depression. 
In conclusion, future longitudinal studies need to investigate the hypothesis 
that prefrontal over-recruitment during planning performance normalizes after 
recovery from depression in MDD without comorbid anxiety. Also, whereas the 
present results indicate that within the context of a neutral task executive 
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functions in MDD and anxiety disorders are not grossly abnormal, future 
research should investigate whether executive functions are compromised 
when processing emotional stimuli, to further elucidate the role of executive 
functions in controlling emotions in these disorders. 
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COMPARISON OF THE CURRENT SAMPLE TO THE NESDA MAIN-
SAMPLE
Groups were highly representative of the main NESDA sample with respect to 
diagnosis distribution, sexe distribution, depression severity and anxiety severity 
at the time of baseline measurement. Out of the 2981 included in the main 
sample, 1961 matched our diagnostic inclusion criteria and were aged between 18 
and 57. Of these 1961, 19 % (66% female) fulfilled the criteria for our MDD group, 
33 % (66% female) for CDA, 21% (70 % female) for ANX  and 28% (67 % female) 
for the HC group. Finally, the total group of subjects in the MRI study consisted 
of 24 % (63% female) MDD, 30 % (66% female) CDA, 23 % (72% female) ANX and 
23 % (62% female) HC. Although the sub sample of participants included in the 
MRI study were highly representative of the main sample at the time of baseline 
interview, at the time of scanning diagnostic groups showed lower depressive 
scores than at the time of baseline measurements (paired sample non-parametric 
test; MDD: z=-5.0; CDA: z=-4.1; ANX: z=-3.7; all p<.001, see table S2), but showed 
equivalent anxiety scores (mean # days between baseline measurement and MRI 
= 65 ± 45). Overall, patients groups included in the MRI study were on average two 
years younger. The sub sample of healthy controls were slightly older (+ 2.8) and 
higher educated (+ 1.4 years) than the HC in the main sample.
TABLE S-1:  
ILLNESS SEVERITY 
AT T1 AND T2 WITHIN 
PATIENT GROUPS
IDS= Inventory of Depressive 
Symptomatology; BAI= Beck’s 
Anxiety Inventory; T1=time of 
baseline assessment; T2=time 
of MRI measurement; interval 
= time between T1 and T2.
Variable Mean SD Mean SD Mean SD
IDS T1 total score 28.18 9.67 32.8 11.81 22.55 1.66
IDS T2 total score 19.76 11.03 29.06 11.83 18.67 10.70
BAI T1 total score 12.05 9.05 18.13 9.00 14.16 8.02
BAI T2 total score 9.13 8.27 18.33 9.06 13.60 9.50
interval days 65.95 39.95 58.66 51.12 68.11 31.18
MDD (n=65) CDA (n=82) ANX (n=64)
TABLE S-2: 
MAIN EFFECTS OF 
INCREASING TASK 
LOAD OVER ALL 
SUBJECT (N=274)
Main effects for the contrast 
‘increasing task load’ are 
reported at p<.05, FWE-
corrected. BA= Brodmann 
Area; side=hemisphere; 
L=left; R=right.
Lobe region x y z Z value
Frontal
Left superior frontal -21 12 54 >8
middle frontal -36 30 39 7.07
middle frontal -36 54 12 5.82
Right superior frontal 27 12 54 >8
middle frontal 33 24 48 >8
medial frontal 3 24 45 6.54
Parietal
Left precuneus (BA 7) -6 -63 42 7.70
inferior parietal -51 -51 42 7.24
inferior parietal -54 -42 42 6.58
Right precuneus (BA 7) 9 -63 48 6.95
precuneus (BA 7) 9 -60 57 6.89
inferior parietal 51 -45 42 7.21
inferior parietal 48 -54 42 6.79
Occipital
Left angular gyrus (BA -42 -72 36 5.70
Right angular gyrus (BA 42 -72 33 6.72
MNI coordinate
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SUBMITTED FOR PUBLICATION 
Background: Evaluating emotional information involves coordinated activity 
of prefrontal and subcortical brain regions that may be compromised in Major 
Depressive Disorder (MDD). This study tested whether patients with MDD show 
altered functional connectivity during the processing of emotional information 
with a set of independently derived brain networks that in previous research 
have shown high correspondence with different task demands, including 
stimulus salience and emotional processing.
Methods: Twenty-five medication-free MDD patients and 25 right-handed 
matched controls performed an event-related, subject-paced emotional word 
evaluation task during functional magnetic resonance imaging. Data were 
analyzed with a dual regression approach using eight independently derived 
template independent component networks. First, a time series was estimated 
for each template per subject. Next, a subject-specific weighted spatial map 
of brain connectivity with that template was created based on the time series 
created in the first regression step. Individual spatial connectivity maps were 
used to evaluate between-group differences using permutation tests. 
Results: In patients with MDD, we observed decreased functional connectivity 
of the medial prefrontal cortex, ventrolateral prefrontal cortex, and ventral 
striatum with a network that has previously been associated with stimulus 
salience and emotional task execution compared with controls. Within MDD, 
results were unrelated to illness severity, but related to the number of words 
evaluated as positive. No other independent component networks showed 
between-group differences.
Conclusion: The decreased connectivity of prefrontal and ventral-striatal 
regions with the salience network during emotional word evaluation confirms 
the hypothesis of a relative (para)limbic-cortical decoupling that may serve to 
explain abnormal emotional regulation in MDD.  







Failure to adaptively process emotional information is one of the key features 
of Major Depressive Disorder (MDD). The ability or tendency to continuously 
evaluate significant stimuli in our surroundings provides us with the ability 
to limit the magnitude or duration of negative emotions, thus allowing us to 
devote attention and resources to other important needs or goals. Equally, the 
capability to “lift oneself up” by evaluating stimuli in a positive manner provides 
one of the primary motivations needed in an active and productive day-to-
day life. Anhedonia, a fundamental aspect of MDD, may in large part reflect 
an inability to engage in such positive emotional appraisal. Animal research 
and neuroimaging studies with humans indicate that adaptive appraisal of 
emotional stimuli depends on intact interactions between (para)limbic and 
subcortical brain structures, and dorsal and lateral prefrontal cortical (PFC) 
areas (Ochsner et al., 2004; Phillips et al., 2003a; Wager, Davidson, Hughes, 
Lindquist, & Ochsner, 2008). A reduction in the coordinated engagement of 
such neural systems is one possible mechanism underlying MDD.
Processing external (and internal) emotional information involves the 
perception of a stimulus (e.g., word, picture, bodily sensation) and appraisal 
of this stimulus for its content, meaning, and significance. Any negative or 
positive emotional state resulting from this process of primary appraisal can 
subsequently be increased or decreased in amplitude through continuing 
reappraisal of the stimulus or situation. Circuits responsible for these processes 
may include perception areas (visual cortex, auditory cortex, sensory cortex), 
areas associated with initial evaluation of or conditioned responding to 
potentially salient information (amygdala, ventral striatum, insula) and areas 
supporting more elaborate cognitive appraisal and top-down control such as 
dorsal and lateral prefrontal cortex (Ochsner et al., 2009; Urry, van Reekum, 
Johnstone, & Davidson, 2009; Wager et al., 2008). 
Functional magnetic resonance imaging (fMRI) studies that have specifically 
tested the connectivity of (para)limbic and prefrontal regions in MDD suggest 
abnormal connectivity of the amygdala (Anand et al., 2005; Chen et al., 2008; 
Cullen et al., 2009), thalamus (Anand et al., 2005), frontal regions (Lemogne 
et al., 2009; Sheline, Price, Yan, & Mintun, 2010) including the ACC (Anand et 
al., 2005; Cullen et al., 2009; Sheline et al., 2010) and parietal regions (Bluhm 
et al., 2009; Sheline et al., 2010; Zhou et al., 2010) during emotional paradigms 
(Anand et al., 2005; Chen et al., 2008; Lemogne et al., 2009) and without any 
externally cued task (the so called resting state) (Bluhm et al., 2009; Cullen et 
al., 2009; Sheline et al., 2010). However, these studies used seed-based analyses 
where signal from one brain region is correlated with signal from other voxels 
in the brain or a (set of) predefined brain region(s). Such approaches only allow 
to test for connectivity based upon a limited number of seed regions (e.g. the 
amygdala), potentially missing important information about the involvement 
of broadly interconnected regions throughout the brain. Further, choosing a 












is based at least partially on the data being analyzed (Kriegeskorte, Simmons, 
Bellgowan,& Baker, 2009). Independent component analysis (ICA), on the other 
hand, is a multivariate data-driven approach that allows studying whole-brain 
intrinsic connectivity. Using ICA, functional data is decomposed into a set of 
independent spatial maps and their associated time series which can then be 
compared between conditions. It is now established that a highly consistent 
set of component maps can be identified across multiple studies and human 
samples (Beckmann, DeLuca, Devlin, & Smith, 2005; Biswal et al., 2010; 
Damoiseaux et al., 2006). Recent evidence suggests that such independent 
component maps depict networks of brain regions that co-activate when 
particular categories of tasks or cognitive processes are being performed 
(Smith et al., 2009), including perception, motor processing, cognition, and 
emotional processing.
So far, whole brain ICA approaches for analyzing functional imaging data 
have been sparingly applied in MDD. There is some evidence, based on resting-
state ICA that prefrontal networks are altered in MDD, though some studies 
have indicated increased (Greicius et al., 2007) while others have revealed 
decreased (Veer et al., 2010) connectivity. However, the lack of a specific task 
during resting-state studies means that brain activation and connectivity may 
be influenced by a variety of perceptual, emotional or cognitive processes 
preceding or during the resting state session (Harrison et al., 2008; Pyka et 
al., 2009; Waites, Stanislavsky, Abbott, & Jackson, 2005). Also, differences in 
cortico-limbic connectivity in MDD might become more apparent when studied 
during tasks that tap into cortico-limbic processes. So far, to our knowledge, no 
study attempted to investigate whole-brain connectivity during execution of an 
emotional task in MDD. 
In this study we tested whether depressed patients showed different patterns 
of connectivity in distributed networks during emotional processing compared 
with controls, using a subset of independently derived brain networks that are 
involved in perception, and emotional appraisal and regulation. We used a set 
of template independent component networks (ICNs) derived from a resting 
state study using healthy individuals (Beckmann et al., 2005). These ICNs 
also show strong correspondence to a set of spatial components estimated 
in a meta-analysis of the BrainMap database, which consists of activation 
maps from nearly 30,000 subjects engaged in a wide variety of tasks (18). We 
hypothesized that prefrontal and limbic connectivity within these template 
networks, specifically those found previously to become active during emotion 
tasks, would be reduced in a group of individuals with MDD compared to a 
sample of matched healthy controls. 
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PARTICIPANTS 
Twenty-five right-handed medication-free patients with a half-year diagnosis 
of MDD (16 female; age range: 20-52), with no past or present diagnosis of 
comorbid anxiety disorders were selected from the Netherlands Study of 
Depression and Anxiety (NESDA, see supplemental material) neuroimaging 
study. Diagnoses according to Diagnostic and Statistical Manual of Mental 
Disorders – Fourth Edition (DSM-IV) algorithms were established using the 
structured Composite International Diagnostic Interview (CIDI) – lifetime 
version 2.1 (Robins et al., 1988), administered by a trained interviewer. The 
control group consisted of 25 age, sex, handedness, scan-center and education 
matched healthy control participants also recruited through NESDA (HC; 
17 female; age range: 21-54), who were currently free of, and had never met 
criteria for depressive or anxiety disorders or any other axis-I disorder, and were 
not taking any psychotropic drugs. Exclusion for all participants in this analysis 
were: 1) a history of major internal or neurological disorder, 2) dependency 
or recent abuse (past year) of alcohol and/or drugs, 3) hypertension, 4) left 
handedness, 5) general MR-contraindications. 
TASK PARADIGM
We employed an event-related subject-paced word encoding paradigm 
(Daselaar et al., 2003), programmed in E-prime software (Psychology Software 
Tools, Inc., Pittsburgh, PA, USA). Forty positive, 40 negative, 40 neutral study 
words, and 40 baseline trials were presented in a pseudo-randomized order in 20 
blocks of eight words. Each block consisted of two negative words, two positive 
words, two neutral words, and two control words. Words were matched for 
length (ranging from three to twelve letters) and frequency of use. The task was 
paced by the subject, but each word was presented with a maximum duration 
of 5 sec. Subjects had to indicate whether they thought the word presented was 
positive, negative, or neutral to them (response options were displayed at the 
bottom of the screen). Control words were ‘<< left’, ‘<< middle>>’, and ‘right >>’ 
and participants were instructed to press the corresponding button. This task 
was part of a word recognition paradigm. Therefore, the task started and ended 
with three filler words to protect for the ‘primacy-recency’ memory effect. 
PROCEDURE
MR imaging was performed in one of the three participating centers, the Leiden 
University Medical Center (LUMC), Academic Medical Center (AMC), University 
of Amsterdam, or University Medical Center Groningen (UMCG). The Ethical 
Review Boards of each center approved this study. All participants provided 
written informed consent after having received written information about the 
study.
Severity of depression and anxiety on the day of scanning was assessed 
using Dutch versions of the Beck’s Anxiety Inventory (Beck et al., 1988), the 









and the Inventory of Depressive Symptomatology (Rush et al., 1986). Before 
the word encoding task, self-rated anxiety levels were monitored using a Visual 
Analogue Scale ranging from 0 to 100. The words paradigm was performed as 
part of a larger functional imaging session, including a visuospatial planning 
task (van Tol et al., 2011), an emotional faces paradigm (Demenescu et al., 
2011), and resting-state imaging (Veer et al., 2010).
IMAGE ACQUISITION
Imaging data were acquired using Philips 3-tesla MR-systems (Best, The 
Netherlands) located at the LUMC, AMC, and UMCG Neuroimaging Center, 
equipped with a SENSE-8 (LUMC and UMCG) and a SENSE-6 (AMC) channel 
head coil, respectively. For each subject, echo-planar images (EPI) were 
obtained using a T2*-weighted gradient echo sequence (repetition time 
[TR]=2300 ms, echo time [TE]=30ms [UMCG: TE=28 ms], matrix size: 96x96 
[UMCG: 64x64], 35 axial slices [UMCG: 39 slices], interleaved acquisition, 
2.29x2.29mm in-plane resolution [UMCG: 3x3mm], 3mm slice thickness). 
EPI’s were scanned parallel to the anterior-posterior commissure plane. Scan 
session length was dependent on the subjects’ pace of completing the task and 
varied between 128 and 240 volumes. Anatomical imaging included a sagittal 
3D gradient-echo T1-weighted sequence (TR=9 ms, TE=3.5 ms; matrix 256x256; 
voxel size: 1x1x1mm; 170 slices). 
STATISTICAL ANALYSIS
Imaging data acquired during the word encoding task were processed using 
FSL software (FMRIB’s Software Library, www.fmrib.ox.ac.uk/fsl, (Smith et al., 
2004)). Preprocessing of the fMRI images was carried out using FEAT (FMRI 
Expert Analysis Tool) Version 5.98, implemented in MELODIC Version 3.10. 
The following processing steps were applied: motion correction, slice timing 
correction, non-brain removal, spatial smoothing using a Gaussian kernel of 
5 mm full width at half minimum, grand-mean intensity normalization of the 
entire 4D dataset by a single multiplicative factor, high pass temporal filtering 
(Gaussian-weighted least-squares straight line fitting, with sigma= 150 s). Next, 
the functional images were registered to MNI-152 standard space (T1 standard 
brain averaged over 152 subjects; Montreal Neurological Institute, Montreal, 
QC, Canada) using a two-step registration from functional to high resolution 
structural T1 image to MNI template. Normalized 4D data sets were resampled 
to 4 mm isotropic voxels to reduce computational burden in the subsequent 
analysis steps. 
Resampled and normalized data sets from both MDD patients and HCs were 
then entered into a dual regression analysis (Beckmann, Mackay, Filippini, & 
Smith, 2009) using the set of eight standard independent component networks 
(ICNs) as described in detail in Beckmann et al. (2005). In the dual regression 
procedure, two stages of multiple linear regression analyses are performed. 1) 
A time series is estimated for each ICN template per subject, using the subject’s
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functional data as the predicted variable and the set of spatial ICNs as 
predictors; 2) A subject-specific weighted spatial map is created using the 
time series created in [1] as predictors of the participant’s functional data. The 
resulting spatial maps represent an unbiased measure of the degree to which 
BOLD signal fluctuations in each voxel covary with each ICN time series for each 
subject separately. More simply, each participant’s spatial map for a given ICN 
can be considered a voxelwise map of the strength of functional connectivity 
with that ICN. 
To assess main effects across both groups of functional connectivity within 
each ICN, individual spatial maps were included in a one-sample t-test 
performed separately for each ICN. To assess group differences in functional 
connectivity within each ICN, individual spatial maps were compared in an 
independent samples t-test performed separately for each ICN. All results are 
reported at p<.05, family wise error corrected for multiple comparisons using 
permutation tests (# permutations=5000) with cluster-mass thresholding 
(voxelwise threshold: z=2.3) (Hayasaka & Nichols, 2003). 
Table 1 lists sample characteristics. MDD showed higher depression and anxiety 
scores than controls (MADRS, IDS, BAI: All U>38.5; all p<.001). Between the 
NESDA interview (Time_1) and the MRI-session (Time_2) depressive symptom 
ratings decreased in MDD (IDS, z=-3.35, p<.001). At the time of scanning, eight 
MDD patients were in the remitted stage. No group difference was observed in 
the number of volumes acquired during the self-paced task (F1,49=.69, p=.41). 
An interaction of valence classification and diagnosis was observed (F1,2; 
53,2= 6.0, p=<.05, ŋ²=.12): MDD patients indicated less words as ‘positive’ and 
more words as ‘neutral’ than the healthy controls (F>6.07, p<.05) (figure 1), 
independent of illness severity. No effect of diagnosis on classifying negative 
words was observed and no interaction of diagnosis and valence occurred on 
response times. 
As a check of overall fit of data to the template ICNs, we assessed main effects 
across groups of functional connectivity with each ICN to evaluate the spatial 
correlation pattern per template ICN. Overall, mean spatial maps over both 
groups (i.e., one sample t-tests per component) closely matched the template 
ICNs, although the components often included additional regions compared 
with the templates. 
Comparison of spatial maps between the two groups showed decreased 
connectivity of the bilateral medial PFC, nucleus accumbens, caudate nucleus, 
right orbitofrontal cortex (OFC), and right putamen with a template network 
including the ventrolateral-PFC, dorsolateral PFC, anterior cingulate gyrus, 
medial PFC, cerebellum, and cuneus (Figure 2) in MDD compared with controls. 










MDD: Major Depressive 
Disorder; HC: healthy controls; 
MADRS: Montgomery Åsberg 
Rating Scale; IDS: Inventory of 
Depressive Symptomatology; 
BAI: Beck Anxiety Inventory; 
VAS: Visual Analogue Scale; T1: 
time of the Netherlands Study 
of Depression and Anxiety 
baseline interview; T2: time of 
Magnetic Resonance Imaging 
session; # volumes: number 
of volumes acquired during 
the word classification task; # 
words_pos/neg/neu: number 
of words classified as positive, 
negative, or neutral; rt pos/
neg/neu; response time of 
classifying positive/negative/
neutral words. 
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BrainMap database (Smith et al., 2009) and has previously been described 
as the salience network (Seeley et al., 2007). Therefore, we will refer to this 
network as the salience network for the remainder of this report. 
We exported the individual subject beta-values of the 8 sub-clusters (see 
Table 2) for this independent component network to SPSS to test for possible 
confounds. A one-way MANOVA confirmed the voxelwise analysis, with 
lower values in MDD than in controls (F8,41=2.86, p<.05, ŋ²= .36). Adding age, 
education, and scan center (2 dummy variables) did not change the result 
(F8,37=2.35, p<.05, ŋ²= .34). In a previous study, we reported on decreased inferior 
frontal gyrus and rostral anterior cingulate gyrus gray matter volumes in MDD 
(van Tol et al., 2010). As these regions are implicated in the salience network, we 
explored the relation between regional anterior cingulate cortex and inferior 
frontal gyrus volume and connectivity within the salience network. However, 
no correlation was observed (rKendall’s tau<.11, p>.26). Moreover, connectivity of 
the medial PFC-striatal regions within the salience network was not associated 
with depression severity (IDS_T2:(rKendall’s tau=.02, p=.87).
MDD (n=25) HC (n=25)
female n 16 17
amc/lumc/umcg n 8/10/7 8/10/7
age years; mean (sd) 33.9 (9.9) 37.2 (10)
education years; mean (sd) 12.9 (2.6) 13.8 (2.3)
recurrent MDD N 15 -
age of onset years; mean (sd) 25 (11) -
MADRS mean (sd) 14.4 (10.2) .9 (1.7)
range 0 - 33 0 - 6
IDS_T2 mean (sd) 19.2 (11.9) 3.8 (3.3)
range 2 - 39 0 - 11
IDS_T1 mean (sd) 28.5 (10.5 5.3 (2.8)
range 2 -47 0 - 10
BAI mean (sd) 8.5 (7) 2.3 (2.2)
range 0 - 26 0 - 8
VAS mean (sd) 24.8 (20.4) 24 (22.3)
range 0 - 65 0 - 80
# volumes mean (sd) 168.8 (18.8) 163.9 (22.3)
range 128 - 207 138 - 240
classification behavior
# words_pos mean (sd) 37.6 (9.5) 44.6 (9.7)
# words_neg mean (sd) 40 (2.5) 39.9 (6.8)
# words_neu mean (sd) 48 (10.2) 40 (9.8)
rt pos sec; mean (sd) 1.52 (.33) 1.36 (.28)
rt neg sec; mean (sd) 1.28 (.27) 1.27 (.44)
rt neu sec; mean (sd) 1.66 (.39) 1.55 (.36)
FIGURE 1:
plots showing mean and 
standard errors for number of 
words classified as positive, 
neutral or negative (top), and 
response times in seconds 
during classifying words as 




We then explored whether connectivity was related to word classification 
behavior and response times. Within MDD, connectivity of the medial PFC 
with the salience network was positively correlated with the number of words 
classified as positive (rKendall’s tau=.33, p=.03). Connectivity in the fronto-
striatal areas was unrelated to response times during classification of positive, 
neutral and negative words (rKendall’s tau<.18, p>.25). 
No significant between-group differences were observed for the other 
networks. 
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TABLE 2:
EFFECT OF DIAGNOSIS 
ON CONNECTIVITY 
WITH THE SALIENCE 
NETWORK: MDD<HC
L=left hemisphere; R=right 
hemisphere; MNI: Montreal 
Neurological Institute 
coordinate system. Results 
are reported at p<.05, 
Family wise error corrected 
for multiple comparisons 
using permutation tests (# 
permutations=5000) of cluster-
mass (voxelwise threshold: 
z=2.3). 
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Location x y z No. of voxels
R orbitofrontal cortex 16 24 -4 102
L nucleus accumbens -12 20 -8 70
R medial prefrontal gyrus, frontal poles 8 60 4 63
R caudate nucleus 4 4 6 20
R frontal pole/ventrolateral prefrontal gyrus 24 50 -12 7
L medial/superior prefrontal gyrus -20 44 0 3
R ventral caudate nucleus 8 20 -4 1
R putamen 20 12 -8 1








N In this study we investigated whole-brain functional connectivity in MDD 
during execution of an emotional word classification task using a subset of eight 
independently derived independent component networks. We demonstrated 
decreased functional connectivity of the medial PFC, putamen, caudate 
nucleus, OFC, and ventral striatum (including the nucleus accumbens) within 
the salience network in MDD as compared with healthy control participants. 
Results were unexplained by age, education, sex, and brain volume of regions 
implicated in the neuroanatomical profile of MDD. Moreover, within MDD, 
decreased functional connectivity of the fronto-striatal regions was unrelated 
to illness severity. No differences in functional connectivity were observed 
within any other network.
These results confirm the hypothesis that abnormal intrinsic connectivity of 
cortical and subcortical and (para)limbic regions during emotional processing 
is part of the functional pathophysiology of MDD. Our results indicate that this 
decreased coupling might not be a state phenomenon of MDD, but appears 
to be a trait-like phenomenon that continues into the (newly) remitted phase. 
Moreover, the decreased subcortical-cortical coupling was observed within 
the salience network, a network that has been found to specifically correlate 
with subjective emotional ratings  (Seeley et al., 2007).Furthermore, the 
salience network is the only work of the Smith et al. (2009) study that showed 
a high load on emotional processes and tasks in a large scale meta-analysis of 
the BrainMap database, but also loads on sensory perception, including pain 
perception, working memory, explicit memory, cognition, and action inhibition 
(Smith et al., 2009). These processes are highly relevant for MDD symptoms 
such as sad mood, failure to stop negative thoughts, attentional deficits, and 
altered bodily sensations related to appetite and temperature.
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Interestingly, we observed relative decoupling of the medial prefrontal cortex 
and striatum within the salience network in MDD. The medial prefrontal cortex 
is thought to be an important region for regulating emotional states through 
cognitive appraisal (Johnstone et al., 2007; Ochsner et al., 2009), self-referential 
processing (Lemogne et al., 2009), and affective conflict processing (Ochsner, 
Hughes, Robertson, Cooper, & Gabrieli, 2009). Moreover, the strength of 
connectivity in the medial prefrontal cortex and striatum was associated with 
positive word evaluation. Therefore, our findings indicate that the distributed 
network involved in cognitive appraisal, self-referential processing, and 
affective conflict processing is compromised in MDD, potentially related to the 
processing of positive information. The medial PFC has numerous connections 
with other regions that have been implicated in normal and abnormal mood 
regulation, including the striatum, thalamus, pallidum, and dorsal cortical 
areas, and therefore it has been suggested that the medial PFC may play an 
important role in moderating visceral processes related to emotions (Price & 
Drevets, 2010). Also, the nucleus accumbens, a part of the ventral striatum, 
showed lower connectivity with the salience network. This region receives 
projections from the amygdala, and further projects to the medial PFC and 
thalamus (Price & Drevets, 2010), and has been repeatedly associated with 
reward processing. Moreover, a failure to sustain activation is this region during 
upregulation of positive emotional states has been linked to anhedonia in MDD 
patients (Heller et al., 2009). This finding corroborates the present observation 
of diminished connectivity of the striatum with the salience network that was 
associated with positive word evaluation and suggests that decreased fronto-
striatal coupling with the salience network may be specific to lacking a positive 
mood state. However, we were not able to investigate whether para(limbic)–
cortical connectivity varied as a function of hedonic capacity or current mood 
state, as we did not include a measure specifically probing current mood state 
and anhedonia. 
The present results are in concordance with the low-frequency seed-based 
correlation analysis of Anand et al. (2005), who showed decreased limbic-
cortical connectivity of the pallido-striatum with the ACC during positive, 
negative, and neutral picture viewing in MDD. However, in this seed-based 
analysis, time series of only four seeds were included in the analysis and 
therefore connectivity of the striatal regions with other prefrontal regions 
could not be studied. Our results indicate that the decreased connectivity of 
the striatal regions during positive, negative, and neutral word classification 
extends to the dorsolateral PFC, inferior frontal gyrus, and dorsomedial PFC. 
Similar results have been observed in a small adolescent MDD sample during 
resting-state imaging, in which decreased connectivity of the subgenual ACC 
and a network including the rostral ACC, inferior frontal gyrus, medial frontal 
pole, and dorsolateral cortical areas was demonstrated, independent of illness 
severity (Cullen et al., 2009).
In the present study we could not replicate findings of decreased connectivity
of the amygdala with hippocampal regions, or with orbitofrontal or medial PFC 
regions that have been observed in both task- and resting-state connectivity 
analyses (Johnstone et al., 2007; Hamilton & Gotlib, 2008; Matthews, Strigo, 
Simmons, Yang, & Paulus, 2008; Almeida et al., 2009; Lui et al., 2009; Veer 
et al., 2010). This discrepancy in findings could be the result of the template 
ICN method used. The independently derived ICNs used in this study did 
not include limbic regions and therefore detecting connectivity differences 
between (para)limbic and prefrontal regions is less likely than studies that use 
a limbic seed region. However, synchronicity between posterior visual regions 
and the amygdala was observed in the mean spatial maps of the lateral visual 
component across participants from both groups, but no differences were 
observed in this component, consistent with previous reports (Anand et al., 
2005; Cullen et al., 2009).
In the present study, we used a new approach to study functional connectivity 
during the execution of an emotional word classification task. We used 
template ICNs to create subject specific component maps, based on the times 
series that best fit the weighted templates using the dual regression approach 
(Beckmann et al., 2009). This template-based dual regression approach has 
the advantage that templates are acquired independently of the data under 
study (Kriegeskorte et al., 2009). These template components have been found 
to be highly consistent and have been independently detected in a number 
of populations (e.g., Alzheimer’s disease (Rombouts et al., 2009), MDD (Veer 
et al., 2010), healthy controls (Beckmann et al., 2005)). Overall, use of the 
template ICNs and dual regression approach resulted in highly consistent 
components across groups, even though the number of acquired brain volumes 
differed between participants. Indeed, a strength of this approach is that it is 
not limited to standard fMRI task paradigms with associated restrictions on the 
timing and number of trials, but can be used to study sustained engagement 
of brain networks over the duration of a task. Another advantage is that the 
template-ICN dual regression method allows for the study of connectivity 
across groups and tasks in a standardized and unbiased way, which is crucial 
for studies involving comparisons between clinical and non-clinical samples. 
Also, using the template ICNs should increase reproducibility of effects, due to 
the independence of the ICN templates in reference to the data under study. 
Taken together, we believe that this template-based dual regression method is 
a potent approach to study differences in functional connectivity during both 
rest and task paradigms, particularly when comparing across patient groups (or 
scan sessions in treatment studies) when an unbiased and reliable comparison 
is crucial. 
Using an unbiased whole-brain functional connectivity approach, we showed 
decreased connectivity of medial prefromtal regions and ventral subcortical 
and paralimbic regions in MDD during the execution of an emotional word 
evaluation task with a distributed the salience network. Future studies should 
test the specificity and generalizability of our results to different MDD
5
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sub-samples and different tasks. For example, medial PFC connectivity with 
the salience network was unrelated to illness severity but was related to the 
number of words as ‘positive’. This finding might suggest that decreased 
fronto-striatal coupling within the salience network may be specific to lacking a 
positive mood state. Given the power of this technique to compare distributed 
patterns of connectivity in an unbiased way, future studies should also examine 

















Participants were recruited from NESDA (Netherlands Study of Depression and 
Anxiety), a large-scale multi-site longitudinal observational cohort study. The 
rationale, methods, and recruitment have been described in detail elsewhere. 
(Penninx et al., 2008) In short, NESDA has been designed to be representative 
of those with depressive and anxiety disorders in different health care settings 
and stages of the developmental history. Therefore, the sample is stratified for 
setting (community, primary care, and specialized mental health) and set up 
to include a range of psychopathology. Out of the 2981 NESDA respondents 
(main sample, T1), participants aged between 18 and 57 years were asked to 
participate in the NESDA neuroimaging study (T2; N=301)) if they met DSM-
IV criteria for a half-year diagnosis of MDD and/or anxiety disorder (Panic 
Disorder, Social Anxiety Disorder, or Generalized Anxiety Disorder), or no 
lifetime DSM-IV diagnosis (i.e. healthy controls [HC]). Personality disorders 
were not obtained/screened for and so were not used in the inclusion/exclusion 
criteria, although persons with known personality disorders (either reported by 
psychiatrist or participant) were not included in the NESDA sample. The total 
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Background: Childhood emotional maltreatment (CEM) has been associated 
with a profound and enduring negative impact on behavioral and emotional 
functioning. Animal models have shown that adverse rearing conditions, such 
as maternal separation, can induce a cascade of long-term structural alterations 
in the brain, particularly in the hippocampus, amygdala, and prefrontal cortex. 
However, in humans, the neurobiological correlates of CEM are unknown.
Methods: Using high-resolution T1-weighted 3T magnetic resonance imaging, 
anatomical scans and a whole-brain optimized voxel-based morphometry 
approach, we examined whether healthy control subjects and unmedicated 
patients with depression and/or anxiety disorders reporting CEM before age 
16 (n= 84; age: mean=  38.7) displayed structural brain changes compared with 
control subjects and patients who reported no childhood abuse (n= 97; age: 
mean= 36.6).
Results: We found that self-reported CEM is associated with a significant 
reduction in predominantly left dorsal medial prefrontal cortex volume, even in 
the absence of physical or sexual abuse during childhood. In addition, reduced 
dorsal medial prefrontal cortex in individuals reporting CEM is present in males 
and females, independent of concomitant psychopathology.
Conclusions: In this study, we show that CEM is associated with profound 
reductions of medial prefrontal cortex volume, suggesting that sustained 
inhibition of growth or structural damage can occur after exposure to 
CEM. Given the important role of the dorsal medial prefrontal cortex in the 
regulation of emotional behavior, our finding might provide an important link in 

















N Every year, approximately one in ten children growing up in Western 
societies experiences childhood emotional maltreatment (CEM) (Gilbert et 
al., 2009). Emotional maltreatment encompasses any act of commission (i.e., 
verbal abuse) or omission (i.e., emotional neglect) that is (potentially) harmful, 
or insensitive to the child’s emotional development and has been associated 
with a profound and enduring negative impact on behavioral, emotional, and 
social functioning (Egeland, 2009; Gilbert et al.,2009). For instance, CEM is 
associated with maladaptive emotional functioning in adulthood (Teicher, 
Samson, Polcari, & McGreenery, 2006), which in turn is a key vulnerability 
factor for the development of psychiatric disorders when faced with stressors 
in later life (Beck, 2008). In line with this, CEM is an important predictor for 
the development of depressive and anxiety disorders in adulthood (Gibb, 
Chelminski, & Zimmerman, 2007; Spinhoven et al., 2010). However, the 
neurobiological correlates underlying the emotional sensitivity in individuals 
reporting CEM remain unknown. 
In animals, adverse rearing environments such as maternal separation, loss, 
or isolation rearing induce a  cascade of long-term alterations on the level 
of cognitive functioning, hypothalamic-pituitary-adrenal axis functioning, 
(immediate) gene expression, and brain morphology (Sanchez, Ladd, & Plotsky, 
2001). Structural alterations in the brain include reduced dendrite length, 
dendritic branching, spine density, and suppression of neurogenesis and have 
predominantly been observed in limbic structures (amygdala, hippocampus) 
and prefrontal cortex (PFC) (Arnsten, 2009; Lupien, McEwen, Gunnar, & Heim, 
2009; McEwen, 2008; Sanchez et al., 2001). In line with this, human studies 
examining the neuroanatomical correlates of childhood maltreatment in adults 
found decreased gray matter volume in the hippocampus (Kitayama, Vaccarino, 
Kutner, Weiss, & Bremner, 2005; Vythilingam et al., 2002) and medial PFC 
(Andersen et al., 2008; Cohen et al., 2006; Frodl, Reinhold, Koutsouleris, Reiser, 
& Meisenzahl, 2010; Tomoda et al., 2009; Treadway et al., 2009). However, 
these studies focused mainly on the impact of sexual (Andersen et al., 2008; 
Kitayama et al., 2005; Vythilingam et al., 2002) and/or physical abuse (Tomoda 
et al., 2009) or did not exclude co-occurence of different types of abuse (Cohen 
et al., 2006; Frodl et al., 2010; Treadway et al., 2009). 
One way through which chronic stress may lead to structural changes is 
through enhanced activation of neuroendocrine systems (McEwen, 2008). 
During chronic stress, increased secretion of glucocorticoids (i.e., the stress 
hormone cortisol in humans) interferes with the transcriptional mechanisms that 
control the expression of brain-derived neurotrophic factor (BDNF), a growth 
factor that has been linked to neuronal proliferation and plasticity (McEwen, 
2008; Nestler et al., 2002). In this way, chronic stress may inhibit cytogenesis 
and increase vulnerability to attrition within the hippocampus, amygdala, or 
PFC (Lupien et al., 2009; McEwen, 2008). In line with these findings, childhood 
maltreatment has been linked to enhanced cortisol reactivity to psychosocial 
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stress in patients with depression and anxiety disorders (Elzinga, Spinhoven, 
Berretty, de Jong, & Roelofs, 2010; Heim et al., 2000; Heim et al., 2002) and to 
blunted cortisol reactivity in healthy subjects (Carpenter et al., 2007; Elzinga et 
al., 2008). Additionally, altered patterns of cortisol reactivity during stress have 
been found in individuals reporting CEM (Carpenter et al., 2009). Furthermore, 
white matter tract abnormalities were found in a small sample of young adults 
reporting CEM (n =16) (Carpenter et al., 2009; Choi, Jeong, Rohan, Polcari, & 
Teicher, 2009). However, it is unknown whether CEM is similarly associated with 
structural gray matter abnormalities in adulthood. Given the important role of 
the limbic brain regions (hippocampus and amygdala) and the medial PFC in the 
perception and regulation of emotional behavior and stress response (Arnsten, 
2009; Cardinal, Parkinson, Hall, & Everitt, 2002; Lupien et al., 2009; McEwen, 
2008; Sanchez et al., 2001), gray matter abnormalities in (one of) these regions 
might underlie the maladaptive emotional functioning associated with CEM. 
Therefore, we sought to investigate the effect of CEM on adult brain 
morphology in unmedicated patients currently diagnosed with depression 
and/or anxiety disorder controls. We used high-resolution magnetic resonance 
imaging (MRI) and a whole-brain optimized voxel-based morphometry (VMB) 
analysis approach, specifying the amygdala, hippocampus, and medial PFC 
(including the anterior cingulate gyrus) as regions of interest. We examined 
whether adult patients and controls reporting multiple incidents of CEM before 
age 16 (n= 84) displayed structural brain changes in compared with patients and 
controls who did not report a history of childhood abuse (n= 97). In addition, to 
examine whether these structural brain changes are related to the development 
of psychopathology, we investigated whether these brain alterations were 
more apparent in individuals with a depression or anxiety disorder compared 
with individuals who never developed a depression or anxiety disorder. 
PARTICIPANTS
Participants were drawn from the Netherlands Study of Depression and Anxiety 
(NESDA), (n= 2981), a large cohort study (Penninx et al., 2008). A subset of the 
NESDA participants (both  patients and controls) was selected to undergo MRI 
scanning for the NESDA MRI study. Inclusion criteria for patients in the NESDA-
MRI study were current major depressive disorder (MDD) and/or anxiety 
disorder (ANX; panic disorder and/or social anxiety disorder and/or generalized 
anxiety disorder in the past six months according to DSM-IV criteria). Diagnoses 
were established using the structured Composite International Diagnostic 
Interview (Robins et al., 1988), administered by a trained interviewer. Exclusion 
criteria were the presence of Axis I disorders other than MDD, panic disorder, 
social anxiety disorder, or generalized anxiety disorder; any use of psychotropic 
medication other than a stable use of selective serotonin reuptake inhibitors 
or infrequent benzodiazepine use (three times two tablets weekly or within 48 
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controls were the presence or history of major internal orneurological disorder; 
dependency or recent abuse (past year) of alcohol or drugs; hypertension 
(>180/130 mmHg); heavy smoker (>5 cigarettes/day); and general MRI 
contraindications. The healthy control participants had no lifetime depressive or 
anxiety disorders and  were not taking any psychotropic drugs. Thus, 301 native 
Dutch-speaking participants (233 patients and 68 controls) were included and 
underwent MRI at one of the three participating centers (i.e., Leiden University 
Medical Center, Academic Medical Center Amsterdam, and University Medical 
Center Groningen). The ethical review boards of each participating center 
approved this study. All participants provided written informed consent. 
CLINICAL ASSESSMENTS
In the NESDA study, childhood maltreatment was assessed with the Nemesis 
Trauma Interview (De, Bijl, Smit, Vollebergh, & Spijker, 2002). In this interview, 
respondents were asked whether they had experienced emotional neglect, 
psychological abuse, physical abuse, and/or sexual abuse before age 16; how 
often this had occurred (i.e., never, once, sometimes, regularly, often, or 
very often); and what their relationship with the perpetrator was. Emotional 
neglect was described as “people at home didn’t listen to you, your problems 
were ignored, and you felt unable to find any attention or support from the 
people in your house”. Psychological abuse was described as “you were cursed 
at, unjustly punished, your brothers and sisters were favored—but no bodily 
harm was done”. CEM was defined as multiple incidents (more than once) of 
emotional neglect and/or emotional abuse before age 16 years, because we 
assumed that only multiple incidents of emotional abuse and/or emotional 
neglect might be associated with neuroanatomical changes. Overall CEM 
frequency was defined as the most frequent occurrence as reported (e.g., 
if psychological abuse occurred often and emotional neglect sometimes, 
overall CEM score is often). Negative life events were assessed using the List 
of Threatening Events Questionnaire (LTE-Q) (Brugha, Bebbington, Tennant, 
& Hurry, 1985). In addition, at the day of scanning, depression and anxiety 
severity was  measured using the Montgomery Åsberg Depression Rating Scale 
(MADRS) (Montgomery & Åsberg, 1979) and the Beck Anxiety Inventory (BAI) 
(Beck et al., 1988). 
ADDITIONAL EXCLUSION CRITERIA 
High-resolution anatomical images were obtained from 291 participants 
(imaging data from 10 participants were excluded because of poor image 
quality). Additionally, two healthy control subjects were excluded from the 
NESDA-MRI study because of MADRS scores that indicated possible depressive 
symptomatology on the day of scanning (MADRS>8) (Muller et al., 2000). 
For this study, individuals using selective serotonin reuptake inhibitors were 
excluded (n= 79) given their potential effect on neuronal plasticity (Dranovsky 
& Hen, 2006). Additionally, individuals reporting physical or sexual abuse but
6
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no CEM were also excluded (n= 5). Finally, individuals reporting only a single 
incident of CEM (n= 24) were excluded. Our final sample (n= 181) consisted of 
84 participants re- porting CEM and 97 participants who reported no abuse (the 
No Abuse group). 
THE CEM AND NO ABUSE GROUPS 
The CEM group consisted of participants who reported emotional neglect 
and/or psychological abuse during childhood that had occurred sometimes, 
regularly, often, or very often (n= 84: i.e., MDD, n= 20; ANX, n= 21; comorbid 
depression and anxiety disorder [CDA], n= 30), and controls, n= 13; 36 of these 
84 participants also reported childhood physical and/or sexual abuse, Table 1). 
The No Abuse group consisted of individuals who did not report CEM, physical 
abuse, or sexual abuse (n= 97: i.e., MDD, n= 22; ANX, n= 22; CDA, n= 13; and 
controls, n= 40). In the CEM group, 96.4% (n= 81) of the participants reported 
having been emotionally neglected, whereas 57.1% (n= 48) reported having 
been psychologically abused, and 54% (n= 45) reported both emotional neglect 
and psychological abuse. In addition, 97.6% reported that the individual’s 
biological parents were the perpetrators of CEM (n= 82). 
MAGNETIC RESONANCE IMAGING ACQUISITION
Imaging data were acquired using Philips 3-tesla MR systems (Philips, Best, The 
Netherlands) located at the participating centers, equipped with a SENSE-8 
(Leiden University Medical Center and University Medical Center Groningen) 
and a SENSE-6 (Academic Medical Center) channel head coil. For each subject, 
an anatomical image was obtained using a sagittal 3-dimensional gradient-
echo T1-weighted sequence (repetition time: 9 msec; echo time: 3.5 msec; 
matrix 256x256; voxel size: 1x1x1mm; 170 slices). Each scanning session also 
included several functional MRI runs, both “resting state” and task related. 
These results, as well as those of VBM comparisons between diagnostic groups 
(irrespective of childhood maltreatment), have been reported elsewhere (van 
Tol et al., 2010).  
IMAGE PROCESSING
An optimized VBM approach following the Diffeomorphic Anatomical 
Registration through Exponentiated Lie algebra (DARTEL) (Ashburner, 2007) 
was performed using SPM5 (Statistical Parametric Mapping software; http://
www.fil.ion.ucl.ac.uk/spm) implemented in Matlab 7.1.0 (The MathWorks 
Inc., Natick, MA, USA). VBM-DARTEL preprocessing included the following 
steps: 1) manual reorientation of the images to the anterior commissure; 2) 
segmentation of the anatomical images using the standard segmentation 
option implemented in SPM5; 3) applying the DARTEL approach for registration, 
normalization, and modulation, leaving the images in DARTEL space (In this 
approach, a DARTEL template is created based on the deformation fields that 
are produced by the segmentation procedure. Next, all individual deformation 
























































































































































































































































































































































































































































































































































































































































































































































fields are warped  (and modulated) to match this template.), and 4) smoothing 
of the gray matter and white matter images using an 8-mm, full-width-at-half-
maximum Gaussian kernel to increase the signal-to-noise ratio. In the resulting 
gray matter images, each voxel represents an absolute amount of gray matter 
volume, equivalent to the gray matter volume per unit before normalization. 
VBM ANALYSIS 
Gray matter (or white matter) segments in native space were used to calculate 
absolute total gray matter (white matter) volumes. Next, smoothed gray matter 
(white matter) density images were entered into a voxel-by-voxel analysis of 
variance for between-group comparisons, with age and total absolute gray 
matter (white matter) as covariate to correct for total brain volume. Effect 
of center was added by means of two dummy variables as extra regressors 
in all analyses. To achieve maximal sensitivity and to optimize voxel residual 
smoothness estimation and exclude false positives in non-gray matter (-white 
matter) tissue, voxelwise comparisons were masked using a comparison-
specific explicit optimal threshold gray matter (white matter) mask created 
using the Masking toolbox (http://www.cs.ucl.ac.uk/staff/g.ridgway/masking) 
(Ridgway et al., 2009). 
For the a priori–set regions of interest (medial PFC, anterior cingulate cortex, 
amygdala, and hippocampus), we set a threshold of p<.001, uncorrected, with 
a spatial extent threshold of 50 contiguous voxels for group interactions. To 
further protect against Type I error, small volume correction was applied by 
centering a sphere of 16-mm around the peak voxel. The resulting volumes of 
interest had to meet p<.05, corrected for family wise error (FWE) rate at the 
voxel level, to be considered significant (i.e., Z>3.50). For regions not specified 
a priori, a voxel level threshold of p<.05 whole brain, FWE corrected, was 
set. If significant group differences were observed in the VBM analysis, we 
exported the volume of the significant clusters per subject to SPSS. Clinical 
and demographic group differences were analyzed using SPSS-17 (http://www.
spss.com), and in all analyses, age, total gray matter (white matter) volume, 
and dummy regressors for the scan centers were included as covariates. 
THE NEUROANATOMICAL CORRELATES OF CEM 
To investigate the neuroanatomical correlates of CEM, we first set up a VBM 
analysis to compare the gray matter density maps/images of individuals 
reporting CEM (n= 84) with gray matter density maps of the No Abuse group (n= 
97). These analyses revealed that CEM was associated with a 5.14% reduction 
in the left dorsal medial PFC ([x=-11, y=23, z=40], Brodmann area 8, cluster size/
number of voxels (K)= 263, Z =3.80, p< .05 (small volume corrected; Table 2)).No 
significant differences were observed in hippocampus or amygdala or in other 
brain regions. Only at a very low threshold was CEM associated with reduced 




right posterior hippocampal volume ([x=29; y=-35, z=-6], Z= 2.06, ns). 
Additionally, CEM was not associated with a significant increase in regional 
gray matter volumes. Finally, CEM was not associated with white matter 
reductions in or surrounding our regions of interest or with increased regional 
white matter volume. 
To explore possible interactions among CEM, current diagnosis, and sex, a 2 
(CEM) x 4 (diagnosis: MDD, ANX, CDA, and controls) x 2 (sex) univariate analysis 
of covariance (ANCOVA) was performed, with local dorsal medial PFC volume 
(milliliters [ml]) as a dependent factor. Again, individuals from the CEM group 
had smaller dorsal medial PFC volumes than the No Abuse group ([CEM (M ± 
SEM)]: 4.80 ± .06 ml vs. no abuse: 5.06 ± .06 ml; F1,161 = 12.36, p< .01, Cohen’s 
d= .53). Interestingly, there was no interaction between CEM and diagnosis 
(F3,161 = .45, p= .72, d= .01), and post hoc analyses indicated that the dorsal 
medial PFC reductions are present in all groups, even though the numbers were 
relatively small for such comparisons (one-sided: MDD, F1,34 = 8.65, p< .01, d= 
.93; ANX, F1,35= 2.55, p=.06, d= .50; CDA, F1,35= 2.63, p=.06, d= 55; and controls, 
F1,45= 1.85, p= .09, d=.44). In addition, there was no interaction between CEM 
and sex (F1,161= 2.01, p= .99, d= .21). Taken together, these results indicate that 
reduced dorsal medial PFC volume was present in all CEM groups (i.e., male 
and female subjects with MDD, ANX, CDA, and in the control group). Moreover, 
similar results were obtained when depression and anxiety severity were 
added as covariates (F1,155= 12.41, p< .01, d= .53)
1, indicating that our results 
cannot be explained by the presence of more severe depressive and/or anxious 
symptomatology among individuals reporting CEM. 
NEUROANATOMICAL CORRELATES OF ISOLATED EMOTIONAL 
MALTREATMENT IN CHILDHOOD
To exclude the possibility that our results are driven by concurrent history 
of physical and/or sexual abuse in some of the participants, we conducted 
a whole-brain VBM analysis to compare the gray matter density maps of 
individuals reporting only CEM (n= 48, i.e. MDD, n= 13, ANX, n= 12, CDA, n= 13, 
and controls, n= 10; Table S-1 in the supplemental material 1) with individuals 
reporting No Abuse (n= 97). n this analysis, the 36 individuals who also reported 
childhood physical and/or sexual abuse were excluded. This analysis showed 
that individuals reporting only CEM had a volume reduction of 7.2% in left and 
right (although predominantly left) dorsal medial mPFC ([x=-11, y=21, z=40], 
Brodmann’s area 8, K= 767, Z= 4.37, p< .05 [small volume corrected]; Table 2), 
extending into the anterior medial PFC and anterior cingulate gyrus (Figure 
1, Table 2). Furthermore, no hippocampal, or amygdalar differences were 
observed, nor decreases in other brain regions.
Again, only at a very low threshold was CEM associated with reduced right 
posterior hippocampal volume ([x=29, y=-35, z=-6], Z= 2.45, ns). Finally, CEM 
was not associated with white matter reductions in or surrounding our regions 
1 Four participants were miss-
ing because of incomplete de-




THE NEUROANATOMICAL CORRELATES OF CHILDHOOD EMOTIONAL MALTREATMENT 
VS. NO ABUSE
Childhood Emotional Maltreatment (CEM), R=right sided, L=left sided, BA=Brodmann Area, K=cluster size 
(number of voxels), **p<.05, SVC 16 mm FWE corrected. 
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R/L BA region k x y z z-value
L 8 Medial prefrontal gyrus 263 -11 23 40 3.80 **
L+R 8 medial prefrontal gyrus 767 -11 21 40 4.37 **
-5 9 42
R/L BA region k x y z z-value
R 9/32 cingulate gyrus/medial prefrontal gyrus 87 6 18 36




Only CEM (n=48) < No abuse (n=97)
CEM (n=84 ) < No Abuse (n=97)
FIGURE 1 :
The medial PFC region 
showing 7.2 % volume 
reduction amongst 
individuals reporting only 
childhood emotional 
maltreatment displayed on 
a sagittal (A),coronal (B) and 
transversal (C) plane.
A full-color image can be 
found on the supplementary 
sheet.
2 History of alcoholism (abuse 
or dependence as meas-
ured with the Composite 
International Diagnostic 
Interview) did not affect the re-
sults (i.e., history of alcoholism 
[yes or no] was not a signifi-
cant covariate in the analysis), 
F1,124= 1.76, P=.19, nor did it 
have an impact on the main 
effect of CEM on dorsal medial 
PFC volume, F1,124= 15.98, p< 
.001, d= .71).
3 Exclusion of the “sometimes” 
group (n= 4), due to its small 
size, did not affect the results, 
including the main effect of 
CEM on dorsal medial PFC vol-
ume [F1,120= 15.8, p<.001, d= 
.73].
of interest or with increased regional gray matter of white matter volume. 
An ANCOVA confirmed the main effect of CEM (CEM: M ± SEM: 4.78 ± .07 ml; 
No Abuse: 5.15 ± .06 ml; F1,125= 15.15, p< .001, d= .69). Moreover, the reduced 
dorsal medial PFC volume was present in all CEM groups and in both male and 
female individuals (i.e., no interaction was found with diagnosis; F3,125 = .27, 
p=.85, d= .09), and even within these small groups, post hoc analyses revealed 
a (marginally) significant (one-sided) impact of CEM only on dorsal medial PFC 
volume (MDD, F1,27= 7.72, p<.01, d=1; ANX, F1,26=2.93, p<.05. d=.63; CDA, F1,18= 
3.20, p< .05, d= .73; and controls, F1,42= 1.96, p= .08, d= .51), and CEM did not 
interact with sex (F1,125=.08, p=.78, d= .05). Additionally, these results could not 
be explained by higher symptom severity among individuals reporting CEM 
because similar results were obtained when depression and anxiety severity 
were added as covariates (F1,116= 15.72, p< .001, d= .70)
2.
 
ASSOCIATIONS BETWEEN FREQUENCY OF EMOTIONAL MAL-
TREATMENT AND MPFC VOLUME 
To investigate whether the dorsal medial PFC volume reductions were 
dependent on CEM frequency, we performed a 5 (frequency of CEM: No 
Abuse, sometimes, regularly, often, and very often) x 4 (diagnosis: MDD, ANX, 
CDA, and controls) ANCOVA, with local dorsal medial PFC volume (ml) as a 
dependent  factor. The analysis revealed a main effect of frequency of CEM on 
dorsal medial PFC volume [F4,120= 4.89, p< .001, d= .39]
3 which did not interact 
with psychopathology [F12,120= .93, p= .52, d= .17]. As is illustrated in Figure 
2, dorsal medial PFC volumes were reduced in individuals who reported that 
CEM happened regularly or more often. Individuals reporting CEM occurred 
“sometimes” did not have a significantly lower dorsal medial PFC volume 
compared with the no abuse group; however, this group was extremely small 





Estimated Marginal Means 
and Standard Error of Mean 
(SEM) of medial PreFrontal 
Cortex (mPFC) volume 
amongst the different 
frequencies of Childhood 
Emotional Maltreatment 
(CEM), and contrast results 
of EM frequencies vs. the No 
Abuse group. ***= p <.000, * 








































In this study, self-reported CEM was found to be associated with a significant 
reduction in predominantly left dorsal medial PFC gray matter volume, 
independent of sex, and psychiatric status, at least in individuals who reported 
CEM occurring regularly or more frequently. Furthermore, the dorsal medial 
PFC gray matter volume reduction was not due to concomitant childhood 
physical and/or sexual abuse, because the reductions were also found when 
CEM was experienced in absence of concurrent childhood physical and/
or sexual abuse. These findings provide an important clinical extension of 
preclinical observations that the dorsal medial PFC is highly sensitive to the 
effects of chronic stress in childhood (Arnsten, 2009; Lupien et al., 2009; 
Sanchez et al., 2001). The medial PFC is one of the brain regions that undergo 
major  developmental changes during childhood and adolescence (Lupien et al., 
2009; Sanchez et al., 2001)). Exposure to emotionally abusive episodes during 
this developmental period may increase secretion of glucocorticoids, which 
may interfere with the transcriptional mechanisms that control the expression 
of brain-derived neurotrophic factor and may thereby inhibit cytogenesis and 
increase vulnerability to attrition within the medial PFC (Arnsten, 2009; Heim 
et al., 2000; Lupien et al., 2009; Sanchez et al., 2001). Moreover, the fact that 
reductions in hippocampal volume were only observed at a very low threshold 
and no significant changes were observed in the amygdala, concurs with 
findings of animal models on isolation rearing or maternal separation that 
indicate a specific and profound impact on the medial PFC (Levine et al., 2008; 
Sanchez et al., 2007), in comparison with the hippocampus and amygdala 
(Schubert, Porkess, Dashdorj, Fone, & Auer, 2009). For example, in animals, 
it has been shown that architectural changes in prefrontal dendrites can be 
observed after only one week of stress or even after a single stressful incident 
(Arnsten, 2009). In contrast, structural changes in the hippocampus only appear 
after several weeks of stress, which might be an indication that the medial PFC 
is more sensitive to the detrimental effects of stress (Arnsten, 2009). 
The finding that CEM is associated with (predominantly left) dorsal medial 
PFC reduction is of particular interest considering that the medial PFC plays an 
important role in emotion regulation (Cardinal et al., 2002; Phillips et al., 2003a). 
Moreover, reduced activity in the left PFC in particular has been associated with 
negative emotional states (Demaree, Everhart, Youngstrom, & Harrison, 2005). 
Furthermore, the dorsal medial PFC is essential for the regulation of autonomic 
and neuroendocrine stress response and arousal associated with emotional 
states and behavior, whereas the ventral medial PFC has been implicated in 
generating these emotional states as well as behavior (Drevets et al., 2008; 
Phillips et al., 2003a). The dorsal and ventral medial PFC are reciprocally 
functionally related, and abnormalities in the function of either, or both, may be 
associated with abnormalities in emotional behavior and regulation (Phillips et 
al., 2003a). In line with these findings, decreased blood flow in the dorsal medial 
PFC has been associated with increased autonomic responsiveness, anxiety, 
and sad mood (Phillips et al., 2003a) In addition, dorsal medial PFC dysfunctions 
have been implicated in many psychiatric disorders, including depressive 
disorders (Drevets et al., 2008) and anxiety disorders (Zhao et al., 2007). Taken 
together, these results suggest that the reduced dorsal medial PFC volume 
may (in part) underlie the enhanced emotional sensitivity associated with 
CEM. It should be noted that, contrary to our predictions, the reduced medial 
PFC volume associated with CEM was independent of psychopathological 
status, indicating that the reduced medial PFC volume was present not only in 
individuals with psychopathology but also in controls who never developed a 
depression or anxiety disorder (although the number of controls with reported 
CEM is relatively small, and effect sizes of medial PFC reductions were also 
smaller in the controls than in individuals with depression and/or anxiety). 
Therefore, reduced medial PFC volume does not seem to be directly linked 
to the development of depressive or anxiety disorders in individuals reporting 
CEM. This finding is more consistent with the idea that additional risk factors, 
such as genetic makeup (Frodl et al., 2010; Gatt et al., 2009; Joffe et al., 2009) 
alone or in interaction with exposure to stressful life events during adulthood 
may additionally determine who will subsequently develop a depressive and/ or 
anxiety disorder (Beck,2 008; Caspi & Moffitt, 2006). In line with this suggestion, 
individuals with current depressive and/or anxiety disorder reporting CEM (n= 
65) indeed reported more negative life events (mean ± SEM: 5.96 ± .55) than 
controls reporting CEM (n= 13; 4.62 ± .24, t76=-2.26, p< .05). 
Although our results are compelling, several potential limitations must be 
taken into account. The use of the DARTEL VBM approaches is not without its 
limitations (Ridgway et al., 2008), although recent studies (McLaren, Kosmatka, 
Kastman, Bendlin, & Johnson, 2010; Yassa & Stark, 2009) demonstrated that 
it is an improvement to standard voxel-based approaches. In addition, the 
sensitivity of the DARTEL approach for detecting hippocampal atrophy has 
been demonstrated in MDD patients (Bergouignan et al., 2009). Nevertheless, 
manual tracing or shape-based analyses techniques, as have been used in 
most previous studies on hippocampal structural abnormalities, might be 
more sensitive in detecting deformations compared with an automated 
segmentation approach. Furthermore, although a clinically diagnosed 
posttraumatic stress disorder diagnosis was an exclusion criterion for NESDA, 
unidentified current or lifetime posttraumatic stress disorder symptoms may 
still have been present, which may have influenced our findings. However, 
CEM-related medial PFC gray matter reductions were also present among 
controls who had never developed a depressive or anxiety disorder; therefore, 
it is unlikely that current or lifetime posttraumatic stress disorder may have 
confounded our results. In addition, history of childhood maltreatment was 
retrospectively assessed by means of an interview, and it is important to 
acknowledge the inherent subjectivity of self-reported CEM. For instance, the 
retrospective assessment of CEM may be subject to recollection bias, so that 
individuals with current psychopathology may over-report, whereas controls 
6
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may underreport, a history of childhood maltreatment. However, in the NESDA 
sample, current affective state did not moderate the association between CEM 
and lifetime affective disorder, indicating that recall of CEM in the current 
sample was not critically affected by current mood state (Spinhoven et al., 2010). 
Finally, our findings are based on a cross-sectional study. Whereas the idea that 
CEM is associated with dorsal medial PFC gray matter volume reductions fits 
well with numerous preclinical studies, the possibility of reversed causality 
cannot be excluded. For instance, individuals with reduced dorsal medial PFC 
volume might report more CEM as a result of impaired  emotion regulation. 
Another explanation may be that the reduced dorsal medial PFC volume was 
preexistent and that inadequate emotion regulation associated with reduced 
dorsal medial PFC volume might increase children’s risk for exposure to CEM. 
Following this line of thought, one would expect that reports of presence or 
absence of life stressors later in life would also be related to dorsal medial PFC 
volume. Nevertheless, presence of life stressors (yes or no) was not associated 
with medial PFC volume (F1,109= .09, p= .76, d= .05], and the impact of CEM 
on medial PFC volume remained unchanged when adding presence of life 
events into the analysis (F1,109= 9.08, p<.01, d= .54]. Theoretically, longitudinal 
studies examining neuroanatomical developmental changes over time among 
individuals reporting CEM are needed to shed more light on the aetiology of 
our findings. To the best of our knowledge, such studies have not yet been 
conducted, and from an ethical point of view, it would be highly problematic 
to prospectively follow children who are known to be exposed to CEM without 
interfering in their situation. 
In summary, we found in a large sample of unmedicated adults that self-
reported CEM is associated with a substantial reduction in dorsal medial PFC 
gray matter volume. In line with an accumulating number of animal studies 
(Caspi & Moffitt, 2006; Levine et al., 2008; Sanchez et al., 2007; Sanchez et al., 
2001), our finding suggest that sustained inhibition of growth, or even structural 
damage, can occur after exposure to emotional maltreatment in childhood. 
In addition, previous studies have shown that CEM is associated with altered 
hypothalamic-pituitary-adrenal axis reactivity to stress (Carpenter et al., 2009; 
Elzinga et al., 2008) and that CEM is an important predictor for the development 
of depressive and anxiety disorders in adulthood (Gibb et al., 2007; Spinhoven 
et al., 2010). Given the important role of the mPFC in the perception and 
regulation of emotional behavior and stress responses (Arnsten, 2009; Cardinal 
et al., 2002; Lupien et al., 2009; McEwen, 2008; Radley, Williams, & Sawchenko, 
2008; Sanchez et al., 2001), our finding might provide an important link in 
understanding the increased emotional sensitivity in individuals reporting CEM. 
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Background: Neuroticism and extraversion are personality factors associated 
with the development of affective disorders, possibly through differential 
impact on brain structures implicated in emotional processing. To date, 
studies on brain morphology mainly focussed on neuroticism, yielding 
conflicting findings concerning the association with personality, partially due 
to methodological issues and samples under study. 
Methods: In the present study, high resolution structural T1-weighted MR 
images of 65 healthy adults were processed using an optimized Voxel Based 
Morphometry approach. Multiple regression analyses were performed to test 
for associations of neuroticism and extraversion with prefrontal and subcortical 
volumes. 
Results: Orbitofrontal and right amygdala volume were both positively related 
to extraversion. Neuroticism scores not significantly correlated with these brain 
regions. 
Conclusion: The present results indicate that the reduced likelihood on 
developing affective disorders associated with high extraversion may be 
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Neuroticism and extraversion are personality factors that have been 
directly linked to emotional states: neuroticism has been associated with 
susceptibility to negative emotional states, whereas extraversion has been 
linked to susceptibility to positive emotional states (Larsen & Ketelaar, 1991). 
Also, neuroticism has been shown to correlate positively, whereas extraversion 
correlated negatively, with (subsyndromal) symptoms of depression and 
anxiety in the general population (Jylha & Isometsa, 2006). Other personality 
traits, such as agreeableness, openness to experiences, and conscientiousness 
have been proposed to play a more indirect role in influencing affective states 
(Larsen & Ketelaar, 1991). Consequently, neuroticism and extraversion may 
respectively put one at risk for (Bienvenu et al., 2004), or protect one against 
(Clark, Watson, & Mineka, 1994) development of affective disorders. 
More insight in the relation between personality and brain regions associated 
with emotion processing and regulation may help to understand the influence 
of personality on the manifestation of subclinical anxiety and depression 
symptoms. On a functional level, it has previously been shown that neuroticism 
modulates neural activity in prefrontal and subcortical brain regions related to 
affective processing (Canli, 2004; Cremers et al., 2010). Neuroticism has been 
related to more amygdala activation in response to distracting negative facial 
expressions during a cognitive task (Haas, Omura, Constable, & Canli, 2007) and 
to less anterior cingulate cortex–amygdala connectivity during processing of 
negative emotional facial expressions (Cremers et al., 2010). Extraversion on 
the other hand, was found to be positively associated with amygdala activation 
in response to happy faces (Canli, 2004). Together, these findings indicate that 
core brain structures involved in emotion processing, such as the amygdala and 
the ventral part of the prefrontal cortex, including the orbitofrontal cortex, may 
play a role in the relation between personality and affective behaviour.
Structural variation might underlie these functional relations of personality 
and regions related to emotion perception and appraisal. In an adolescent 
sample, an association between extraversion, but not neuroticism, and 
prefrontal volume (Blankstein, Chen, Mincic, McGrath, & Davis, 2009) has 
been observed, which has also been demonstrated in adults (DeYoung et al., 
2010), although not consistently (Wright et al., 2006). Therefore, the relation 
between brain volume and affect related personality traits remains unclear. 
Inconsistencies in reported findings may be due to methodological and 
technical issues, such as the use of different segmentation and normalization 
strategy (e.g. analysis based on modulated vs unmodulated images (Omura, 
Todd Constable, & Canli, 2005)), not accounting for total brain volume (Gardini, 
Cloninger, & Venneri, 2009), or to sample characteristics and processes of brain 
maturation (e.g. by including only elderly (Jackson, Balota, & Head, 2009; 
Wright, Feczko, Dickerson, & Williams, 2007) or only adolescents (Blankstein 
et al., 2009). Aging is an important predictor of regional brain volume, and the 












personality (Jackson et al., 2009). It is therefore necessary to further elucidate 
the complex relation between affect related personality traits and regional 
brain volume in an adult sample, controlling for these important factors. In the 
present study, we used an optimized voxel based morphometry approach to 
investigate the relationship between neuroticism, extraversion, and regional 
brain volume in a large sample of healthy adults. We focussed on brain regions 
involved in the initial processing of emotional information (amygdala) and on 
regions related to the appraisal and decision making influence of emotional 
information, (anterior cingulate cortex and orbitofrontal cortex) (Drevets et al., 
2008). As such, we aimed to identify neuro-anatomical substrates associated 
with affect-related personality traits. 
ETHICS STATEMENT
The study was carried out in accordance with the Declaration of Helsinki. Also, 
the Ethical Review Boards of the Leiden University Medical Center, Academic 
medical Center Amsterdam, and University Medical Center Groningen 
approved this study. All participants provided written informed consent after 
complete description of the study. 
PARTICIPANTS
Sixty-five healthy control participants were selected from the NESDA 
(Netherlands Study of Depression and Anxiety) neuroimaging study (Penninx 
et al., 2008). The MRI main sample is described in detail elsewhere (van Tol 
et al.,2010). Exclusion criteria for the current sample were: 1) a history of or 
current DSM IV axis I pathology, 2) taking any psychoactive drugs, 3) the 
presence or history of major internal or neurological disorder, 4) dependency 
or recent abuse (past year) of alcohol and/or drugs, 5) hypertension 6) general 
MR-contraindications. 
PERSONALITY QUESTIONNAIRE 
To asses personality traits, all participants completed the NEO Five Factor 
Inventory (Costa & McGrae, 1992). 
IMAGE ACQUISITION
Imaging data were acquired using Philips 3-tesla MR-systems (Best, The 
Netherlands) located at the Leiden University Medical Center (LUMC), 
Academical Medical Center (AMC) University of Amsterdam, and University 
Medical Center Groningen (UMCG), equipped with a SENSE-8 (LUMC and 
UMCG) and a SENSE-6 (AMC) channel head coil, respectively. For each subject, 
anatomical images were obtained using a sagittal 3D gradient-echo T1-
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DATA ANALYSIS
Voxel Based Morphometry (VBM) following the Diffeomorphic Anatomical 
Registration Through Exponentiated Lie (DARTEL) algebra software 
(Ashburner, 2007) implemented in Matlab 7.1.0 (The MathWorks Inc., Natick, 
MA, USA) was used. The preprocessing and masking procedure is described in 
detail elsewhere (van Tol et al., 2010). Briefly, after segmentation, data were 
registered, normalized, and modulated using the DARTEL pipeline. Gray matter 
(GM) images were normalized to Montreal Neurological Institute (MNI) space 
and smoothed at 8 mm full width at half maximum (FWHM). In the resulting 
images, each voxel represents an absolute amount of brain volume, equivalent 
to the brain volume per unit prior to normalization. 
Next, we performed a regression analysis with neuroticism and extraversion 
as independent variables. Age, gender, scan center, and gray matter total 
volumes were entered as nuisance variables. Based on the literature on 
emotion processing in affective disorders (Drevets et al.,2008), we set the 
following regions of interest (ROI): amygdala, orbitofrontal cortex (OFC), 
anterior cingulate cortex (ACC). Results are reported at p<.05 Family wise error 
(FWE) corrected for the spatial extent of the ROIs (small volume corrections). 
The ROIs were defined by the Automated Anatomical Labeling (AAL) templates 
implemented in the Wake Forest University (WFU) pickatlas (Maldjian et al., 
2003). For regions other than the ROI’s, a voxel level threshold of p<.05 whole 
brain FWE corrected was set a priori. Demographic and clinical data were 
analyzed with SPSS 16.0 (SPSS Inc., Chicago, Il, USA) and significance was set 
at p<.05. 
SAMPLE CHARACTERISTICS AND PERSONALITY SCORES 
The age range of the 65 participants (42 females) was: 21-56, Mean (M) =40.5, 
standard deviation (sd) =9.7; years of education: M=14.3, sd=2.9). Neuroticism 
(range= 13-36; M=24.2, sd=4.9) correlated negatively to extraversion (range 
27-56; M=43.7, sd=6.2) (r =-0.4, p<.05) and total gray matter volume (r =-0.3, 
p<.05). Extraversion was positively correlated to total gray matter volume (r 
=0.3, p<.05). No correlation was observed between neuroticism or extraversion 
and age, years of education, and sex (all p>.13). 
PERSONALITY AND REGIONAL BRAIN VOLUME
The right orbitofrontal cortex (BA 11; MNI coordinates: [x=13 y=16 z=-14], 
Z=3.77, clustersize= 329) and right amygdala (MNI coordinates: [x=21 y=-10 
z=-21], Z=3.34, clustersize= 31)) showed a positive relation with extraversion. 
Neuroticism did not show a significant relation with regional brain volume in 
any of our regions of interest. Adding the other three personality variables 
(openness, agreeableness, and conscientiousness) from the NEO_FFI did 
not significantly change the results (orbitofrontal cortex: Z=3.28; amygdala, 











EXTRAVERSION IN THE 
AMYGDALA AND OFC
A) Positive correlation of 
extraversion and volume of 
the right orbital frontal gyrus
B) Positive correlation of 
extraversion and right 
amygdala volume. 
Correlations of extraversion 
with volume of the 
orbitofrontal cortex and 
amygdala are overlayed on 
the mean high-resolution T1-
weighted template in MNI 
space at p<.005 for display 
purposes. 
In the present report, we used an optimized VBM approach to test for 
personality related variations in regional brain volume, while controlling for 
age and gender, and demonstrated a positive correlation of extraversion and 
OFC and amygdalar volume in an adult sample. This result confirms the role of 
the OFC in personality, a region that was already associated with personality 
changes in the case report of Phineas Gage (Damasio, Grabowski, Frank, 
Galaburda, & Damasio, 1994). We also found a positive correlation between 
extraversion and volume of the amygdala. However, we did not find strong 
structural correlates of neuroticism.
 The observation that extraversion correlated positively with volume of 
both the OFC and amygdala is of interest because of the role these regions 
play in affective processing (Rolls, 2004; Rolls & Grabenhorst, 2008). The OFC 
has often been associated with controlling reward and punishment related 
behavior, emotion regulation, and decision making (Kringelbach & Rolls, 2004). 
The amygdala has a well-documented role in emotion processing and has bi-
directional connections with the OFC (Price, 2003). Interestingly, a positive 
correlation of OFC thickness with extraversion and fear extinction has been 
described in a small study (Rauch et al., 2005). In another study, humor-driven 
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with extraversion in the right OFC (Mobbs, Hagan, Azim, Menon, & Reiss, 
2005). In the amygdala, activation during happy face viewing was found to be 
positively related to extraversion (Canli, 2004). Hence, the increased volumes 
of OFC and amygdala may play a role in the increased sensitiveness to positive, 
pleasant information and (social) reward, and the propensity to experience 
positive affect which characterizes extraversion (Clark et al., 1994). The nature 
of this role, however, awaits further elucidation, as increased volumes of GM in 
brain areas may be reflective of processes involving amongst others glia cells, 
inhibiting or excitatory interneurons, and neurons. However, these processes 
can not be assessed directly in vivo. 
The present result is in line with findings of Blankenstein and colleagues 
(2009) who used a similar methodology (i.e. an optimized VBM approach) in an 
adolescent sample. The present results are also in line with results of previous 
studies that have shown a relation between personality and orbitofrontal 
cortical thickness (Wright et al., 2006) and lateral PFC volume (Wright et al., 
2007) in smaller samples of young adults and elderly. However, Wright and 
colleagues (2006) reported that neuroticism was negatively related to OFC 
volume and extraversion was positively related to lateral PFC volume in a young 
adults. Accordingly, in the present study, we expected neuroticism to account 
for a substantial portion of the volumetric variation in regions associated 
with emotional perception and regulation. However, no such relation was 
observed. Instead, extraversion was found to be the main predictor of regional 
brain volume in affective brain regions. Discrepancy in findings might be due 
to methodological issues such as outlined before; in this study we used an 
optimized VBM method in a relatively large adult subject sample.   
In the present study we examined structural correlates of extraversion 
and neuroticism in a cross-sectional design. Therefore, it is possible that the 
found correlates are not primary, but secondary to individual personality 
characteristics. For instance, high extraversion is known to be associated with 
different lifetime experiences than low extraversion. As of yet unpublished 
finding from the same NESDA study indicate that extraversion and negative 
life events mediate the course of depressive symptoms (Spinhoven et al. 2011). 
Extraversion and lifetime experiences may also lead to a differential effect on 
brain structures involved in social interaction or hedonia. 
Given the augmenting evidence for a significant relation between extraversion 
and OFC and amygdala volumes, it will be important to further elucidate this 
relation in studies addressing structural and functional connectivity of the OFC 
and the amygdala. This would also provide more insight the trajectory from 
health to psychopathology, and as such identify neuroanatomical markers for 
the risk of affective disorders. 
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Brain structure and brain function in patients with Major Depressive Disorder 
(MDD) and prevalent anxiety disorders were studied in this thesis. The first aim 
of this study was to identify disorder specific and shared neuroanatomical and 
functional abnormalities, with a focus on emotional information processing 
and executive functions. Structural and functional MRI patterns of patients 
with both MDD and anxiety disorders (comorbid depression-anxiety) were 
directly compared with those of patients with only MDD or anxiety disorders. 
The second aim of this study was to study the relation of common risk factors 
of mood- and anxiety disorders, namely neuroticism and childhood emotional 
abuse, and regional brain volume. Giving insight into the shared and distinct 
neurobiological underpinnings of MDD and anxiety disorders is important to 
understand their high comorbidity, for the classification of MDD and anxiety 
disorders, and subsequently for the treatment and course of these highly 
prevalent psychiatric disorders. 
Both brain morphometry and brain function related to cognitive and emotional 
processes were investigated with the use of magnetic resonance imaging 
(MRI). The anxiety disorders included in this study were social anxiety disorder, 
panic disorder, and generalized anxiety disorder. The studies described in this 
thesis are based on data acquired in the context of the Netherlands Study of 
Depression and Anxiety (NESDA), a large scale, multi-site, observational cohort 
study. In this final chapter, we will summarize and discuss the main results of the 
studies presented (Chapter 2-7). Finally, implications and recommendations for 
future research are provided. 
The question whether MDD, comorbid depression-anxiety disorder, and anxiety 
disorders were associated with volumetric abnormalities in regions linked 
to emotion perception and regulation was adressed first. In Chapter 2, we 
showed that reduced volume of the rostral and dorsal anterior cingulate cortex 
(ACC) is a generic effect in MDD and anxiety disorders. This ACC reduction was 
observed independent of comorbidity and was unrelated to variations in illness 
severity, medication use, and sex. This generic effect supports the notion of 
a shared aetiology in MDD and anxiety disorders and may reflect a common 
symptom dimension related to altered emotion processing. Decreased regional 
volume of the inferior frontal cortex in MDD and lateral temporal cortex in 
anxiety disorders without comorbid MDD, on the other hand, may reflect 
disorder-specific symptom clusters. In addition, early onset of depression was 
found to be associated with reduced volume of the subgenual ACC, extending 
into the orbitofrontal gyrus, compared with healthy controls. This additional 
volume reduction in the affective subdivision of the ACC further suggests that 
vulnerability for MDD is related to volume of the ventral ACC. 
The neural (functional MRI) correlates of emotional word memory in MDD 
















correlates of emotional memory processes is of interest to MDD and anxiety 
disorders, because abnormalities in the encoding and remembering of 
emotional information might reinforce negative mood and could contribute 
to the prolonged course of the disease (Elliott et al., 2002). In Chapter 3, we 
demonstrated that decreased activation of the hippocampus during positive 
word encoding is a common phenomenon in depression and anxiety disorders 
that may constitute a common vulnerability for biased information processing 
in MDD and anxiety disorders. This effect was observed independent of illness 
severity, medication use, and regional volume. Moderately and severely 
depressed MDD patients were additionally characterized by increased 
activation of the insula, amygdala, and by trend-wise increased activation of 
the striatum and prefrontal cortex during encoding of negative words. These 
findings may mark an increased sensitivity for negative stimuli. Furthermore, 
illness severity dependent increased activation of fronto-polar regions in 
comorbid depression-anxiety, irrespective of valence was observed. These 
results emphasize the current distinction between MDD and anxiety disorders 
(with and without comorbid MDD) with respect to processing of mood-
congruent information (i.e., negative words), although a hippocampal hypo-
response to positive words may mark a general insensitiveness to positive 
information. 
The involvement of dorsal prefrontal regions such as the dorsal ACC, 
dorsolateral PFC, and dorsomedial PFC during the non-emotional Tower 
of London visuospatial planning task was studied in Chapter 4. Here, we 
demonstrated that only moderately to severely depressed MDD patients are 
characterized by increased left dorsolateral prefrontal activity as a function 
of executive task load together with subtle performance differences. Mildly 
depressed and remitted MDD patients, as well as anxiety patients showed 
normal task performance and no activation differences were observed. 
Combined these results indicate that prefrontal hyperactivation during high 
planning demands is a state (i.e., depressive episode dependent) characteristic 
and not a trait (i.e., depressive episode independent) characteristic of MDD. 
We conclude that executive dysfunction during a non-emotional visuospatial 
planning task is not a feature of anxiety disorders, supporting the current 
diagnostic distinction between anxiety disorders and depression. 
 In Chapter 5, we studied whole-brain connectivity during an emotional word 
classification task using template independent component networks. We aimed 
to directly investigate the connectivity of subcortical and (para)limbic regions 
associated with emotion perception and generation of emotional states on the 
one hand, and dorsal cortical regions associated with emotional regulation on 
the other hand. We demonstrated that patients with MDD who were life-time 
free of anxiety disorders showed decreased connectivity of the medial PFC and 
ventral-striatal regions within the salience network (Seeley et al., 2007) during 
the classification of negative, neutral, and positive words, unrelated to illness 
severity. Furthermore, connectivity of the medial PFC with the task-executive 
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network was positively related to the number of words classified as positive 
in the MDD group. This decreased connectivity of fronto-striatal regions 
within the salience compared with controls confirms the hypothesis of a 
relative ventral-dorsal decoupling that may serve to explain the compromised 
emotional regulation in MDD.  
In Chapter 6 we focused on the long-term anatomical correlates of childhood 
emotional maltreatment. We demonstrated that childhood emotional 
maltreatment is associated with lower volume of the dorsal medial PFC, 
independent of current psychopathological status and independent of 
concomitant physical or sexual abuse. This finding suggests that sustained 
inhibition of growth or structural damage can occur after exposure to childhood 
emotional maltreatment. Given the important role of the dorsal medial 
prefrontal cortex in the regulation of emotional behavior, our results may 
provide an important link in understanding the increased emotional sensitivity 
in individuals reporting childhood emotional maltreatment.
The correlations of the personality traits neuroticism and extraversion was 
studied in Chapter 7. We showed that orbitofrontal and subgenual ACC volume 
in healthy control participants was positively related to extraversion. No 
relation with neuroticism was observed. In addition, extraversion was positively 
correlated to right amygdalar volume. These findings indicate that extraversion 
is a potent factor in predicting regional brain volume in structures related to 
emotional processing. High levels of extraversion may modulate emotion 
processing through the orbitofrontal cortex, thereby affecting the likelihood of 
developing affective disorders. 
Taken together, these findings suggest that MDD and common anxiety 
disorders share neuroanatomical and neurophysiological abnormalities, but at 
the same time are characterized by unique neuroanatomical abnormalities and 
activation patterns during cognitive and emotional processes. Next, we showed 
that besides current psychopathology, personality factors and emotional 
traumatic experiences during childhood are associated with variations in 
volume of structures that are important for mood regulation. Therefore, 
these effects could mediate the vulnerability for developing MDD and anxiety 
disorders. Overall, no effect of SSRI use on functional and structural measures 
was observed.
This is the first series of neuroimaging studies that studied MDD, prevalent 
anxiety disorders, and comorbid depression-anxiety together, while at the 




In this section, the shared neuroanatomical- and functional MRI correlates of 
MDD and anxiety disorders will be discussed, followed by a discussion of the 
unique neurophysiological correlates of MDD and anxiety disorders. Next, 
the question of whether to regard comorbid depression-anxiety as MDD plus 
anxiety or as a different diagnostic category will be discussed. Subsequently, 
risk factors of mood and anxiety disorders will be discussed. Also, the result 
of relatively normal cognitive functioning in our sample will receive attention. 
Furthermore, the stability of effects and the question of causality will be 
addressed. Finally, the present results will be reflected on in light of the 
frequently used neuroanatomical models of mood regulation and depressive 
pathology. Considerations and implications of the results presented in this 
thesis will be discussed. 
MDD = ANXIETY DISORDERS
This study demonstrated for the first time that MDD and anxiety disorders share 
morphologic and activation abnormalities. Both MDD patients and patients 
with anxiety disorders showed reduced volume of the dorsal and rostral ACC. 
This volumetric abnormality was also observed in patients with both MDD 
and anxiety disorders. ACC reductions have been previously observed in MDD 
and panic disorder, but groups had not been compared directly. Also, studies 
in MDD and anxiety disorders performed to date were often confounded by 
the inclusion of comorbid anxiety or MDD, respectively, and the specificity 
of these findings remained therefore unclear. Evidence is now provided that 
suggests that MDD and anxiety disorders share a common neuroanatomical 
characteristic that may explain, at least in part, the emotional dysregulation 
that is associated with both anxiety disorders and MDD. Interestingly, this 
abnormality is observed in the rostral ACC, a region that has been considered 
the emotion-cognition integration component in the Mayberg model (1997) 
(See chapter 1). A common abnormality in this region in both depression and 
anxiety indicates that regulation between dorsal and lateral cortical regulatory 
and subcortical and (para)limbic appraisal regions may be compromised owing 
to this structural abnormality. This rostral ACC abnormality may lead to sub 
optimal frontal-subcortical regulation, resulting in a variety of symptoms 
associated with both mood and anxiety disorders. 
Next, a common abnormality in MDD and anxiety disorders was observed 
during the encoding of mood-incongruent (i.e., positive) words. MDD and 
anxiety patients showed less activation of the right hippocampus, also when 
a diagnosis of both depression and anxiety was present. This suggests that 
abnormal processing of positive information might be considered a trait 
phenomenon of both depression and anxiety disorders, because the effect was 
observed independent of illness severity. This suggestion is further supported 
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disorders: fewer words were classified as positive compared with controls, 
whereas no difference in classification of negative words was observed. In the 
study of MDD and anxiety disorders, the focus has been predominantly on 
processing of mood congruent or disorder specific information. The shared 
abnormality as demonstrated in this study may be linked to the increased 
(negative) self-focus that is associated with both depression and anxiety 
(Borden, Lowenbraun, Wolff, & Jones, 1993; Spurr & Stopa, 2002; Watkins & 
Teasdale, 2004). Processing of self-referential material, for example, has been 
associated with increased memory success (Symons & Johnson, 1997). In a sad 
emotional state, negative words may be more relevant for the self than positive 
words, and therefore self-relevant information is more likely to affect the 
negative mood state. As a result, positive words may be considered less salient 
and as a consequence are processed in a less efficient manner. This less efficient 
processing of positive information may be reflected in the words classification 
behavior, prolonged response times and the reduced hippocampal activation 
during positive encoding. Consequently, positive information may be less 
potent in affecting the current mood state, thereby influencing the course of 
the disease in a negative way as well. However, the influence of a negative 
self-focus on processing of external positive information and the role of the 
hippocampus therein needs to be further investigated. 
These results underline the importance of abnormalities in processing 
positive information in MDD and anxiety disorders and further emphasize that 
next to the traditional focus on mood-congruent processing abnormalities, 
mood-incongruent processing abnormalities should also be considered. Not 
only in the study of MDD, but also in the study of anxiety disorders. Recently, 
evidence was provided that patients with MDD have difficulties in engaging 
in positive mood states for prolonged periods of times, as was reflected in a 
failure to sustain activity in the nucleus accumbens (Heller et al., 2009), which 
is an important structure implicated in the reward system. Whether such a 
mechanism generalizes to patients with (comorbid) anxiety disorders, remains 
to be elucidated. 
MDD ≠ ANXIETY DISORDERS
Besides the shared characteristics, distinct neuroanatomical and 
neurophysiological abnormalities were observed in MDD and anxiety. These 
unique characteristics could help explain the specific symptomatology of the 
disorders. 
MDD patients, but not patients with anxiety disorders with or without 
MDD, showed lower volume of the right inferior frontal gyrus compared with 
controls. The inferior frontal gyrus region has been associated with processes 
of selective attention, cognitive conflict resolution, goal maintenance, and 
emotional inhibition (Forstmann et al., 2008; Lieberman et al., 2004; Matthews
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et al., 2009; Ochsner et al., 2009; Phillips et al., 2003a). Interestingly, in our 
study, prefrontal abnormalities during executive processes were only observed 
in moderately and severely depressed patients and not in patients with remitted 
or mildly depressed states, nor in patients with current anxiety disorders. 
Although connectivity was not investigated in patients with anxiety disorders 
or comorbid depression-anxiety disorders, our results of decreased connectivity 
of the ventral striatum and the ventral medial PFC within the salience network 
during the execution of an emotional word classification task further suggests 
that top-down control of prefrontal regions over ventral emotion generating 
regions is compromised in MDD. Importantly, the specificity of this finding for 
MDD needs to be tested. In this study, we did not test for the directionality of 
cortical-paralimbic connectivity. However, dorsal prefrontal regions have been 
uniquely associated with top-down emotional regulation (Ochsner et al., 2009).
Moreover, moderately and severely depressed MDD patients showed 
increased responsiveness of the amygdala, striatum, and PFC during encoding 
of negative words. This may indicate an increased sensitivity for negative 
information in general that is specific to MDD in the ‘active’ depressed state, 
because it was not observed in remitted and mildly depressed MDD patients nor 
in patients with anxiety disorders. Also, MDD patients showed depressive state 
dependent ACC hyperactivation during encoding of positive words and state-
independent increased activation of the left insula during encoding of negative 
words. Together these results indicate that the increased ‘sensitivity’ of limbic 
and prefrontal regions for negative information and increased attentional 
control during positive encoding is primarily associated with depressive 
pathology. Furthermore, these observations are in line with the suggestion that 
MDD and MDD with comorbid anxiety disorders should be considered different 
diagnostic categories. 
In summary, MDD is uniquely characterized by inferior frontal volume 
reduction, state dependent dorsolateral PFC activation abnormalities as 
a function of planning load, increased sensitivity for encoding negative 
information, and by an increased demand for attentional control during 
encoding of positive words as reflected in increased ACC activation. The latter 
phenomenon may be reflective of a conflict resolution between the personal 
mood state and the emotional valence of the words presented during the task. 
Together these unique characteristics indicate more deficient involvement of 
dorsal frontal regions in MDD than in anxiety disorders, together with increased 
sensitivity for general negative information. 
Structural abnormalities specific for anxiety disorders were observed as well. 
Patients with a current diagnosis of anxiety, but not those with a concurrent 
diagnosis of MDD, showed decreased volume of the superior temporal gyrus 
volume. This may mark a neuroanatomical vulnerability related to impaired 
evaluation of interoceptive information (Uchida et al., 2008) and altered threat 
processing (Phillips et al., 1998). These processes may be more specific for 
anxiety disorders than for MDD. During recognition of positive words, patients
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with anxiety disorders showed increased activation in the left inferior frontal 
gyrus. No subcortical functional abnormalities were observed in patients with 
anxiety disorders in this study, which may be related to the more general 
tasks that were administered to investigate emotional processes: no specific 
(social) threat stimuli were included in the functional imaging paradigms. 
The use of social or situational threat paradigms may better highlight anxiety 
specific abnormalities, as the symptomatology of anxiety disorders is often 
more situational bound that in MDD. However, fearful faces were presented 
in the emotional faces paradigm, a task that was included in the NESDA 
neuroimaging study but not subject of this thesis. Analysis did not reveal 
functional abnormalities during viewing of fearful faces in patients with 
anxiety disorders, nor in the other patient groups (Demenescu et al., 2010). To 
conclude, our results suggest that outpatients with prevalent anxiety disorders 
are not functionally affected during executive task execution and processing of 
general negative information. 
COMORBID DEPRESSION-ANXIETY VS. MDD AND 
ANXIETY
Contrary to our expectations, patients with comorbid depression-anxiety 
showed structural and functional abnormalities similar to patients with only 
MDD or anxiety disorders. This is surprising, considering the higher symptom 
severity in comorbid depression-anxiety on both measures of depression and 
anxiety than in ‘singular’ (i.e., without comorbidity) MDD and anxiety. Because 
comorbid depression-anxiety is associated with worse outcome, we expected 
to see this reflected in the neuroanatomical and functional patterns. It is 
possible that the currently used paradigms in combination with the current 
analysis approaches were not sensitive enough to detect differentiating 
characteristics in comorbid depression-anxiety. Nevertheless, patients with 
comorbid depression-anxiety were not characterized by comorbid depression-
anxiety specific abnormalities, but by abnormalities in rostral ACC volume 
and right hippocampal reactivity during positive word encoding similar to 
patients with singular MDD and anxiety disorders. In the moderately and 
severely depressed state, patients with comorbid depression-anxiety were 
characterized by increased fronto-polar recruitment when recognizing 
previously encoded emotional words, independent of valence. As a function 
of visuospatial planning only trend-wise increased dorsal PFC activation was 
observed. Together these results might suggest that comorbid depression-
anxiety patients are characterized by increased frontal recruitment during 
attentional demanding tasks only in the presence of emotional distraction or 
content, and only in the severely depressed and anxious state. However, at the 
moment, this suggestion is tentative and needs further investigation. 
Volume reductions in the inferior frontal gyrus were observed in patients 
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with MDD only, and not in patients with comorbid depression-anxiety. This 
difference in result could be the result of a difference in aetiology in MDD and 
comorbid depression-anxiety: in most comorbid depression-anxiety patients, 
the anxiety disorder was the first to manifest. Possibly, anxiety related 
pathology is the primary pathology, and the occurrence of the comorbid 
depression later on only minimally affects the primary neuropathology. 
Interestingly, this explanation does not clarify why the superior temporal 
gyrus volume abnormality was only observed in anxiety without MDD and 
not in comorbid depression-anxiety. However, these findings indicate that 
anxiety and anxiety with comorbid MDD are not characterized by an identical 
neurobiological profile. These differences might explain the syndrome specific 
characteristics. 
In sum, no evidence was provided for the suggestion that comorbid 
depression-anxiety is associated with more severe structural and functional 
abnormalities than patients with singular MDD or anxiety disorders on the 
measures included in this study. Although not subject of this thesis, fMRI 
was also applied during an emotional face viewing task data in the NESDA 
neuroimaging study. Analyses also failed to demonstrate differences between 
patients with comorbid depression-anxiety and patients with singular MDD 
and/or anxiety disorders in amygdalar response to negative emotional 
faces (Demenescu et al., 2010). Nevertheless, on measures presented in this 
thesis, comorbid depression-anxiety showed overlap with the functional and 
structural pattern observed in both anxiety disorders and MDD, but no overlap 
with MDD specific abnormalities was observed. Analysis of symptom course 
trajectories of the NESDA sample suggests that patients with anxiety disorders 
and comorbid depression-anxiety disorder are characterized by lower recovery 
rates and a higher proportion of patients with a chronic course than MDD 
patients without comorbid anxiety disorders (Penninx et al., 2010). The present 
neuroimaging results further suggest that patients with comorbid depression-
anxiety disorders are not primarily characterized by MDD related pathology. 
Whether comorbid depression-anxiety is better characterized by anxiety 
related pathology on a neurobiological level should be studied further. 
STATE VS. TRAIT
In this study, all patients fulfilled criteria for MDD, panic disorder, social 
anxiety disorder or generalized anxiety disorder in the last six months (plus 
scan interval). Remission as discussed in this thesis should therefore be 
considered ‘recent remission’ and caution should be taken when discussing our 
observations in light of proper state vs. trait related phenomenon. In this study, 
rostral ACC, inferior frontal gyrus, and superior temporal gyrus volume was 
observed independent of illness severity. Whether normalization of regional 
brain volume occurs in the absence of symptoms for a longer period 
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of time could not be tested in this cross-sectional study. Longitudinal analyses 
should confirm the hypothesis that reduced volume in these regions is a trait 
phenomenon of depression and anxiety disorders and therefore most likely 
constitutes a common vulnerability for a new anxiety- or depressive episode. 
The only longitudinal volumetric study performed in MDD to date indicates 
that remitted patients show less volume decline than non-remitted patients 
after a 3 year stable remission period (Frodl et al., 2004). Importantly, no 
volume ‘normalization’ was reported in remitted patients (Frodl et al., 2004). 
Depression and anxiety severity related abnormalities were observed during 
tasks as measured with functional MRI. For example, in MDD prefrontal over-
recruitment during planning, increased amygdalar, striatal and prefrontal 
cortex activation during the encoding of negative words, and increased 
dorsal ACC activation during the encoding of positive words, was found to 
be specific for the moderately and severely depressed state. Trait-like effects 
were observed during the encoding of positive and negative words in MDD, 
but not as a function of planning load. Hippocampal blunting during positive 
encoding and the insular hyperactivation in MDD during negative encoding 
were observed independent of current symptom severity. In anxiety disorders, 
hippocampal hypoactivation during encoding of positive words and inferior 
frontal hyperactivation during recognition of positive words were observed, 
although the latter was trend-wise associated with severity of anxiety. 
Relative decoupling of the ventral striatum and medial prefrontal cortex with 
a task executive network in MDD during classification of emotional words was 
observed independent of depression severity as well. Whether these trait-like 
effects persist after six month of full and stable remission should be studied 
using a longitudinal analysis approach. 
Taken together, our results indicate that MDD, comorbid depression-anxiety, 
and anxiety disorders without MDD are characterized by trait like abnormalities 
that may constitute a vulnerability factor in patients who recovered from an 
anxious or depressive episode. However, the stability of effects need to be 
confirmed in longitudinal analyses, for example with the use of the longitudinal 
imaging data that are obtained in the context of the NESDA neuroimaging 
study. These data are currently available and analyzed. State related 
abnormalities, on the other hand, may reflect the episode specific symptoms, 
such as increased negative focus on the self and increased attentional problems 
in MDD. 
THE ROLE OF RISK FACTORS IN NEUROANATOMY OF 
MDD AND ANXIETY
Early life experiences and personality characteristics were related to volume 
in regions associated with emotion perception and regulation, next to 
abnormalities related to current psychopathological status. Remarkably, the
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experience of two or more incidents of psychological trauma or emotional 
neglect was associated with lower volume of the dorsal medial prefrontal 
cortex compared with participants who reported no incidence of any type of 
trauma in their lives. This volumetric abnormality was observed independent 
of current psychopathological state and is most likely associated with an early 
disruption of the human stress system in the developmental phase. These 
results indicate that vulnerability for developing mood- and anxiety disorders 
after exposure to early life trauma may be mediated by a neuroanatomical 
abnormality in regions associated with regulation of stress response. Next to 
regulation of stress responses, the dorsomedial PFC has been associated with 
the regulation of autonomic responses and regulation of arousal associated 
with emotional states and behavior (Phillips et al., 2003a; Urry et al., 2009). 
Abnormal morphometry of this region could therefore affect normal affective 
regulation, and could enhance sensitiveness for mood- and anxiety disorders. 
In addition to these abuse related effects, we found that extraversion was 
associated with volume of the orbitofrontal cortex and orbitofrontal cortex/
subgenual ACC. These regions have been associated with the gating of 
information in- and outflux from the amygdala (Price, 2003) and with control 
over amygdalar responsiveness (Milad & Rauch, 2007). The orbitofrontal 
cortex (including the subgenual ACC) could therefore be considered an visceral 
regulatory component, in line with the Mayberg model (1997). Furthermore, 
extraversion was positively associated with volume of the amygdala, a key area 
in salience detection and processing of emotional cues. Even though we only 
studied variation of the personality factors neuroticism and extraversion and 
only in healthy control participants, these results underline that personality 
factors are associated with morphometry of areas important for emotional 
perception and regulation. High levels of neuroticism have been associated 
with an increased risk for develop mood and anxiety disorders (Bienvenu 
et al., 2004), whereas high levels of extraversion have been found to act as 
a protective factor for developing mood and anxiety disorders (Clark et al., 
1994). In this context, the present results suggest that this vulnerability may 
be mediated by personality dependent variations in orbitofrontal volume. 
In a functional connectivity study, also based on NESDA neuroimaging data, 
neuroticism has been shown to influence connectivity of the ACC and amygdala 
during negative face viewing (Cremers et al., 2010). Although the authors 
controlled for variations in extraversion, they did not test for the direct effect of 
extraversion on amygdala connectivity.  
Alternatively, the present results could be interpreted as being reflective 
of variations in depression and anxiety related symptomatology in healthy 
subjects. Neuroticism has been shown to correlate positively with symptoms of 
depression and anxiety, even in the general population, whereas extraversion 
was found to be negatively correlated with symptoms of depression and 
anxiety in the general population (Jylha & Isometsa, 2006).Neuroticism and 
extraversion could therefore be regarded important personality dimensions 
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reflecting depression and anxiety related symptomatology. In this context, 
our results indicate that volume of subgenual regions vary as a function of 
this personality dimension (i.e., extraversion), even in healthy participants, 
and may reflect subsyndromal or normal variations in depressive and anxious 
symptomatology. 
Interestingly, we also observed lower gray matter volume of the subgenual 
and orbitofrontal volume in patients with early age at onset of the first 
depressive episode in addition to the rostral ACC reduction that was observed 
in all patients (Chapter 2). Although we did not test for the correlation of 
extraversion in this region in patients with onset of MDD before the age of 
18, these volumetric abnormalities suggest that the orbitofrontal region is an 
important region associated with vulnerability for developing depression and 
anxiety disorders. Given the numerous connections of this subgenual ACC/
OFC regions with other important regulatory regions, this may also explain the 
heightened vulnerability for developing mood and anxiety in patients at high 
risk and the worse course of patients with early onset of depression.  
In summary, risk factors associated with MDD and anxiety disorders were 
associated with volumetric variation in structures that have been linked to 
emotional perception and emotional regulation. Therefore, these factors are 
potent to influence the likelihood of developing mood and anxiety disorders. 
However, the exact causal mechanism from risk factor to affective disorder 
should be further investigated. Possibly, these factors set the homeostasis 
of the emotional regulation circuitry different, thereby making the brain 
circuitry associated with emotional and stress regulation more susceptible 
for dysregulation under stressful events, such as negative life events. The fact 
that childhood maltreated patients with MDD and/or anxiety disorders were 
characterized by the experience of more negative life events supports this 
suggestion (Chapter 6). 
CAUSE OR EFFECT?
In this study, we investigated the relation between current psychopathology, 
emotional childhood abuse, and personality factors on one hand, and brain 
function and structure on the other hand using a cross-sectional design. 
Although early life factors such as early onset of depression and the experience 
of childhood emotional maltreatment appear to have a profound influence 
on brain morphometry, no conclusions with respect to cause and results can 
be drawn from the studies presented in this thesis. It is plausible though, that 
childhood emotional trauma would lead to abnormalities in the ‘settings’ of the 
human stress system, thereby affecting neurogenesis of regions that are rich 
in glucocorticoid receptors and are important for emotional control. However, 
this statement on causality can’t be derived from the current study design. A 
current diagnosis of depression and/or anxiety disorder was associated with 
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volumetric and activation abnormalities as well. Whether these abnormalities 
are causal to the symptoms associated with MDD and anxiety disorders remains 
unclear. In our voxel based morphometry study, no relation between the number 
of episodes and volume of the rostral ACC or volume of the hippocampus was 
observed, suggesting that multiple episodes of depression do not aggravate 
the neuropathology. Again, however, the cross-sectional study design does not 
allow to infer on cause and result relationships and to study long-term effects 
of disease factors within patients. Longitudinal analyses should give insight 
into the causality of the relationship. To date, longitudinal imaging studies in 
MDD and anxiety disorders are virtually non-existent, with the exception of the 
volumetric studies of Frodl et al. (2004). Moreover, no longitudinal analyses in 
at risk populations have been performed that could answer the cause or effect 
questions. 
COGNITIVE PERFORMANCE IN MDD AND ANXIETY
Contrary to our expectations, patients with MDD, comorbid depression-
anxiety, and anxiety disorders showed no gross abnormalities in task 
performance during the visuospatial planning task and during the emotional 
word memory task. Only two cognitive tasks were administered, and therefore 
only little can be concluded about the status of neuropsychological functioning 
in MDD and anxiety disorders. The present results of relatively normal cognitive 
executive performance and absence of mood-congruent memory biases could 
be explained by the methods used to assess cognitive functions and by the 
moderate symptom severity of the outpatient sample included. Both options 
and implications of our findings will be discussed.
Behavioral results of the Tower of London task indicated only subtle slowing 
in the most depressed MDD patients during execution of the most difficult 
trials, in the context of normal planning accuracy. It could be argued that this 
computerized version was not sensitive enough to detect differences between 
groups, possibly owing to the two-answer option provided (as opposed to 
open-end questions/trials). However, in other psychiatric groups, this version 
of the Tower of London was sensitive enough to detect abnormalities in 
task performance (van den Heuvel et al., 2005a). Additionally, no effect of 
diagnosis on overall memory performance was observed in the present study. 
Nevertheless, performance differences were observed with the use of the 
same task in participants at high risk for developing depression or anxiety 
(Wolfensberger et al., 2008), suggesting the task is sensitive enough to detect 
performance differences. In this study, the retention interval was relatively 
short. Lengthening the retention interval or including a free-recall session could 
increase the sensitiveness of the test to detect subtle cognitive biases or deficits. 
Also, no effect of diagnosis on memory performance of mood-congruent or 
mood-incongruent words was observed. Possibly, words presented during the 
encoding phase were not salient enough to influence memory formation. Also, 
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presented words were not disorder-specific and therefore may not have been 
potent to affect memory formation. No depression or anxiety specific words 
were presented: instead words had a genera;;u negative, neutral, or positive 
connotation. 
Because cognitive performance was also unaffected in the most severely 
anxious and depressed patients in the present sample, an alternative 
explanation is that cognitive functions are relatively unaffected in outpatients 
with MDD and/or anxiety disorders. Our results of normal cognitive 
performance in MDD and anxiety disorders, although sparingly assessed, 
are in line with a number of neuropsychological studies in outpatient 
samples that reported normal neuropsychological functioning in MDD and 
anxiety (Castaneda et al., 2008; Castaneda et al., 2010; Gladsjo et al., 1998; 
van Wingen et al., 2009). Our results of relatively unaffected planning and 
memory performance support the suggestion that cognitive capacities are not 
diminished in MDD and anxiety. Our results of slightly longer response times 
and increased dorsolateral PFC activation in the most difficult trials may be 
reflective of the narrowed attentional focus hypothesis instead (in: Hartlage 
et al., 1993): extra frontal resources were recruited to focus on external task 
demands that were not depression-relevant. Moreover, emotional words did 
not affect memory performance in a mood-congruent of mood-incongruent 
manner. Nevertheless, abnormal activation of limbic areas was observed during 
encoding of emotional information. Combined with the observation of slower 
encoding of positive words, our results suggest that positive information is to 
a lesser extent linked to (less) available positive material. Thereby, positive 
information could be less potent in affecting mood in a positive manner. 
Discrepancies in results with studies that reported cognitive deficits in MDD 
and anxiety disorders (Airaksinen, Larsson, & Forsell, 2005; Basso et al., 2007; 
Paelecke-Habermann, Pohl, & Leplow, 2005; Porter et al., 2003; Purcell et 
al., 1997; Rose & Ebmeier, 2006; Tavares et al., 2007) may lie in differences in 
clinical characteristics. In this study, all patients were recruited in the outpatient 
setting, were never hospitalized for their psychiatric disorder, were relatively 
young (all aged under 57), did not use any antidepressant medication other 
than SSRIs at the time of the scanning session, were moderately depressed 
on average, and were free of a diagnosis of alcohol abuse. Our findings are 
therefore unlikely affected by negative side effects of, for example, sedative 
drugs on visuospatial capabilities and concentration (Golombok, Moodley, & 
Lader, 1988). Instead, our findings may be representative of the on average 
mildly depressed outpatient sample. 
Interestingly, cognitive dysfunction could contribute to the functional 
impairment experienced by the patients and could therefore constitute a 
predictor or reason for hospitalization (Elliott, 1998; Jaeger et al., 2006; Withall 
et al., 2009). Neurocognitive findings obtained in the inpatient setting may 
therefore not necessarily generalize to the outpatient population. Elliott et al. 
(1996) demonstrated that inpatient performed worse on several
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neuropsychological test in a direct comparisons of MDD in- and outpatients. 
Importantly, the in- and outpatients did not differ on any clinical variable, 
including illness severity. In addition, Purcell et al. (1997) reported that in 
a group of young MDD outpatients, those with a history of hospitalization 
performed worse on executive tasks. Together, these findings suggest that 
cognitive dysfunction is not merely a symptom of the disease, but could be a 
predictor of clinical care utilization. 
IMPLICATIONS FOR NEUROANATOMICAL MODELS OF 
MDD AND ANXIETY 
ANTERIOR CINGULATE CIRCUITRY
Our results emphasize the importance of the rostral ACC for both MDD 
and anxiety disorders. The rostral ACC has been implicated in the cognition-
emotion integration hub, also including the medial PFC and orbitofrontal gyrus 
(Mayberg, 1997). This structural abnormality is likely to affect brain function, 
although the relation between structural and functional abnormalities in 
psychiatric disorders is barely studied. However, the importance of the 
rostral (or pregenual) ACC region for adaptive emotion regulation has been 
emphasized in the study of both MDD (Mayberg, 1997; Seminowicz et al., 
2004) and anxiety disorders (Etkin, Egner, Peraza, Kandel, & Hirsch, 2006). Our 
results support the suggestion of a shared neuropathology in MDD and anxiety 
disorders, and indicate that this rostral or pregenual ACC subdivision should be 
considered for a general neuroanatomical model of psychopathology. 
Functionally, the rostral ACC has been less frequently associated with 
depressed or anxious psychopathology than the subgenual ACC, a more ventral 
ACC locus. However, abnormal BOLD responses in the pregenual ACC have 
been observed and linked to altered glutaminergic metabolism in MDD (Walter 
et al., 2009). Deep brain stimulation of the subgenual ACC has been associated 
with immediate symptom improvement on symptoms such as restlessness, 
mood, interests, and motivation, even in treatment resistant MDD (Lozano 
et al., 2008). Also, this subgenual locus has been associated with treatment 
response in social anxiety disorder (Furmark et al., 2002). This may indicate that 
the subgenual ACC is a target area for successful treatment, but could also be 
considered an important starting point to understand the neuropathology of 
MDD and anxiety disorders. 
A diffusion tensor imaging study that applied probabilistic tractography, a 
technique that calculates the direction of white matter tracts from any chosen 
seed, demonstrated that the subgenual and pregenual ACC are distinct regions 
in terms of structural connectivity (Johansen-Berg et al., 2008). Although 
both ACC subregions were found to project on the dorsal ACC, frontal poles, 
hypothalamus, and nucleus accumbens in healthy participants, the pregenual 
ACC was shown to have the strongest connections with the medial PFC and
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dorsal ACC. The subgenual PFC on the other hand was most strongly connected 
to the amygdala, anterior hippocampus, nucleus accumbens, hypothalamus, 
and orbitofrontal cortex. Therefore, stimulating the subgenual ACC most 
likely influences the subcortical and (para)limbic emotion appraisal and 
generation regions, and could explain the immediate improvements in mood 
and motivation. In fact, deep-brain stimulation of the subgenual PFC decreased 
metabolism in the orbitofrontal cortex and medial PFC, also after six month 
follow up in treatment responders (Lozano et al., 2008). 
Importantly, the pregenual ACC is anatomically connected to the dorsal ACC 
(Johansen-Berg et al., 2008). Functionally, the dorsal ACC has been found 
to influence amygdala activity negatively, both direct and via the posterior 
cingulate gyrus (Stein et al., 2007). In this thesis, we also described lower 
volume in the posterior cingulate gyrus in MDD and anxiety disorders, although 
below threshold. This finding suggests that connectivity of the dorsal ACC with 
the amygdala may be compromised in two ways: as a result of lower volume 
of the rostral and dorsal ACC, and as a result of lower posterior cingulate 
volume. Moreover, the pregenual ACC was found to inhibit amygdala activation 
during an emotional task in healthy controls, a process that was associated 
with emotional conflict resolution (Etkin et al., 2006). In treatment studies of 
MDD, the pregenual ACC was found to differentially influence metabolism in 
the subgenual ACC, orbitofrontal cortex, and dorsolateral PFC, depending on 
successful or unsuccessful treatment (Seminowicz et al., 2004). Finally, the 
pregenual ACC has been found to show abnormal connectivity with the anterior 
insula in MDD, dependent on illness severity (Horn et al., 2010). To sum up, the 
pregenual ACC appears an important region that is interconnected with a large 
number of other important regions implicated in neuroanatomical models 
of affect regulation. As it appears, the pregenual and subgenual ACC regions 
should both be considered important visceral regulation areas and should be 
considered at the center of an ‘emotion regulation circuitry’ affected in MDD 
and anxiety disorders.
In this context, our finding of reduced dorsal and rostral ACC gray matter 
(extending into the subgenual regions and adjacent white matter volume) 
in MDD indicates that communication with the dorsal ACC, subgenual ACC, 
orbitofrontal cortex, and medial PFC may be compromised in outpatients with 
MDD and/or anxiety disorders, leading to a range of symptoms. This suggestion 
is further supported by our findings of decreased connectivity of the medial 
PFC and ventral striatum with a salience network involving dorsal prefrontal 
regions, including the dorsal ACC, dorsomedial PFC, ventrolateral PFC, and 
dorsolateral PFC, although unrelated to volume of the rostral ACC. However, 
we did not investigate the connectivity within this task executive network in 
patients with anxiety disorders or comorbid depression-anxiety, and therefore 
the generalizability of this result to anxiety and comorbid depression-anxiety 
remains unclear. Previous studies have emphasized the importance of the 
medial PFC in both mood regulation through cognitive appraisal (Johnstone 
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 et al., 2007; Ochsner et al., 2009), self-referential processing (Lemogne et al., 
2009), and affective conflict processing (Ochsner et al., 2009). In summary, 
abnormal mood and anxiety regulation in MDD and anxiety disorders may 
be the result of compromised communication between rostral ACC - medial 
PFC, rostral ACC – dorsal ACC, dorsal ACC – amygdala, dorsal ACC – posterior 
cingulate gyrus – amygdala, amygdala – hippocampus, amygdala – subgenual 
ACC – orbitofrontal gyrus, originating from a common volumetric abnormality 
of the rostral ACC. Functional connectivity and structural connectivity studies 
should test whether deficient connectivity between these regions is linked to 
lower volume of the rostral ACC. 
LATERAL FRONTAL AND TEMPORAL CIRCUITRY
In addition to the proposed common neuropathology, inferior frontal gyrus and 
the lateral temporal regions may moderate the emotional circuitry in a disorder 
specific manner. For example, Brodmann 45 in the inferior frontal gyrus, or 
ventrolateral PFC, projects on the dorsolateral PFC, medial PFC, orbitofrontal 
cortex (Price & Drevets, 2010). It has been suggested that the ventrolateral 
PFC could be regarded a multi-modal cortex which connects to circuits 
responsible for emotions as well (Price & Drevets, 2010). In the context of mood 
regulation in MDD, the ventrolateral PFC has been associated with increased 
activation when reappraising negative stimuli and abnormal engagement in 
a ventrolateral PFC - ventromedial PFC – amygdalar circuitry (Johnstone et 
al., 2007). This circuitry is associated with effort to down-regulate negative 
emotions. Therefore, abnormal volume of the right inferior frontal gyrus in MDD 
could contribute to this abnormal circuitry and affect the capability to regulate 
negative emotions. Additionally, increased left dorsolateral PFC activation was 
observed as a function of increasing planning load in moderately and severely 
depressed MDD patients, suggesting that even in the context of emotional 
non-demanding task demands, extra frontal resources are called upon to focus 
on external task demands. This finding may indicate that the dorsolateral PFC 
in the active depressed state is less potent in controlling dorsolateral PFC 
dependent emotion regulation. The superior temporal gyrus on the other hand, 
projects to the medial prefrontal circuitry as well (Price & Drevets, 2010), and 
thereby could affect medial PFC linked emotional regulation as well. 
MEDIAL TEMPORAL AND LIMBIC CIRCUITRY
Although frequently associated with abnormal processing of emotional 
stimuli in MDD and anxiety disorders, only modest abnormalities in amygdalar 
function were observed. No volumetric differences were found in the amygdala. 
Abnormal activation was demonstrated in moderately to severely depressed 
MDD patients only during the encoding of negative words. Analysis of the 
emotional faces data acquired in the context of the NESDA neuroimaging 
study, although not subject of this thesis, failed to provide evidence for the 
suggestion that abnormal amygdalar and subcortical signaling in response to
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sad and fearful faces is at the base of the disorders (Demenescu et al., 2010). 
However, the fact that no gross between group effect was observed in the 
amygdala in anxiety and comorbid depression-anxiety, does not rule out the 
amygdala as an important structure in the pathophysiology of depression and 
anxiety. For example, in an emotional conflict resolution task, the rostral ACC 
was found to inhibit amygdalar response in healthy controls (Etkin et al., 2006), 
whereas this inhibitory effect was absent in patients with generalized anxiety 
disorder (Etkin et al., 2010). 
In the NESDA study, connectivity during ‘resting state’ was studied in first 
episode MDD patients. Veer et al. (2010) reported decreased connectivity of the 
amygdala and the frontal poles with an affective network including the anterior 
insulae, dorsal ACC, ventromedial PFC, temporal poles, and amygdalae. Also, 
using NESDA neuroimaging data, Cremers et al. (2010), demonstrated that 
connectivity of the right amygdala and the medial PFC during negative face 
viewing is positively correlated with neuroticism scores, whereas connectivity 
of the left amygdala and the dorsal ACC was found to correlate negatively with 
neuroticism in healthy controls. As mood and anxiety disorders are associated 
with high levels of neuroticism, it is likely that amygdalar-dorsal PFC connectivity 
maybe be altered in patients with MDD and/or anxiety disorders compared 
with controls. Finally, the orbitofrontal and subgenual anterior cingulate cortex 
may also affect amygdalar – medial PFC/ACC connectivity, as neuroticism was 
also found to be positively correlated with orbitofrontal and subgenual ACC 
volume (Chapter 7). Given the direct links between the orbitofrontal cortex and 
subgenual ACC on one hand and the amygdala on the other hand, neuroticism 
might further modulate amygdala – ACC connectivity via the orbitofrontal 
cortex. In conclusion, it is possible that amygdalar abnormalities become more 
evident and meaningful when studied in relation to activation of other regions. 
In this, the hippocampus was only found to be functionally affected in MDD 
and anxiety disorders: hippocampal blunting was observed during positive word 
encoding. This result suggest that positive processing is altered in MDD, and 
most likely reflects diminished hedonic capacity. This suggestion was further 
supported by our finding of decreased connectivity of ventral striatal, including 
the nucleus accumbens and medial PFC areas within a salience network, related 
to classifying positive words. However, we could not test the effect of hedonic 
capacity in this study, as no measure of state anhedonia was administered 
on the day of scanning. Nevertheless, neural circuitry in MDD and anxiety 
could differ along a dimension of affective state, such as sad mood or lack of 
positive affect. This suggestion is supported by recent work, where an inability 
to maintain nucleus accumbens activation over time during positive affect 
regulation was related to individual differences in anhedonia in MDD patients 
(Heller et al., 2009). The nucleus accumbens is an important region in the human 
reward circuitry and these results suggest that the reward circuitry fails during 
positive affect regulation in MDD. Whether inter-individual variations in other 
depression or anxiety specific dimensions, such as sad mood or anxious 
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arousal, are related to a specific neural circuitry as well should be studied more 
extensively. 
In summary, implications for models of emotional regulation in MDD and 
anxiety based on results presented in this thesis are 1) the rostral ACC should be 
implicated in a general model of affective disorders, as it is potent to influence 
a wide variety of regions implicated in normal emotional regulation; 2) the 
inferior frontal gyrus, dorsolateral PFC, and superior temporal gyrus could 
affect the emotional circuitry in a disorder specific way; 3) variations in regional 
brain volume related to risk factors could contribute to the understanding of 
the complex neuropathology of depression and anxiety disorders; 4) current 
mood state could influence the dynamics of the mood circuitry, as valence 
specific functional abnormalities were observed.
SAMPLE CHARACTERISTICS
The NESDA neuroimaging study is the first structural and functional MRI study 
implemented in a large observational and longitudinal framework. The NESDA 
study is unique in that it includes both measurements of phenomenological 
as well as biological factors and aims to integrate psychosocial and 
biological models in order to examine predictors of the long-term course and 
consequences of MDD and anxiety disorders. The major advantage of large-
scale observational cohort studies is the possibility to include a large and 
well-characterized sample of participants with a large variety of symptoms, 
comorbidity, personal history, and other ‘real life’ characteristics. This allows 
epidemiologists to identify patterns of psychopathology related to biological 
factors, aetiology, treatment response, and outcome. Nevertheless, some 
issues should be considered. 
First, since the epidemiological NESDA cohort was recruited through general 
practitioners and outpatient clinics, we may not have been fully able to capture 
the most severe end of the depressive and anxious spectrum. Also, patients 
that first participated in an intensive interview session and subsequently were 
willing to participate in a two-hour MRI- and interview session, may not be most 
representative of the MDD sub-sample with large motivational problems. 
Furthermore, because in NESDA the focus is on MDD, dysthymia, social 
anxiety disorder, panic disorder, agoraphobia, and generalized anxiety 
disorder, other modules of the Composite International Diagnostic Interview 
(CIDI) were not included in the interview such as those of posttraumatic stress 
disorder, obsessive-compulsive disorder, eating disorders, bipolar disorder, and 
attention hyperactivity disorder. Although, participants with a formal diagnosis 
of a psychiatric disorder not subject of NESDA were not included in the NESDA 
sample, it is possible that a percentage of participants included in NESDA 
neuroimaging sample formally fulfilled diagnosis for a psychiatric disorder that 
is associated with specific brain abnormalities. 
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obtained from a ‘real life’ sample. All were life time free of a diagnosis or 
subthreshold diagnosis of MDD or anxiety disorders, but a portion of the 
healthy controls were recruited from an at-risk population, namely from the 
Adolescents at Risk for Anxiety and Depression (ARIADNE) cohort study. 
The ARIADNE study focuses on the offsprings of patients with mood- and 
anxiety disorders. Also, for healthy controls recruited through the general 
practitioners, having a first-degree relative with a psychiatric disorder was 
not an exclusion criterion. Several neuroimaging studies focusing on cognitive 
and emotional processes in healthy subject, but also in psychiatric samples, 
included ‘super’ healthy control participants without a first degree relative 
with mood- and anxiety disorders or history of childhood trauma. The inclusion 
of including ‘real life’ healthy controls in NESDA had the major advantage 
of allowing us to study the effects of risk factors for developing mood- and 
anxiety disorders across patients and healthy controls, but may constitutes a 
source of discrepancy between our study and some published neuroimaging 
studies. A second advantage of this recruitment strategy is that our healthy 
controls were also recruited from NESDA, underwent the same screening 
as patients, and were scan-naïve. Therefore, in this study, familiarity with 
researchers and/or experimental procedures could be ruled out as a potential 
confound. In contrast, earlier studies included a control group consisting of, for 
example, staff members (Elliott et al., 1997; Fitzgerald et al., 2007; Okada et al., 
2003). In these studies, it remains therefore unclear whether functional brain 
abnormalities are related to the psychopathology under study, or are related to 
the differences in state anxiety due to the novelty of the situation. 
Finally, in this thesis, panic disorder, social anxiety disorder, and generalized 
anxiety disorder were studied in concert, as if these disorders are not 
characterized by syndrome specific abnormalities. However, panic disorder, 
social anxiety disorder, and generalized anxiety disorder have been associated 
with unique activation patterns in imaging studies and a unique neurobiology 
(Blair et al., 2008; Mathew, Coplan, & Gorman, 2001). Nonetheless, we did not 
aim to study anxiety disorder specific features, but concentrated on the shared 
neurophysiological features of prevalent anxiety disorders that frequently co-
occur with MDD. 
MRI 
In the present thesis, magnetic resonance imaging was administered for 
measures of brain volumetry and brain activation related to executive and 
emotional processes. MRI could be used for other measurements as well, 
including. but not limited to, white matter tract integrity measurements and 
measurements of metabolites in brain tissue (e.g., glutamate). Other imaging 
techniques available have their specific advantages and disadvantages with 
respect to spatial and temporal resolution. In this section, considerations with 
respect to the currently administered imaging techniques will be discussed. 
Although a wealth of information on brain tissue properties and oxygenation
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differences is available in these scans, the techniques have their limitations. The 
MRI techniques used in this study are able to measure brain morphometry and 
activation at a spatial resolution of one or several millimeters and are capable 
to estimate volume and activation at this spatial resolution. The temporal 
resolution of fMRI in our study was 2.3 seconds, meaning brain tissue was 
imaged once in 2.3 seconds. Together with the spatial resolution of our fMRI 
sequence of 3 mm, observations in one 3D volume unit of 3 x 3 x 3 millimeter 
(1 voxel), this means that no microscopic observations can be made and that 
single cell firing or the net result of firing of groups of neurons at a resolution 
of milliseconds could not be recorded. In the case of BOLD-fMRI, we measured 
the net result in heamodynamic changes of a large number of neurons, related 
to neural firing (Logothetis,2002). Subsequently, we compared activation in 
one region during a certain condition to activation in that region to another 
condition, and therefore calculated a relative activation measure. In Chapter 7, 
we calculated the correlation of low frequency BOLD fluctuations as a measure 
of intrinsic connectivity. However, BOLD imaging can not distinguish between 
inhibitory and excitatory neural processes, and comparisons of absolute 
activity between two or more brain regions can not be made (Logothetis, 2002). 
Also, with the use of the currently used imaging techniques, no information 
on neurotransmitter concentration or activity was obtained. Disregulated 
neurotransmission is thought to play a major role in depression and anxiety 
disorders and likely affects regional neuronal activity or connectivity. Studying 
binding of pharmacological agents and neurotransmitter metabolism across 
the brain would be highly interesting and would provide important additional 
information on the neuropathology of MDD and anxiety disorders. However, 
such measurements could not be obtained with the techniques used in this 
study. In addition, the temporal resolution of functional MRI is poorer than 
for electroencephalography, and therefore does not allow to record very rapid 
neuronal firing. Nevertheless, MRI is one of the preferable techniques to study 
the brain, as it has the advantage of allowing studying both activation and 
structure in the same session. Moreover, fMRI allows studying activation deep 
in the brain, such as limbic activity, in a non-invasive way without the need to 
ingest a radioactive tracer.  
CONSIDERATIONS FOR FUTURE OBSERVATIONAL MRI 
STUDIES
Structural MRI serves as an excellent tool to study the brain’s morphometry in 
an observational set-up. Structural imaging techniques are minimally affected 
by day to day variations in symptomatology, medication use, time of scanning 
and site of scanning when similar MRI machines are used. Using functional 
MRI in an observational study is more problematic due to the large number of 
factors that is potent to influence the BOLD pattern. BOLD patterns are more 
likely to be influenced by factors such as time of day, quality of sleep the night 
before the scanning session, and subjective tension level during the scanning
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session. Therefore, cross-sectional analysis could be insufficiently able to 
detect variability in BOLD patterns related to a current diagnosis owing to 
other structural noise factors. 
For future observational functional MRI studies, a design that allows for 
an intra-subject challenge of subcortical/(para)limbic-cortical activity is 
recommended. For example, performing the Tower of London planning 
task before and after a positive or depressed mood induction session, or 
a pharmacological challenge, allows to study within-subject variability in 
response to a fixed experimental factor. Such a design would allow to study 
the flexibility or adaptability of the mood regulation circuitry within patients, 
a design that would be less sensitive to between subject factors such as quality 
of sleep, time of day etc. Monitoring within scanner variability over time and 
between-scanner variability is also highly recommended in order to get an 
estimate of the variability in the data due to scanner variability. 
Finally, using the data obtained from the same sample for several publications 
is defensible considering the costs and effort taken by both researchers and 
participants. However, before setting up a large study, the maximal number of 
publications resulting from (sub) data sets should be determined, in order to 
set an appropriate alpha for considering significance for each report in order to 
sufficiently and appropriately control for multiple comparisons. 
Our results suggest that MDD and anxiety disorders do not constitute distinct 
entities when considering their neuroanatomical and functional MRI profile, 
but instead share characteristics that may explain the maladaptive emotion 
regulation. In the case of comorbid depression-anxiety, researchers, and 
possibly clinicians as well, should keep in mind that the comorbid depression-
anxiety is not simple MDD plus anxiety when considering structural and 
functional abnormalities related to emotional regulation. Instead, comorbid 
depression-anxiety might be better characterized by anxiety neuropathology 
as the primary neuropathology. For example, comorbid depression-anxiety 
disorder does not resemble MDD with respect to executive abnormalities and 
encoding of negative information. Therefore, in the study of regional volume or 
activation, this comorbidity of anxiety disorders may constitutes an important 
predictor instead of a confounder. 
MDD and anxiety disorders appear to share functional and structural 
abnormalities, while at the same time, the disorders appear to be characterized 
by syndrome specific abnormalities. This pattern of both shared and unique 
characteristics seems to parallel the symptomatology of MDD and anxiety: 
large overlap in symptoms exists, but disorder specific symptoms are present 
as well. A more dimensional approach in characterizing both phenomenology 
and neurobiology of depression and anxiety disorders could aid to identify the 












an approach might also better capture the variability in neural abnormalities 
related to illness severity. 
We demonstrated that childhood emotional maltreatment and variations in 
personality factors are also related to variations in volume of regions associated 
with emotional regulation. Although the anatomical correlates of emotional 
maltreatment was observed independent of psychopathological status, this 
aetiological factor could influence the neural circuitry normally responsible 
for adaptive emotion regulation. Variation in personality may also affect the 
neurocircuitry: orbitofrontal and subgenual ACC volume variations may affect 
normal emotional regulation. It is therefore recommended that future imaging 
studies do not consider early advert life events including childhood emotional 
maltreatment and variations in personality structure as confounds, but instead 
considered these factors as potentially important predictors of neurobiological 
variation in MDD and anxiety disorders. 
Finally, symptom severity does not influence every aspect of brain 
structure and function as measured in the NESDA neuroimaging study. We 
observed shared structural and functional abnormalities in both MDD and 
anxiety disorders, even in the remitted state. This may further underline the 
importance of regular check-ups and ‘maintenance’ in patients with a (recent) 
history of depression and/or anxiety disorders. Training in focusing on positive 
events, for example in the context of mindfulness-based therapy may protect 
patients from relapsing into a new episode of depression and anxiety. However, 
the effects of such training on brain circuitry in remitted patients need to be 
further investigated. 
SUGGESTIONS FOR FUTURE IMAGING STUDIES
In future neuroimaging studies that aim to get insight in the shared 
neuropathology of MDD and anxiety, connectivity of the prefrontal cortex and 
ventral regions should be studied in patients with anxiety disorders and directly 
compared to connectivity patterns in patients with MDD. In that way, the 
specificity of our finding of a decreased coupling of ventral striatal and medial 
PFC regions with a task executive network during execution of an emotional 
task could be tested. Related to this suggestion, studying subcortical-cortical 
connectivity during manipulation of mood or anxiety status, for example 
with the use of autobiographical scripts or pharmacological challenges, 
would provide important information. In this way the connectivity and the 
flexibility of the neural circuitry in different mood states could be tested. Such 
manipulations would tell us about the dynamics of the emotion generation and 
regulation system for several emotional states. Also, the brain circuitry involved 
in emotional regulation could be experimentally manipulated, for example with 
the use of neurostimulation techniques, thereby giving further insight in the 
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Furthermore, providing a challenge when studying cognitive processes in 
cross-sectional studies is important. Such a challenge could be a mood or stress 
induction session before a specific task. Also, challenges could be integrated in 
the task. For example, a mixed design including alternating blocks of executive 
trials without emotional distraction and executive trials with emotional 
distraction could be administered, thereby testing the limits of executive 
control in MDD and anxiety disorders. Such a design could be more sensitive for 
detecting emotional relevant disturbances in attentional control, as suggested 
by Wang et al (2008). Furthermore, inclusion of a mood and anxiety regulation 
task would be essential in the study of depression and anxiety. 
Next, characterizing patients along dimensions of depression and 
anxiety related symptom dimensions, as proposed by dimensional models 
of psychopathology, could perhaps better capture the structural and 
functional correlates of current mood and anxiety status than a categorical 
characterization. In this study, we observed that inter-subject variability in 
factors such as personality dimensions was associated with regional brain 
volume in healthy controls. It is possible that using the between subject 
variation within patients in an more optimal way, by for example describing 
their symptomatology in a multi-dimensional space could help us further 
unravel the complex story of brain involvement in mood and anxiety disorders. 
Finally, multivariate and multi-model approaches could help us find 
differentiating patterns of abnormal volume or activity in MDD and anxiety 
disorders. So far, univariate approaches have been predominantly used in 
the study of MDD and anxiety disorders, where a univariate test is performed 
per smoothed voxel. These methods may be less sensitive in detecting 
differentiating patterns in the highly integrated network of limbic-cortical 
regions. Multivariate analyses approaches are sensitive to spatially distributed 
information, whereas using univariate approaches test for between group 
differences per voxel. Using multivariate approaches could lead to the 
detection of highly differentiating features that could also be used in disease 
state prediction. Such multivariate approaches would both increase the 
sensitivity ánd specificity of functional and structural imaging findings. In 
addition, integrating imaging data acquired using different modalities, could 
help understanding the complex interactions of different regions. Combining 
information of regional volume, regional brain activation, metabolism, and 
functional and structural connectivity would be essential to understand the 
complex dynamics of adaptive and maladaptive mood regulation.
CHALLENGES: TREATMENT RESPONSE AND COURSE 
PREDICTION
A major challenge for future neuroimaging studies in MDD and anxiety 
disorders is to identify a set of features that could predict vulnerability for
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developing MDD and anxiety disorders, illness course and treatment response. 
Currently, treatment response is unsatisfactory: up to 60% does not reach a 
good response (Ressler & Mayberg, 2007) and only a small percentage responds 
to mono-therapy with an SSRI. Being able to predict who will respond to mono-
therapy with an SSRI or cognitive behavior therapy, or a combination of the 
two, would be very useful in clinical practice. Longitudinal studies will be very 
important for identifying such predictive features. Long-term outcome and 
treatment response could then be predicted from functional and structural 
MRI patterns, in combination with detailed information on symptomatology, 
occurrence of life events, medical and psychiatric comorbidity, family status 
of depression and anxiety, personality, psychological measures including 
dysfunctional belief systems, and occurrence of childhood maltreatment. So 
far, studies have indicated cognitive, structural, and functional features that 
were associated with treatment responses (Canli et al., 2005; Chen et al., 2007; 
Langenecker et al., 2007; Li et al., 2010). Symptom improvement in MDD have 
been associated with amygdalar response (Canli et al.,2005), ACC and insular 
volume (Chen et al., 2007), dorsolateral PFC volume (Li et al., 2010), and ACC 
activity (Chen et al., 2007). Including genetic variations could be very useful as 
well. Not only have genetic variations in, for example, the serotonin transporter 
gene been associated with the risk of developing mood- and anxiety disorders 
in the context of adverse life events (Caspi et al., 2003). Furthermore, the 
serotonin transporter gene has been associated with variations in amygdala 
response (Bertolino et al., 2005; Hariri et al., 2005; Lau et al., 2009), amygdala 
– ACC connectivity (Pezawas et al., 2005), and brain volume in (para)limbic 
regions (Frodl et al., 2008a) in healthy controls. Moreover, genetic variations 
have been related to treatment response, associated with responsiveness 
of the amygdala and ACC during emotional processing (Baune et al., 2010). 
Such multi-factorial models, including amongst others clinical, genetic, and 
neuroimaging information could then be used to provide an optimal treatment 
strategy for patients. As NESDA obtained information on all these measures, a 
first step in setting up such a model will be taken in the nearby future. 
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IA MAJOR DEPRESSIVE DISORDER
A Major Depressive Episode (MDE) is characterized by 1) depressed/low mood 
and/or 2) loss of interest or pleasure in daily activities during most of the day, 
nearly every day, for at least two weeks. Next to these core symptoms of 
depressed mood or loss of the capacity to experience pleasure (also know as 
‘anhedonia’), an MDE is characterized by at least three (or four when only one 
of the first two criteria are met) of the following symptoms that are present 
nearly every day: 
• weight loss or weight gain when not dieting; 
• insomnia or hypersomnia (loss of sleep or excessive sleeping); 
• psychomotor agitation or retardation (restlessness or slowing of daily   
 activity);
• fatigue or loss of energy; 
• feelings of worthlessness or excessive or inappropriate guilt; 
• attentional problems or indicisiveness; 
• recurrents thoughts of death or recurrent suicidal ideation without a   
 specific plan or a suicide attempt or plans for committing suicide. 
Symptoms are not better accounted for by bereavement or a diagnosis of mania 
or personality disorder. Social, occupational, educational or other important 
functioning should be impaired to fullfil the criteria for a diagnosis of MDD. 
 
SOCIAL ANXIETY DISORDER
Social Anxiety Disorder (SAD), also know as ‘social phobia’ is characterized by 
a persistent fear of one or more social or performance situation in which the 
person is exposed to unfamiliar people or to possible scrutiny by others and the 
individual fears that he or she will act in a way (or show anxiety symptoms) that 
will be embarrassing and humiliating. A diagnosis is made when: 
• exposure to the feared situation almost invariably provokes anxiety, which  
 may take the form of a situationally bound or situationally pre-disposed   
 panic attack (see Panic Disorder);  
• the person recognizes that this fear is unreasonable or excessive; 
• the feared situations are avoided or else are endured with intense anxiety  
 and distress;
The avoidance, anxious anticipation, or distress in the feared social or 
performance situation(s) interferes significantly with the person's normal 
routine, occupational/educational functioning, or social activities or 
relationships, or there is marked distress about having the phobia. Also, the
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fear or avoidance is not due to direct physiological effects of a substance (e.g., 
drugs, medications) or a general medical condition and is not better accounted 
for by another mental disorder.
PANIC DISORDER
Panic Disorder (PD) is characterized by recurrent unexpected Panic Attacks (see 
below), and at least one of the attacks has been followed by 1 month (or more) 
of one (or more) of the following:
• persistent concern about having additional attacks;
• worry about the implications of the attack or its consequences (e.g., losing  
 control, having a heart attack, "going crazy");
• a significant change in behavior related to the attacks;
The Panic Attacks are not due to the direct physiological effects of a substance 
(e.g., drugs, medications) or a general medical condition (e.g., hyperthyroidism) 
and are not better accounted for by another mental disorder. 
PANIC ATTACK:
A panic attack is a discrete period of intense fear or discomfort, in which four 
(or more) of the following symptoms developed abruptly and reached a peak 
within 10 minutes:
• palpitations, pounding heart, or accelerated heart rate;
• sweating;
• trembling or shaking;
• sensations of shortness of breath or smothering;
• feeling of choking;
• chest pain or discomfort;
• nausea or abdominal distress;
• feeling dizzy, unsteady, lightheaded, or faint;
• derealization (feelings of unreality) or depersonalization (being detached  
 from oneself);
• fear of losing control or going crazy;
• fear of dying;
• paresthesias (i.e, numbness or tingling sensations);
• chills or hot flushes.
AGORAPHOBIA
A diagnosis of PD is further specified as PD with agoraphobia or without 
agoraphobia. Agoraphobia is the anxiety about being in places or situations 
from which escape might be difficult (or embarrassing) or in which help may
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not be available in the event of having an unexpected or situationally 
predisposed Panic Attack or panic-like symptoms. Agoraphobic fears typically 
involve characteristic clusters of situations that include being outside the home 
alone; being in a crowd, or standing in a line; being on a bridge; and traveling in 
a bus, train, or automobile. As a result, the situations are avoided (e.g., travel 
is restricted) or else are endured with marked distress or with anxiety about 
having a Panic Attack or panic-like symptoms, or require the presence of a 
companion.
GENERALIZED ANXIETY DISORDER
Criteria for the diagnosis of a Generalized Anxiety Disorder (GAD) are met when 
a person experiences at least six months of excessive anxiety and worry about 
a variety of events and situations and there is significant difficulty in controlling 
the anxiety and worry. Also, three or more of the following symptoms should be 
present for most days over the previous six months: 
• feeling wound-up, tense, or restless;
• easily becoming fatigued or worn-out;
• concentration problems;
• irritability;
• significant tension in muscles;
• difficulty with sleep.
The symptoms cause significant distress or problems in daily life functioning, 
but are not due to the direct physiological effects of a substance (e.g., a drugs, 
medications) or a general medical condition and are not better accounted for 
by another mental disorder. 
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BOLD  Blood Oxygenated Level Dependency 
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CDA  Comorbid Depression-Anxiety
dACC  Dorsal Anterior Cingulate Cortex 
DLPFC  Dorso-Lateral PreFrontal Cortex
dmPFC  Dorso-Medial PreFrontal Cortex
EF   Executive Functions
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GM  Gray Matter
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IFG  Inferior Frontal Gyrus
MDD  Major Depressive Disorder
mPFC  Medial Prefrontal Cortex
MRI  Magnetic Resonance Imaging
OFC  Orbitofrontal Cortex
PCC  Posterior Cingulate Cortex
PD   Panic Disorder
PET  Positron Emission Tomography 
rACC  Rostral Anterior Cingulate Cortex
SAD  Social Anxiety Disorder
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SPECT  Single Photon Emission Computed Tomography
SSRI   Selective Serotonin Reuptake Inhibitor
TE   Echo Time
ToL  Tower of London
TR   Time to Repetition or Repetition Time
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G Depressie en angststoornissen zijn veel voorkomende psychiatrische 
stoornissen die gepaard gaan met een hoge ziektelast voor de persoon en zijn 
omgeving. Ongeveer 30% van de mensen die aan een depressieve stoornis 
lijdt, lijdt ook aan een angststoornis, terwijl ongeveer 50% van de mensen 
die aan een angststoornis lijdt ook ooit een depressieve episode door zal 
maken. Wanneer depressie en angst samen voorkomen, wordt gezegd dat de 
stoornissen ‘comorbide’ voorkomen. Deze comorbide stoornis van angst en 
depressie is in verband gebracht met een langere ziekteduur, meer verlies van 
arbeidsproductiviteit, en ernstigere symptomen of klachten. Doordat depressie 
en angst zo vaak samen voorkomen, maar ook door de overlap in klachten en 
symptomen die patiënten rapporteren, is voorgesteld dat depressieve- en 
angststoornissen ook een gedeelde overlap hebben in biologische factoren die 
kunnen bijdragen aan het ontstaan van de stoornissen. 
Beeldvormend onderzoek bij patiënten met depressie heeft uitgewezen dat 
een aantal structuren een ander volume of activiteitsniveau hebben dan in 
mensen zonder deze stoornissen. De afwijkingen zijn voornamelijk gevonden 
in gebieden die in eerdere studies geassocieerd zijn met het waarnemen en 
reguleren van emoties. Een aantal van deze afwijkingen is ook gevonden in 
mensen met angststoornissen, maar  de patiëntengroepen zijn nog nooit 
samen onderzocht. Het is dus onduidelijk of er gedeelde abnormaliteiten in 
de structuur en het functioneren van een aantal hersengebieden in angst en 
depressie zijn. Ook hebben eerdere studies geen rekening gehouden met de 
comorbiditeit van depressie en angst. 
Het doel van de studies opgenomen in dit proefschrift is om te onderzoeken 
of depressie en angst afwijkingen in de structuur en activatie van een aantal 
hersengebieden delen, of juist worden gekenmerkt door unieke afwijkingen. 
Deze gedeelde afwijkingen zouden kunnen verklaren waarom angst en 
depressie zo vaak samen voorkomen en kunnen helpen de complexe 
pathologie van depressie en angst te begrijpen. In dit proefschrift  ligt het 
focus op hersengebieden die in eerdere studies geassocieerd bleken te zijn 
met emotionele verwerking. Zowel de hersenfunctie als de hersenstructuur 
zijn onderzocht, en er is rekening gehouden met het gebruik van medicatie. 
Alle studies beschreven in dit proefschrift maken uit van de neuroimaging 
deelstudie van de Nederlandse Studie naar Depressie en Angst (NESDA: www.
nesda.nl).
In hoofdstuk 1 wordt het klinisch beeld van depressie en angststoornissen 
besproken en wordt de probleemstelling uiteengezet. Depressie is een zeer 
veel voorkomende psychiatrische stoornis die gekenmerkt wordt door een 
sombere stemming en/of een verminderd vermogen om plezier te beleven aan 
activiteiten of situaties waaraan in normale toestand wel plezier wordt beleefd. 
Om aan de diagnose ‘depressie’ te voldoen moet deze sombere stemming 
of het gebrek aan plezier of interesse minstens 2 weken aanhouden en het 
dagelijks functioneren beïnvloeden. Naast deze ‘kernsymptomen’ (stemming 
en verminderd plezier/interesse) lijden mensen met een depressie volgens de
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criteria nog aan minstens drie van de volgende symptomen: verstoord 
slapen (veel meer of veel minder slapen), verstoorde eetlust (meer of minder 
eetlust), verminderd concentratievermogen, verstoord bewegingspatroon 
(rusteloos of juist veel minder beweeglijk), suïcidale gedachten, en gevoelens 
van waardeloosheid of extreme schuld. De angststoornissen waarover in dit 
proefschrift gesproken wordt, zijn: de paniekstoornis, de sociale angststoornis 
(ook wel sociale fobie genoemd) en de gegeneraliseerde angststoornis. 
Kortweg worden deze stoornissen gekenmerkt door een extreme angst voor 
het krijgen van een paniekaanval (paniekstoornis), voor sociale omgang of 
sociale prestatie (sociale angststoornis), of door algemene extreem zorgelijke 
gedachten (gegeneraliseerde angststoornis). We spreken van stoornissen 
wanneer de klachten in belangrijke mate het normale sociaal en beroepsmatig 
functioneren beïnvloeden. 
Zoals eerder besproken, komen depressie en angststoornissen veel voor. 
Ongeveer een derde van de westerse bevolking zal eens in zijn of haar leven 
een depressieve stoornis doormaken, en voor angst zijn die cijfers ongeveer 
gelijk. Daarbij zal ongeveer de helft van de mensen die ooit een angststoornis 
krijgt, ook een depressie doormaken, terwijl ongeveer 30% van de mensen 
met een depressieve stoornis ooit ook aan een angststoornis zal lijden. In 
de meeste gevallen is de angststoornis de eerste stoornis die zich in het 
leven van een patiënt manifesteert, en het samen voorkomen van angst 
en depressie is geassocieerd met een slechter ziektebeloop (langer ziek), 
ernstigere symptomen, en meer uitval op het werk. Het lijkt er dus op dat 
mensen met depressie én angststoornissen slechter af zijn dan mensen met 
alleen een depressie (of angststoornis). Om deze reden is voorgesteld dat 
de depressie mét en de depressie zonder tegelijk optredende angststoornis 
als aparte stoornissen gezien zouden moeten worden. Tegelijkertijd wordt 
aangenomen dat de stoornissen neurobiologische afwijkingen delen, omdat 
zowel angststoornissen als depressies redelijk effectief behandeld kunnen 
worden met eenzelfde soort behandeling (antidepressiva of (cognitieve) 
gedragstherapie). 
Een aantal studies heeft laten zien dat de activiteit of het volume van 
bepaalde hersenengebieden bij mensen met angst en depressie verschillen 
van die bij mensen zonder deze stoornissen. Hersenactiviteit en volume 
kunnen gemeten worden met behulp van een MRI scanner. MRI staat voor 
Magnetische Resonantie Imaging (vertaling: Beeldvorming). MRI scanners 
kunnen met verschillende instellingen een groot aantal soorten weefsel en 
processen afbeelden. In het geval van functionele MRI wordt met behulp 
van magneetvelden en radiogolven gemeten wat de verhouding is tussen 
zuurstofarm en zuurstofrijk bloed in het hele brein. Zuurstof hecht zich aan 
hemoglobine, een molecuul dat ijzerhoudend is en magnetische eigenschappen 
bezit. De binding van zuurstof aan hemoglobine beïnvloedt de magnetische 
eigenschappen van hemoglobine en op deze manier kan indirect activiteit 
afgeleid worden. Hierbij wordt aangenomen dat meer zuurstof
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gebruik neuronale activiteit weerspiegelt, omdat neuronen in hersengebieden 
die actief zijn meer zuurstof gebruiken als ze actief zijn en minder zuurstof 
gebruiken als ze juist minder actief zijn. Het maken van een serie scans achter 
elkaar maakt dan de activiteit van de hersenen zichtbaar als een functie 
van tijd. Het geeft ook de mogelijkheid te berekenen hoe actief bepaalde 
hersengebieden zijn tijdens het uitvoeren van specifieke opdrachten. 
De gebieden die zich anders lijken te gedragen bij depressie en 
angststoornissen zijn gebieden die in verband zijn gebracht met de primaire 
of vroege waarneming van emoties, zoals de amygdala (amandelkernen), de 
insulaire schors, en het onderste deel van de cingulaire schors. Deze gebieden 
liggen vrij centraal en diep in de hersenen. Andere, vaak iets hoger in het brein 
(richting schedel) gelegen hersengebieden, zijn ook in verband gebracht met 
angst en depressie. Gebieden in de ‘frontale schors’ (in het voorhoofd) zijn 
betrokken bij het aanpassen van de allereerste respons (bijvoorbeeld die in de 
amandelkernen) en dus met het reguleren van emoties. In een voorbeeld: Bij 
het zien van een foto van een huilend kind zullen de amandelkernen meer actief 
worden, en zal de ervaren emotie waarschijnlijk verdriet of medelijden zijn. Als 
je dan bedenkt dat het kind moet huilen omdat het blij is met een cadeau, zal 
het gevoel over die foto wellicht veranderen. Het is dan waarschijnlijk dat de 
frontale schors meer actief wordt, waardoor mogelijk ook de activiteit van 
de amandelkernen gedempt wordt. Aangenomen wordt dat dit mechanisme 
bij depressie verstoord is. Mensen met depressie lijken meer amygdala 
(amandelkern) activiteit te vertonen wanneer er negatieve informatie verwerkt 
wordt. Tegelijkertijd lijkt het erop dat de frontale schors minder actief is,en 
ook minder in staat is om de amandelkernen te dempen. Hierdoor kan een 
ontregeling van de emoties ontstaan waarbij meer negatieve emoties ervaren 
worden. Hoe dit ‘circuit’ van onder andere de amandelkernen en de frontale 
schors verstoord is in mensen met een paniekstoornis, sociale angststoornis, 
en/of gegeneraliseerde angststoornis is minder goed onderzocht dan in 
mensen met een depressieve stoornis. Ook is onduidelijk of in de ziekere groep 
van mensen met depressie én angst deze verstoring ook ernstiger is. 
Naast een verstoorde activiteit is bij mensen met een depressie ook in 
een aantal gebieden in de hersenen een verminderd volume gevonden. Zo 
is bijvoorbeeld een verminderd volume gevonden in de hippocampus, een 
gebied dat belangrijk is voor stressregulatie en voor geheugenvorming, in de 
frontale schors, en in de cingulaire schors. Deze laatste schors wordt gezien 
als een gebied dat belangrijk is voor de integratie van primaire emotionele 
informatie en van cognitieve processen, die samen leiden tot een passende 
emotie. De cingulaire schors kan in het bovengenoemde voorbeeld van de foto 
gezien worden als het schakelstation tussen de amandelkernen en de frontale 
schors. Hoewel verminderd volume van bijvoorbeeld de cingulaire schors ook 
gevonden is bij mensen met paniekstoornis, is onduidelijk of het om precies 
hetzelfde gebied gaat, omdat er geen directe vergelijking met depressieve 
patiënten is gemaakt. Ook is het onduidelijk hoe deze bevindingen beïnvloed 
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zijn door het gelijktijdig aanwezig zijn van een depressie, omdat de 
onderzoekers patiënten met paniekstoornis én een depressie niet buiten de 
studie hadden gelaten. 
In de eerste studie beschreven in dit proefschrift (hoofdstuk 2) wordt 
het volume van een aantal structuren die belangrijk zijn voor emotionele 
verwerking onderzocht bij mensen die lijden aan een depressie, een 
angststoornis of aan beide. In hoofdstuk 2 wordt aangetoond dat de 
cingulaire schors, en dan specifiek het deel dat voor het corpus callosum ligt 
(de zogenaamde rostrale of pregenuale cingulaire schors), een verminderd 
volume heeft bij mensen met alleen een depressieve stoornis, alleen een 
angststoornis of zowel een depressieve als een angststoornis. Deze afname 
treedt onafhankelijk van medicatiegebruik en ziekte-ernst op. Het is voor 
het eerst dat deze afname aangetoond is voor zowel angst en depressie, 
en dat gelet is op het samen voorkomen van de stoornissen. Naast deze 
gedeelde abnormaliteit in hersenstructuur bij depressie en angst, werden ook 
stoornisspecifieke afwijkingen gezien. Zo is alleen de depressieve stoornis 
(depressie) geassocieerd met een verminderd volume van een gebied in de 
laterale frontale schors (gyrus frontalis inferior), dat ook geassocieerd is met 
emotieregulatie. Mensen met alleen een angststoornis vertoonden een afname 
van de gyrus temporalis superior, een gebied dat vaker geassocieerd is met 
angst en met het verwerken van lichaamssignalen. Het kan dus zijn dat deze 
afname weerspiegeld dat mensen die aan angststoornissen lijden, minder 
goed in staat zijn om de signalen die door het eigen lichaam gegeven worden 
correct te interpreteren. Dit is vooral in het geval van de paniekstoornis goed 
denkbaar. Tenslotte wordt in hoofdstuk 1 aangetoond dat het voorkomen 
van  van een depressieve stoornis voor het achttiende levensjaar geassocieerd 
is met een lager volume in het deel van de cingulaire schors dat onder het 
corpus callosum ligt, de zogenoemde subgenuale cingulaire schors. Deze 
afname kan een grotere gevoeligheid voor het ontwikkelen van depressieve en 
angststoornissen weerspiegelen, omdat dit gebied meermalen geassocieerd is 
gebleken met afwijkingen in primaire emotionele verwerking. 
Vervolgens wordt in hoofdstuk 3 bestudeerd of emotionele informatie 
(positief danwel negatief)  anders verwerkt en onthouden wordt door mensen 
met depressie en angst. In het onderzoek zijn in de scanner 40 positieve, 
40 negatieve en 40 neutrale woorden aan de deelnemers getoond en door 
hen beoordeeld op de emotionele betekenis (positief, negatief, of neutraal; 
bijvoorbeeld ‘dakpan’ [neutraal] of verlies [negatief]). Tijdens het beoordelen 
van de woorden zijn scans gemaakt. Na een pauze van ongeveer 20 minuten 
zijn dezelfde woorden weer getoond, tezamen met 120 nieuwe woorden. 
Weer maakten we scans, maar nu moesten de deelnemers aangeven of ze de 
woorden wel of niet hadden gezien tijdens het eerste deel van de taak. Het blijkt 
dat de geheugenprestatie van mensen met angst en depressie niet slechter is,
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maar dat mensen met een depressie, de positieve woorden iets langer bekijken 
voordat een beslissing genomen wordt. De MRI-resultaten wijzen daarnaast 
uit dat zowel de depressieve stoornis als de angststoornis geassocieerd is met 
een verminderde activiteit van de hippocampus tijdens het verwerken van 
positieve woorden die later onthouden bleken te zijn. Deze hippocampale 
abnormaliteit trad op onafhankelijk van ziekte-ernst en onafhankelijk van 
medicatiegebruik en was afwezig tijdens het beoordelen van negatieve 
woorden. De hippocampus is een zeer complexe en belangrijke structuur voor 
het opslaan van informatie, maar ook voor het koppelen van nieuwe informatie 
aan al bestaande informatie. Dat er een abnormale activatie optreedt tijdens 
het verwerken van juist positieve informatie is opmerkelijk en lijkt aan te geven 
dat positieve informatie als minder belangrijk bestempeld wordt. Hierdoor 
wordt de positieve informatie mogelijk minder aan al bestaande herinneringen 
gekoppeld en is positieve informatie mogelijk minder in staat is om de 
stemming op een positieve manier te beïnvloeden. Dat deze verminderde 
hippocampus activiteit ook optreedt in mensen die weer hersteld zijn van hun 
depressie of angststoornis, lijkt aan te geven dat ook wanneer de symptomen 
afwezig zijn, positieve informatie anders verwerkt wordt. Mogelijk maakt 
dit mensen kwetsbaar maakt voor een terugval. Hoewel we verwachtten 
dat mensen met een depressieve stoornis negatieve woorden relatief beter 
zouden onthouden, konden we dit niet aantonen. Wel zagen we dat tijdens 
het onthouden van negatieve woorden de insulaire schors meer activiteit 
vertoonde, en dat bij de ernstig depressieve patiënten de amandelkernen, 
het striatum en de prefrontale schors meer activiteit lieten zien. Deze laatste 
be-vinding onderstreept de suggestie dat wanneer patiënten depressief zijn, 
negatieve informatie anders verwerkt wordt, wat een verklaring kan zijn voor 
het op de voorgrond treden van negatieve emoties. 
In hoofdstuk 4 wordt vervolgens het functioneren van de prefrontale schors 
tijdens het uitvoeren van een niet-emotionele cognitieve taak bestudeerd en 
beschreven. Het wordt veelal aangenomen dat in depressie de uitvoerende 
functies, ook wel executieve functies genoemd, verstoord zijn. Onder de 
executieve functies vallen onder meer de volgehouden en verdeelde aandacht, 
het actief onderdrukken van storende informatie uit de omgeving, en het 
maken en uitvoeren van plannen. Deze functies doen een aanspraak op de 
frontale schors en de gedachte is dat het functioneren van de frontale schors 
bij depressie abnormaal is, wat een verklaring zou kunnen zijn, of zou kunnen 
samenhangen, met de verminderde aandachtsfunctie en de suboptimale 
emotionele regulatie. Bij depressie zijn maar weinig neuroimaging studies 
uitgevoerd die zich richten op het complexe proces van plannen. Tijdens de 
Tower of London planningstaak moesten deelnemers een plan van aanpak voor 
een ruimtelijk probleem maken, dat plan in gedachten  uitvoeren, en tijdens de 
uitvoering in de gaten moesten houden dat wat ze deden, nog steeds tot het 
juiste resultaat zou leiden. Van alle deelnemers is vervolgens de hersenactiviteit
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berekend die samenhangt met het steeds moeilijker worden van de 
opdrachten. Deze patronen van activiteit zijn vervolgens vergeleken 
tussen de patiëntengroepen. De resultaten tonen aan dat mensen met een 
depressie de dorsolaterale prefrontale schors meer activeren om op eenzelfde 
prestatieniveau uit te komen dan gezonde controles.. Het verschil in activiteit 
werd het sterkst waargenomen bij mensen met huidige depressieve klachten, 
en was vrijwel normaal in mensen bij wie de depressie in remissie was gegaan. 
Opmerkelijk genoeg vertoonden mensen die zowel aan een depressie als aan 
een angststoornis leden vrijwel normale activiteit in de dorsolaterale prefrontale 
schors. Wel is duidelijk dat in de groep mensen met alleen een angststoornis 
de hersenactivatie normaal is tijdens de planning taak. Deze bevinding geeft 
aan dat wanneer het op de pure cognitieve functies aankomt, patiënten met 
een depressieve en angstige stoornis van elkaar te onderscheiden zijn en dat 
frontale abnormaliteit tijdens planning specifiek voor depressie specifieke lijkt 
en samenhangt met de ernst van de depressie. 
In hoofdstuk 5 wordt de hypothese getoetst dat de prefrontale schors abnormale 
verbindingen heeft met de dieper gelegen emotionele perceptiegebieden. 
Dit is onderzocht door de samenhang (correlatie) tussen de activiteit van alle 
gebieden in het brein te berekenen. Vervolgens is een vergelijking gemaakt 
tussen de correlatiepatronen van een medicatie-vrije groep van mensen 
met een depressieve stoornis (die nooit in hun leven een diagnose van een 
angststoornis hebben gehad) met de correlatiepatronen in een groep gezonde 
controles. De correlatiepatronen zijn berekend op basis van de activatie tijdens 
het beoordelen van emotionele woorden. We testten verschillende ‘netwerken’ 
in het brein, waarvan uit eerdere studies bekend was dat ze samenhangen met 
een aantal cognitieve en emotionele processen. De resultaten van onze studie 
wijzen uit dat mensen met een depressie minder koppeling laten zien van de 
mediale prefrontale schors en het dieper gelegen striatum met een netwerk dat 
eerder in verband gebracht is met het verwerken van emotionele informatie. 
Deze relatieve ‘ontkoppeling’ hing samen met het aantal woorden dat als 
positief geclassificeerd was. Deze bevindingen bevestigen de hypothese van 
relatieve frontale-subcorticale ontkoppeling tijdens emotionele verwerking in 
depressie. 
In hoofdstuk 6 en 7 worden tenslotte de effecten bestudeerd van twee bekende 
risicofactoren voor angst en depressie, te weten emotionele jeugdmishandeling 
en persoonlijkheidsfactoren, op volume van emotiegerelateerde hersen-
structuren. In hoofdstuk 6 laten we zien dat mensen die in hun kindertijd 
meermalen emotionele mishandeling hebben meegemaakt, minder volume 
in de mediale prefrontale schors hebben dan mensen die nooit emotionele of 
andersoortige mishandeling hebben meegemaakt. Dit effect trad op in zowel 
patiënten met een diagnose van angst en depressie als in gezonde controles. De 
dorsale mediale prefrontale cortex is ook in dierstudies heel gevoelig gebleken
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voor de negatieve effecten van extreme stress. Mogelijk wordt door de stress 
die emotionele mishandeling met zich meebrengt de rijping van dit gebied 
bij jeugdigen geremd, doordat minder groeifactoren aangemaakt worden. 
Onze studie suggereert dat dit volumeverschil de ontbrekende schakel is in 
de relatie tussen jeugdmishandeling en het ontstaan van angst en depressie. 
De afwijking in dit hersengebied zou mensen vatbaarder kunnen maken 
voor de ontregelende effecten van ingrijpende levensgebeurtenissen en 
daardoor kwetsbaarder maken voor angst en depressie. In hoofdstuk 7 
worden de effecten van persoonlijkheid op hersenvolume van structuren 
die belangrijk zijn voor emotie verwerking en –regulatie onderzocht. We 
richtten ons op de persoonlijkheidstrekken Neuroticisme en Extraversie, 
omdat deze persoonlijkheidsfactoren eerder geassocieerd bleken met 
respectievelijk een verhoogde kans en een verlaagde kans op het ontwikkelen 
van psychopathologie. We onderzochten de correlatie van deze factoren met 
volume van het hele brein in gezonde mensen (dus zonder ooit een diagnose 
van depressie en angst) en vonden dat het volume van de orbitofrontale 
schors en van de amygdala groter was bij meer extraversie, maar niet bij 
meer neuroticisme. De amygdala en orbitofrontale schors zijn gebieden die 
geassocieerd zijn met primaire emotionele perceptie. Het beschermende effect 
van extraversie heeft mogelijk dus zijn grondslag in het functioneren van deze 
structuur, doordat het doorsluizen van emotionele informatie anders verloopt. 
Het proefschrift eindigt met een samenvatting en algemene discussie (hoofdstuk 
8) van de bevindingen van hoofdstuk 2 tot en met 7. Ook worden beperkingen 
van de studies besproken en worden suggesties voor vervolgonderzoek gedaan. 
Samenvattend suggereren de bevindingen in dit proefschrift dat depressie 
en angst zowel functioneel als structurele hersenafwijkigen delen, maar dat 
ze tegelijkertijd gekenmerkt worden door unieke afwijkingen tijdens het 
uitvoeren van cognitieve en emotionele taken. Hierbij kan de rostrale cingulaire 
schors voorgesteld worden als een sleutelgebied in het onderzoek naar 
abnormale emotieverwerking en -regulatie die zowel met angst als depressie 
wordt geassocieerd. Het abnormale functioneren van de hippocampus 
tijdens positieve verwerking kan een schakel zijn in het begrijpen van het 
optreden van terugval in een nieuwe depressieve of angstige episode. Over het 
algemeen zijn er geen effecten gevonden van het gebruik van antidepressiva 
op hersenfunctie en structuur, dat wil zeggen: mensen die wel antidepressieve 
medicatie gebruikten, lieten geen andere patronen van activatie en structuur 
zien dan mensen die geen medicatie gebruikten. Wel blijken ervaringen in de 
jeugd, zoals emotionele mishandeling, en persoonlijkheidsfactoren samen te 
hangen met structuur (volume) van hersengebieden die belangrijk zijn voor 
het waarnemen en verwerken van emotionele gebeurtenissen. Dit kan een 
verklaring bieden voor hoe deze risicofactoren tot een kwetsbaarheid voor het 
ontwikkelen van een angst- of depressieve stoornis leiden. 
De bevindingen beschreven in dit proefschrift ondersteunen de aanname dat 
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depressie- en angst hersenafwijkingen delen die de hoge comorbiditeit 
kunnen verklaren, maar geven tegelijkertijd aanwijzingen voor de gedachte 
dat depressie met comorbide angst meer gekenmerkt wordt door 
angstgerelateerde neuropathologie en zich onderscheidt van een ‘pure’ 
depressie. Zo werden geen ernstigere afwijkingen gevonden bij mensen met 
zowel angst als depressie in vergelijking met de depressie groep (zonder 
angst), en werden de afwijkingen die in die ‘pure’ depressie groep werden 
aangetoond, niet gevonden in de comorbide groep. Dit zou verklaard kunnen 
worden door het feit dat mensen met depressie en angst vaak de angststoornis 
als eerste ontwikkelden, en dat daardoor angstgerelateerde pathologie 
de boventoon voert. Verder toont dit proefschrift aan dat angst met meer 
stabiele hersenafwijkingen gepaard gaat,  terwijl de ‘actieve’ depressieve fase 
gekenmerkt wordt door hyperreactiviteit van subcorticale structuren tijdens 
negatieve emotionele verwerking en hyperactiviteit van de frontale schors 
tijdens puur cognitief executief functioneren. Of deze frontale hyperactiviteit 
ook optreedt tijdens negatieve emotionele taken die ook een aanspraak doen 
op executieve functies is nog niet onderzocht. Een dergelijke onderzoeksopzet 
kan de rol van de frontale schors in het reguleren van negatieve emoties 
verduidelijken.
Het is belangrijk om op te merken dat deze studies beperkt rekening gehouden 
is met inter-individuele variatie, alhoewel een belangrijke eerste aanzet is gezet 
naar het meer dimensioneel beschouwen van depressie en angst in neuro-
imaging onderzoek. In de hier gepresenteerde studies zijn de patiënten met 
alleen een huidige diagnose van depressie vaak als één groep behandeld, terwijl 
ze door soms heel verschillende symptoomprofielen en ziektegeschiedenis 
worden gekenmerkt. Ook zijn de patiënten met verschillende angststoornissen 
als één groep behandeld en is geen onderzoek gedaan naar de specifieke 
angst-symptomen (paniek, sociale angst, extreme zorgelijkheid). Dit is een 
beperking van onze studie en we raden ook aan dat in toekomstige studies 
meer naar deze inter-individuele variatie gekeken wordt, mogelijk uitgebreid 
met een dimensionele typering. Een dimensionele benadering van depressie en 
angst kan mogelijk leiden tot een adequatere beschrijving van het symptoom- 
en het biologisch profiel, en daarmee tot een beter begrip van de complexe 
psychopathologie van depressie en angst. 
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